{"title": "PDF", "author": "PDF", "url": "https://edoc.ub.uni-muenchen.de/32306/2/Brombacher_Felix_Konstantin.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "  i Aus dem Institut f\u00fcr Allgemeinmedizin Klinik der Universit\u00e4t M\u00fcnchen Direktor: Prof. Dr. Jochen Gensichen  Interventionen zur Steigerung der  saisonalen Influenza-Impfquote bei chronisch Kranken in der  Allgemeinmedizin:  Ein systematischer Review Dissertation zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakult\u00e4t der Ludwig-Maximilians-Universit\u00e4t zu M\u00fcnchen  vorgelegt von Felix Konstantin Brombacher aus M\u00fcnchen 2023      Mit \tenehmigung der  Medizinischen Fakult\u00e4t der Universit\u00e4t M\u00fcnchen     Berichterstatter= \u0012ro$> Dr> \fochen \tensichen   Mitberichterstatter= \u0012ro$> Dr> \u0014al$ \u001aagner \u0012ro$> Dr> Eva \trill   Mitbetreuung durch die  -romovierte Mitarbeiterin=  Dr> Linda \u0015an$tenberg  Dekan= \u0012ro$> Dr> med> \u0016homas \tudermann   \u0016ag der m\u00fcndlichen \u0012r\u00fc$ung=  2M>0M>2023    \u001dusammen$assung \n $  AA ZZUUSSAAMMMMEENNFFAASSSSUUNNGG  II HH\u000b\u000b\u0010\u0010\u0016\u0016EE\u0014\u0014\t\t\u0014\u0014UU\u0010\u0010DD  /IFKQ BC8I<I  DG=<?CLE> J<iK<EJ M<IJ:?i<;<E<I I<EFDDi<IK<I \"I<Di<E M<I9C<i9<E ;i< $DG=HLFK<E ><><E ;i< J8iJFE8C< $E=CL<EQ8 iE \u001f<LKJ:?C8E; LE; Mi<C<E 8E;<I<E 'UE;<IE N<iK LEK<I ;<D <DG=F?C<E<E )iM<8L\n \u001d<\tJFE;<IJ ><=U?I;<K JiE; +8Ki<EK<E DiK :?IFEiJ:?<E 1FI<IBI8EBLE><E\b ;8 <iE< $E=CL<EQ8\t$E=<BKiFE 9<i i?E<E ?UL=i> <iE<E J:?N<I<E 1<IC8L= EiDDK LE; DiK <iE<I J:?C<:?K<I<E +IF>EFJ< 8JJFQii<IK iJK\n \u001f8 <iE \"IFYK<iC ;<I \u001cIQKBFEK8BK< MFE :?IFEiJ:? BI8EB<E +8Ki<EK<E DiK #8LJUIQK<E JK8KK=iE;<K\b 9i<K<K Ji:? ;i< \u001cCC><D<iED<;iQiE 8CJ D<;iQiEiJ:?<J 0D=<C; =XI $EK<IM<EKiFE<E QLI 1<I9<JJ<ILE> ;i<J<I .iKL8KiFE 8E\n IIII FF\u0014\u0014\u0002\u0002\t\tEE\u0015\u0015\u0016\u0016EELLLLUU\u0010\u0010\t\t  2<C:?< $EK<IM<EKiFE<E JiE; QLI .K<i><ILE> ;<I J8iJFE8C<E $E=CL<EQ8\t$DG=HLFK<E iE ;<I \u001cCC><D<iED<;iQiE 9<i :?IFEiJ:? &I8EB<E ><<i>E<K\u001b IIIIII MM\u0002\u0002\u0016\u0016EE\u0014\u0014\u000b\u000b\u0002\u0002LL  UU\u0010\u0010DD  MMEE\u0016\u0016\n\n\u0011\u0011DDEE\u0010\u0010  $D -8?D<E <iE<J JPJK<D8KiJ:?<E -<Mi<NJ <I=FC>K< <iE< D<K?F;iJ:?< 'iK<I8KLIJL:?< iE ;<E \u001f8K<E98EB<E ( \u001f'$) \b \u001e )/-\u001c'\b  (\u001d\u001c.  LE;  -$\u001e\n 5LJUKQCi:? NLI;<E -<=<I<EQ<E M<I>C<i:?98I<I \u001cI9<iK<E LE; .KL;i<EI<>iJK<I E8:? G8JJ<E;<E \u001cIKiB<CE ;LI:?JL:?K\n \"<E<I<CC NLI;<E ELI ;<LKJ:?\t F;<I <E>CiJ:?JGI8:?i>< I8E;FDiJi<IK< BFEKIFCCi<IK< .KL;i<E <EKJGI<:?<E; LEJ<I<I  iEJ:?CLJJBIiK<Ii<E 9<IX:BJi:?Ki>K\n \u001f8I8L=?iE <I\t=FC>K< <iE< 1FI8LJN8?C ;<I /iK<C LE; 5LJ8DD<E=8JJLE><E MFE QN<i LE89?UE>i><E \u001cLKFI<E\n $D N<iK<I<E 1<IC8L= NLI;<E ;i< 1FCCK<OK< ;<I <iE><J:?CFJJ<E<E \u001cI9<iK<E X9<IGIX=K\b I<C<M8EK< \u001f8K<E <OKI8?i<IK LE; <iE< \u001di8J\t\u001d<N<IKLE> MFI><EFDD<E\n \u001fi< &8K<>FIiJi<ILE> ;<I i;<EKi=iQi<IK<E $EK<IM<EKiFE<E <I=FC>K< LEK<I 8E;<\tI<D 8E?8E; MFE 5i<C>ILGG< LE; \u001cIK ;<I $EK<IM<EKiFE\b JFNi< ;<I \u001cEQ8?C ;<I ;8IiE <EK?8CK<E<E  iEQ<CBFD\tGFE<EK<E\n \u001cLY<I;<D <I=FC>K< <iE< \u001d<KI8:?KLE> ;<I (8YE8?D<E iE \u001c9?UE>i>B<iK ;<J \"<JLE;?<iKJJPJK<DJ LE; iE M<IJ:?i<;<E<E .L9>ILGG<E\n \u001f8J MFCCJKUE;i>< .KL;i<EGIFKFBFCC NLI;< MFI ;<I \u001fLI:?=X?ILE> iE +-*.\t+ -* M<IW==<EKCi:?K \u0006\u001e-\u001f\u0010\u000e\f\r\u0014\r\r\u0010\r\u0012\u000f\u0007\n IIVV EE\u0014\u0014\t\tEEBB\u0010\u0010\u000b\u000b\u0015\u0015\u0015\u0015EE  $EJ><J8DK BFEEK<E \u000e\u0014\u0015\u0011 .KL;i<E i;<EKi=iQi<IK N<I;<E\b ;8MFE NLI;<E \r\u0011 \u001cI9<iK<E iE ;i< 89J:?Ci<Y<E;< \u001f8\tK<E<OKI8BKiFE <iE><J:?CFJJ<E\n 0EJ<I< .KL;i<E Ni<J<E <iE< ?F?< #<K<IF><EiKUK 9<QX>Ci:? +8Ki<EK<EGFGLC8KiFE\b $EK<IM<EKiFEJ8IK\b \"<JLE;?<iKJJPJK<D LE; .KL;i<EHL8CiKUK 8L=\n  .i<9<E .KL;i<E LEK<IJL:?K<E $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C\b NF9<i '<?IM<I8EJK8C\tKLE><E =XI D<;iQiEiJ:?< /<8DJ 9<JFE;<IJ GFJiKiM< -<JLCK8K< Q<i>K<E\b N<EE Ji< 8L= ;i< 1FCCM<IJFI>LE> <iE<J 9<JKiDDK<E &I8EB?<iKJ9iC;<J 8LJ><Ii:?K<K N8I<E\n \u001c:?K .KL;i<E Q<EKIi<IK<E i?I< \u001cEJUKQ< 8L= +8Ki<EK<E\b ?i<I9<i \u001dusammen$assung \n   $$ Ni<J<E G<IJFE8CiJi<IK<  IiEE<ILE><E =XI +8Ki<EK<E <iE<E QLJUKQCi:?<E )LKQ<E ><><EX9<I Ei:?K\tG<IJFE8CiJi<I\tK<E !FID<E ;<I +8Ki<EK<E<IiEE<ILE> 8L=\n  0EK<I 1<IJi:?<IK<E iE <iE<D E8KiFE8C<E \"<JLE;?<iKJ;i<EJK\b iE +8Ki<EK<E DiK \u001fi89<K<J D<CCiKLJ LE; iE +FGL\tC8KiFE<E DiK &FEKIFCC>ILGG<E\t$DG=HLFK<E MFE X9<I \u0012\u0011\u0003 BFEEK<E ><E<I<CC B<iE< Ji>Ei=iB8EK GFJiKiM<E -<JLC\tK8K< ><Q<i>K N<I;<E\n !XI BFDGC<O< \u001cEJUKQ< DiK D<?I 8CJ QN<i (<K?F;<E <I>89 Ji:? B<iE 1FIK<iC ><><EX9<I <iE=8:?<E $EK<IM<EKiFE<E\n  VV \u000e\u000e\u0005\u0005\n\nLLUU\u0015\u0015\u0015\u0015FF\u0011\u0011LL\t\tEE\u0014\u0014UU\u0010\u0010\t\tEE\u0010\u0010   J >i9K Mi<C< M<IJ:?i<;<E< .KI8K<>i<E\b LD ;i< $DG=HLFK<E ><><E J8iJFE8C< $E=CL<EQ8 9<i :?IFEiJ:? &I8EB<E iE ;<I +IiDUIM<IJFI>LE> QL M<I9<JJ<IE\n '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ J:?<iE<E ;89<i ><<i>\tE<K\b ;i<  iEJK<CCLE> ><><EX9<I ;<I $E=CL<EQ8\t$DG=LE> GFJiKiM QL 9<<iE=CLJJ<E\n +<IJFE8CiJi<IK<  IiEE<ILE>J\tJPJK<D< =XI +8Ki<EK<E <I?W?<E F==<E98I ;i< \"C8L9NXI;i>B<iK ;<I 9<I<iK><JK<CCK<E $E=FID8KiFE\b <EKJGI<:?<E; <iE<I G<IJWECi:?<E $DG=<DG=<?CLE> ;LI:? ;<E \u001cIQK\n \u001f8 ;i< $DGC<D<EKi<ILE> BFDGC<O<I $EK<IM<EKiFE<E Ei:?K ;LI:? <EKJGI<:?<E; >IWY<I<  ==<BK< ><I<:?K=<IKi>K NiI;\b J:?<iE<E <iE=8:?< \u001cEJUKQ< =XI ;i< +IiDUIM<I\tJFI>LE> MFE :?IFEiJ:? &I8EB<E ><<i>E<K<I QL J<iE\n +8Ki<EK<E<IiEE<ILE>JJPJK<D< JiE; ;<E (8YE8?D<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C iE i?I<I  ==iQi<EQ N8?IJ:?<iECi:? X9<IC<><E\n \u001fi< !LEBKiFE8CiKUK MFE $E\tK<IM<EKiFE<E iE ;<I \u001cCC><D<iED<;iQiE ?UE>K 8L:? MFD A<N<iCi><E \"<JLE;?<iKJJPJK<D LE; +8Ki<EK<EBCi<EK<C 89\n '8JJ<E Ji:? D<?I 8CJ \u0012\u0011\u0003 ;<I +8Ki<EK<E <iE<I +FGLC8KiFE 8L:? F?E< QLJUKQCi:?< (8YE8?D<E iDG=<E\b JF J:?<iE<E LEJ<I< $EK<IM<EKiFE<E QLI N<iK<I<E .K<i><ILE> ;<I $DDLEiJi<ILE>JI8K<E ELI 9<;iE>K ><<i>E<K\n \"ILE;C<><E; JiE; 8CJF $EK<IM<EKiFE<E iE ;<I #8LJ8IQKGI8OiJ QLI 1<I9<JJ<ILE> ;<I .iKL8KiFE =XI :?IFEiJ:? &I8EB< ;LI:?8LJ 8;UHL8K\b ;8J #<I;<EiDDLEiKUKJ\t)iM<8L NiI; Ji:? 8CC<I;iE>J ;LI:? JFC:?< (8YE8?D<E Ei:?K iDD<I <II<i:?<E C8JJ<E\n \u000bnhalt \n $$$  \u0003\u0003 \n\nNN\t\tAA\f\f\u0012\u0012   A Zusammenfassung ...................................................................................... I I Hintergrund ....................................................................................................................... I II Fragestellung ..................................................................................................................... I III Material und Methoden .................................................................................................... I IV Ergebnisse ......................................................................................................................... I V Schlussfolgerungen .......................................................................................................... II B Inhalt ....................................................................................................... III C Verzeichnisse ........................................................................................... VI I Vorbemerkungen ............................................................................................................ VI II Abk\u00fcrzungsverzeichnis ................................................................................................... VII III Abbildungsverzeichnis .................................................................................................... viii IV Tabellenverzeichnis .......................................................................................................... ix 1 Einleitung .................................................................................................. 2 1.1 Impfm\u00fcdigkeit .............................................................................................................. 2 1.2 Influenza ....................................................................................................................... 2 1.2.1 Pathologie ......................................................................................................................... 2 1.2.2 Symptome und Diagnostik ................................................................................................ 4 1.2.3 Therapie ............................................................................................................................ 4 1.2.4 Prognose, Epidemiologie und globale Bedeutung ............................................................ 4 1.3 Die Influenza-Impfung .................................................................................................. 5 1.3.1 Funktionsprinzip und Herstellung ..................................................................................... 5 1.3.2 Empfehlung ....................................................................................................................... 6 1.3.3 Sicherheit und Wirksamkeit .............................................................................................. 9 1.3.4 Akzeptanz und Umsetzung der Empfehlungen in der Bev\u00f6lkerung der OECD - L\u00e4nder . 10 1.4 Zielsetzungen der Arbeit ............................................................................................ 10 2 Methoden ............................................................................................... 11 2.1 Der systematische Review .......................................................................................... 11 2.2 Vorrecherche .............................................................................................................. 11 2.3 Studienprotokoll und Einschlusskriterien ................................................................... 11 2.3.1 Protokoll .......................................................................................................................... 11 \u000bnhalt \n   $1 2.3.2 Studien ............................................................................................................................ 13 2.3.3 Patienten ......................................................................................................................... 13 2.3.4 \nnterventionen ................................................................................................................. 13 2.3.5 Outcomes ........................................................................................................................ 14 2.3.6 Setting ............................................................................................................................. 14 2.4 \titeratursuche ............................................................................................................. 14 2.4.1 Algorithmus ..................................................................................................................... 14 2.4.2 Durchf0hrung .................................................................................................................. 16 2.5 Studienselektion ......................................................................................................... 1; 2.5.1 Titel-Abstract-Selektion ................................................................................................... 16 2.5.2 \u0016ollte3t-Beschaffung ....................................................................................................... 16 2.5.3 \u0016ollte3t-Selektion ............................................................................................................ 1C 2.; \fualit\u0016tsbewertung .................................................................................................... 1< 2.6.1 Cochrane \u0012isk of Bias Tool ............................................................................................... 1C 2.6.2 P\u0012\nS\rA-Leitlinie .............................................................................................................. 1C 2.6.3 \u0011ualit\u00e4tsfaktor ................................................................................................................ 1D 2.6.4 Umgang mit Cluster-\u0012andomisierung ............................................................................. 1D 2.6.5 \u0016erzerrungsrisiko 0ber die Studien hin2eg .................................................................... 1D 2.< Datensammlung .......................................................................................................... 1> 2.C.1 Datene3traktion .............................................................................................................. 19 2.C.2 Statistische \rethoden .................................................................................................... 19 2.= Datensynthese ............................................................................................................ 20 2.D.1 \u000bontrollgruppen .............................................................................................................. 20 2.D.2 Aus2ahl des Effektma-es ............................................................................................... 20 2.D.3 \bruppierung der \nnterventionen ..................................................................................... 20 2.D.4 Darstellung der Daten ..................................................................................................... 22 $ Erge\u000fnisse ............................................................................................... 2& 3.1 Auswahlprozess .......................................................................................................... 25 3.2 \u0011berlick \u00fcber eingeschlossene Studien ...................................................................... 25 3.2.1 Allgemeines ..................................................................................................................... 25 3.2.2 \besundheitspolitischer \u0012ahmen ..................................................................................... 29 3.2.3 Patienten ......................................................................................................................... 29 \u000bnhalt \n 1  3.2.4 \nnterventionen ................................................................................................................ 31 3.2.5 \u0016erzerrungsrisiko ............................................................................................................ 32 3.3 Effektivit\u0016t der Interventionen ................................................................................... 34 3.3.1 Effektivit\u00e4t \u000each \u000bategorien ........................................................................................... 34 3.3.2 Effektivit\u00e4t nach \besundheitssystem und Setting ........................................................... 39 3.3.3 Effektivit\u00e4t nach \u000bontrollgruppen-\nmpf*uote ................................................................. 42 3.3.4 Effektivit\u00e4t nach spezifischer \brunderkrankung ............................................................. 42 % \u0005is\u0017ussion ............................................................................................... %% 4.1 Einordnung der Ergebnisse und Schlussfolgerungen ................................................. 44 4.1.1 Allgemeines ..................................................................................................................... 44 4.1.2 \nnterventionen mit Fokus auf medizinischem Personal .................................................. 44 4.1.3 \nnterventionen mit Fokus auf Patienten ......................................................................... 45 4.1.4 \u000bomple3it\u00e4tsgrad der \nntervention ................................................................................. 4C 4.1.5 Wirksamkeit der \nnterventionen in \u0012elation zum \besundheitssystem ........................... 4C 4.1.6 Wirksamkeit der \nnterventionen in verschiedenen Subgruppen .................................... 4D 4.1.C Ceiling Effect ................................................................................................................... 49 4.2 \timitationen ............................................................................................................... 51 4.2.1 \benerelle Limitationen .................................................................................................... 51 4.2.2 Publikation-Bias ............................................................................................................... 51 4.2.3 \u0012andomisierungs-\rechanismen ..................................................................................... 52 4.2.4 Heterogenit\u00e4t .................................................................................................................. 52 4.3 Fazit ............................................................................................................................ 54 \u0005 Eidesstattliche Versicherung ..................................................................... \fI E Anhang .................................................................................................... \fII I Durchgef\u00fchrte Suchen ................................................................................................... \u0013II 4.3.1 \u000bey2ord-Suchen ............................................................................................................. \u0018\n\n 4.3.2 Thesaurus-Suche ............................................................................................................ \u0018\n\n\n II Extrahierte Items ............................................................................................................ \u0013V III \u000bRISMA-\u0003heckliste ....................................................................................................... \u0013VII \u0007 \titeratur ................................................................................................. \f\fI \u0019erzeichnisse \n   1$ \u0004\u0004 \u0014\u0014EE\u0010\u0010ZZEE\n\n\u0004\u0004\t\tNN\n\nSSSSEE  II VV\u0011\u0011\u0014\u0014BBEEMMEE\u0014\u0014KKUU\u0010\u0010\t\tEE\u0010\u0010  ,L<CC<E8E>89<E <I=FC>K<E 8E8CF> ;<J 18E:FLM<I\t.KiCJ\n -<=<I<EQ8E>89<E iEE<I?8C9 <iE<J .8KQ<J 9<Qi<?<E Ji:? 8LJJ:?Ci<YCi:? 8L= ;<E J<C9i><E\b -<=<I<EQ8E>89<E E8:? <iE<D .8KQ 8L= ;<E MFI?<Ii><E \u001c9J8KQ\b 9QN\n ;i< MF\tI8LJ><?<E;< .8KQ=FC><\n 2WIKCi:?< 5iK8K< NLI;<E DiK \u001cE=X?ILE>JQ<i:?<E D8IBi<IK\n \u001fi< MFICi<><E;< \u001cI9<iK LEK<IJL:?K <iE iEK<IE8KiFE8C<J !FIJ:?LE>J=<C; LE; 9<KI8:?K<K +L9CiB8KiFE<E 8LJ Mi<C<E M<IJ:?i<;<E<E 'UE;<IE\n  iE \"IFYK<iC ;<I M<IN<E;<K<E 'iK<I8KLI JK8DDK 8LJ <E>CiJ:?JGI8:?i><E 5<iKJ:?Ii=K<E\n 5iK8KiFE 8LJ JFC:?<I 'iK<I8KLI <I=FC>K< iE iE;iI<BK<I !FID DiK G8I8CC<C<I T9<IJ<KQLE>\n 5LI 1<I9<JJ<ILE> ;<I '<J98IB<iK LE; QLI 1<ID<i;LE> MFE (iJJiEK<IGI<K8KiFE<E NLI;<E iD !8:?><9i<K 8E<IB8EEK< \u001d<>Ii==Ci:?B<iK<E 8LJ ;<D  E>CiJ:?<E K<iCN<iJ< X9<IEFDD<E\b =8CCJ B<iE< >C<i:?N<IKi>< ;<LKJ:?< T9<IJ<KQLE> QL =iE;<E N8I\n  \u001cLJ \"IXE;<E ;<I C<i:?K<I<E '<J98IB<iK NiI; iE ;<I MFICi<><E;<E \u001fiJJ<IK8KiFE ;i< ><NF?EK< DUEECi:?< .GI8:?=FID 9<i G<IJFE<E9<QF><E<E .L9JK8EKiM<E LE; +IFEFD<E M<IN<E;<K\n \u001fi<J iDGCiQi<IK A<;F:? B<iE< \u001d<E8:?K<iCi>LE> ;<J N<i9Ci:?<E \"<J:?C<:?KJ\b JFE;<IE JFCC iD .iEE< ;<I JGI8:?Ci:?<E 1<I<iE=8:?LE> 8CJ ><\tJ:?C<:?KJE<LKI8C QL M<IJK<?<E J<iE\n   \u0019erzeichnisse  \n  1$$ IIII \u0002\u0002BBKK\u0018\u0018\u0014\u0014\u001d\u001dUU\u0010\u0010\t\t\u0015\u0015\u0019\u0019EE\u0014\u0014\u001d\u001dEE\u000b\u000b\u0005\u0005\n\n\u0010\u0010\u000b\u000b\u0015\u0015  \u001c\u001c!+ \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n American Association of Family Physicians \u001c\u001e$+ \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Advisory Comitee of Immunization Practices \u001d(% \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n British Journal of Medicine \u001e\u001f\u001e \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Center for Disease Control \u001e$  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Konfidenzintervall :)1 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n chronisches Nierenversagen \u001e*).*-/ \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Consolidated Standards of Reporting Trials \u001e*+\u001f \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Chronical obstructive pulmonary disease, chronisch obstruktive Lungenerkrankung \u001f( \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Diabetes mellitus  +*\u001e \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Cochrane Effective Practice and Organization of Care Group !\u001d \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Felix Brombacher #(* \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Health Maintenance Organization %\" \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Prof. Dr. med. Dipl.-p\u00e4d. Jochen Gensichen, MPH B#& \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n koronare Herzkrankheit LS \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Dr. rer. nat. Linda Sanftenberg (\u001e* \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Managed care organization\b Managed Care Organization * \u001e\u001f \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Organisation for Economic Cooperation and Developement +\u001e- \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Polymerase chain reaction, Polymerase-Kettenreaktion +-$.(\u001c \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Transparent Reporting of Systematic Reviews and Meta-Analysis +-*.+ -* \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n International prospective register of systematic reviews ,! \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Qualit\u00e4tsfaktor -- \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Risk ratio ./$&* \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n St\u00e4ndige Impfkommission am Robert-Koch-Institut K)1 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n terminales Nierenversagen 0).\u001f \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n United Nations Statistics Division 2#* \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n World Health Organization\b World Health Organization \u0002bk\u00fcrzungen< \u0002bbildungen und \u0016abellen \n   Miii  IIIIII \u0002\u0002BBBB\u000b\u000bLLDDUU\u0010\u0010\t\t\u0015\u0015\u0019\u0019EE\u0014\u0014\u001d\u001dEE\u000b\u000b\u0005\u0005\n\n\u0010\u0010\u000b\u000b\u0015\u0015   \u001c99iC;LE> \r _ \"IXE;< =XI ;8J 1<IJULD<E MFE $DG=LE><E\b E8:? \u001d<KJ:? \u0004 .:?Di; <K 8C\n 6\u0014\b\u00157 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f \u001c99iC;LE> \u000e _ \u001fi< =XE= .:?IiKK< ;<I  9(\b E8:? -\n (W?C<I 6\r7 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \r\u000e \u001c99iC;LE> \u000f _ \"ILGGi<ILE> ;<I $EK<IM<EKFE<E DiK !FBLJ 8L= +8Ki<EK<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\r \u001c99iC;LE> \u0010 _ \"ILGGi<ILE> ;<I $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\r \u001c99iC;LE> \u0011 _ T9<IJi:?K QLI .KL;i<E8LJN8?C\b E8:? +-$.(\u001c 6\u0011\u00147\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\u0012 \u001c99iC;LE> \u0012 _ T9<IJi:?K X9<I <iE><J:?CFJJ<E< \u001cCK<IJ>ILGG<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f\f \u001c99iC;LE> \u0013 _ T9<IJi:?K X9<I ;i< >IWYK<E <iE><J:?CFJJ<E<E  IBI8EBLE>J>ILGG<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f\f \u001c99iC;LE> \u0014 _ T9<IJi:?K X9<I ;i< -iJB\tF=\t9i8J\t\u001d<N<IKLE> ;<I <iE><J:?CFJJ<E<E .KL;i<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f\u000f \u001c99iC;LE> \u0015 _ !FI<JK +CFK\u0016  ==<BKiMiKUK MFE $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C \n\n\n\n\n\n\n\n\n\n\n \u000f\u0011 \u001c99iC;LE> \r\f _ !FI<JK +CFK\u0016  ==<BKiMiKUK MFE $EK<IM<EKiFE<E DiK ;<D !FBLJ 8L= +8Ki<EK<E\b E8:? &8K<>FIi<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f\u0013 \u001c99iC;LE> \r\r _ !FI<JK +CFK\u0016  ==<BKiMiKUK MFE $EK<IM<EKiFE<E DiK ;<D !FBLJ 8L= +8Ki<EK<E\b E8:? QLJUKQCi:?<E $E?8CK<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000f\u0014 \u001c99iC;LE> \r\u000e _ \u001f8IJK<CCLE> ;<I $EK<IM<EKiFE<E iE -<C8KiFE QLD A<N<iCi><E \"<JLE;?<iKJJPJK<D \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0010\f \u001c99iC;LE> \r\u000f _ \u001f8IJK<CCLE> ;<I  ==<BK>IWY< iE \u001c9?UE>i>B<iK ;<I $DG=HLFK< ;<I &FEKIFCC>ILGG< \n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0010\r \u001c99iC;LE> \r\u0010 _ !FI<JK +CFK\u0016 T9<IJi:?K X9<I ;LI:?><=X?IK< .L9>ILGG<E8E8CPJ<E iE ;<E <iE><J:?CFJJ<E<E .KL;i<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0010\u000f \u001c99iC;LE> \r\u0011 _ \u001f8IJK<CCLE> ;<I  ==<BK>IWY< iE \u001c9?UE>i>B<iK ;<I $DG=HLFK< ;<I &FEKIFCC>ILGG< DiK D8OiD8C QL <II<i:?<E;<I  ==<BK>IWY< \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0011\f \u001c99iC;LE> \r\u0012 _ !LEE<C +CFK\u0016 $EK<IM<EKiFE<E DiK !FBLJ 8L= +8Ki<EK<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0011\u000f \u001c99iC;LE> \r\u0013 _ !LEE<C +CFK\u0016 $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0011\u000f     \n  iO IIVV \u000f\u000f\u0002\u0002BBEELLLLEE\u0010\u0010\u0019\u0019EE\u0014\u0014\u001d\u001dEE\u000b\u000b\u0005\u0005\n\n\u0010\u0010\u000b\u000b\u0015\u0015   /89<CC< \r _ &FEKI8iE;iB8KiFE<E ;<I $E=CL<EQ8\t$DG=LE> iE \u001c9?UE>i>B<iK ;<I $DG=JKF==8IK<E\b DF;i=iQi<IK E8:? \"IF?JBFG= <K 8C\n 6\u000e\u00107 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u0014 /89<CC< \u000e _ 1<IN<E;<K< .L:?9<>Ii==< iE ;<I &<PNFI;\t.L:?<\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \r\u0011 /89<CC< \u000f _ 1<IN<E;<K< .L:?9<>Ii==< iE ;<I /?<J8LILJ\t.L:?<\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \r\u0011 /89<CC< \u0010 _ \u001cE>89<E QLI ;LI:?><=X?IK<E .L:?JKI8K<>i< \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \r\u0011 /89<CC< \u0011 _ #8LGKKPG<E MFE \"<JLE;?<iKJJPJK<D<E DF;i=iQi<IK E8:? \u001dW?D <K 8C\n 6\u0012\u00147 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\u000f /89<CC< \u0012 _  I><9EiJX9<IJi:?K\u0016 $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\u0013 /89<CC< \u0013 _  I><9EiJX9<IJi:?K\u0016 $EK<IM<EKiFE<E DiK !FBLJ 8L= +8Ki<EK<E \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \u000e\u0014 /89<CC< \u0014 _  OKI8?i<IK< $K<DJ NU?I<E; ;<I \u001f8K<E<OKI8BKiFE\b E8:? +iKKC<I <K 8C\n 6\r\r\u00157 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n 31 /89<CC< \u0015 _ +-$.(\u001c\t\u001e?<:BCiJK< E8:? .?8DJ<<I 6\r\u000e\f7 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n 31$$   \u000bm-$m\u00fcdigkeit  \n \u000e  \u0016\u0016 EE\n\nNN\f\fEE\n\n\u0012\u0012UUNNGG  \u0019\u0019\u0015\u0015\u0019\u0019 IIMM\u0012\u0012FFMM\u0018\u0018DD\u000b\u000b\t\tKKEE\u000b\u000b\u0016\u0016   iED8C AU?ICi:? M<IW==<EKCi:?K ;i< 2#* ;i< >IWYK<E \u001d<;IF?LE><E =XI ;i< >CF98C< \"<JLE;?<iK ;<J =FC><E;<E %8?I<J\n !XI \u000e\f\r\u0015 ><?WIK< ?i<IQL <IJKD8CJ ;8J N<CKN<iK M<IJKUIBK< \u001cL=KI<K<E MFE $DG=DX;i>B<iK \u0006<E>C\n vaccine hesitancy\u0007 6\u000e7\n \u001f<I \u001d<>Ii== 9<Q<i:?E<K ;8J 1<IJULD<E MFE <DG=F?C<E<E .:?LKQiDG=LE><E QLD ><<i>E<K<E 5<iKGLEBK =XI Ji:? J<C9JK F;<I .:?LKQ9<=F?C<E<\b KIFKQ 8LJI<i:?<E;<I 1<I=X>98IB<iK 6\u000f7\n   \"ILE;C<><E; M<IJ:?C<:?K<IK $DG=DX;i>B<iK ;<E $DDLEiJi<ILE>JJK8KLJ ;<I \u001d<MWCB<ILE>\n $DG=HLFK<E JK8>\tEi<I<E F;<I =8CC<E CFB8C 9<>I<EQK 8L= iEJL==iQi<EK< 2<IK< 89\n !FC>Ci:? BFDDK <J QLD M<ID<?IK<E \u001cL=KI<K<E iDG=GIUM<EK89C<I  IBI8EBLE><E\b iE !FID MFE CFB8C 9<>I<EQK<E F;<I G8E;<DiJ:?<E \u001cLJ9IX:?<E\n \u001d<iJGi<C?8=K ?i<I=XI iJK ;i< #UL=LE> MFE (8J<IE=UCC<E \u000e\f\r\u0014\u000b\u000e\f\r\u0015 iE  LIFG8 6\u0010\b \u00117\b N<C:?< <iE< \u001fiJBLJJiFE X9<I ;i<  iE\t=X?ILE> <iE<I G8IKi<CC<E $DG=G=Ci:?K iE;LQi<IK< 6\u00127\n   \u001cLJ9IX:?< 9<;IF?<E Ei:?K ELI ;i< \u001cCC><D<iE9<MWCB<ILE>\b JFE;<IE JK<CC<E iEJ9<JFE;<I< <iE< \"<=8?I =XI MLC\tE<I89C< +FGLC8KiFE<E ;8I\n .FC:?< +8Ki<EK<E <I=8?I<E ?UL=i> 9<JFE;<IJ D8Ei=<JK< &I8EB?<iKJM<ICUL=< DiK J:?C<:?K<I +IF>EFJ<\n \u001cLY<I;<D 9<<iE=CLJJ<E \u001cLJ9IX:?< MFE $E=<BKiFEJBI8EB?<iK<E Ni< ;<I $E=CL<EQ8 ;i< (FIK8CiKUK iE 8E=UCCi><E +8Ki<EK<E>ILGG<E 6\u00137\n   \"IXE;< 8L= .<iK<E ;<I +8Ki<EK<E JiE; <iE< Ei<;Ii>< $DG=9<I<iKJ:?8=K 8L=>ILE; MFE B8K<>FIiJ:?<I F;<I G8IKi\t<CC<I \u001c9C<?ELE>\b 9<iJGi<CJN<iJ< ;LI:? \u001diC;LE>JCX:B<E\b JFNi< )8:?CUJJi>B<iK<E\n $E \u001c99iC;LE> \r =iE;<E Ji:? M<IJ:?i<;<E< \"IXE;< =XI $DG=DX;i>B<iK 8LJ ;<D \u0010\u001e\t(F;<C MFE \u001d<KJ:? <K 8C\n 6\u0014\b \u00157\n \u001cL= .<iK<E ;<I RIQK< LE; ;<J D<;iQiEiJ:?<E +<IJFE8CJ iJK F=K D8E><CE;< \u001cL=D<IBJ8DB<iK 9<QX>Ci:? ;<J $DG=JK8KLJ F;<I <iE< G8I\tKi<CC< $DG=JB<GJiJ MFI?8E;<E\n \u001fi< UIQKCi:?< $E;iB8KiFEJJK<CCLE> FIi<EKi<IK Ji:? ?UL=i> MFII8E>iE> 8E ;<I G<I\tJWECi:?<E  iEJK<CCLE>\b 8L:? ?i<I B8EE 9<iJGi<CJN<iJ< LEQLCUE>Ci:?<J #iEK<I>ILE;NiJJ<E LIJU:?Ci:? J<iE\n 6\r\f_\r\u000f\b \u00157  \u0019\u0019\u0015\u0015\u001a\u001a II\u0010\u0010FFLLUUEE\u0010\u0010\u001d\u001d\u0002\u0002  11..22..11 PPAATTHHOOLLOOGGIIEE  \u001fi< J8iJFE8C< $E=CL<EQ8 iJK <iE< $E=<BKiFEJBI8EB?<iK ;<J (<EJ:?<E\b N<C:?< iE ;<I -<><C ;LI:? $E=CL<EQ8MiI<E ;<I \"8KKLE> \u001c F;<I \u001d M<ILIJ8:?K NiI;\n 0D>8E>JJGI8:?Ci:? 8L:? echte Grippe ><E8EEK\b iJK Ji< 8CJ GFK<EQi<CC C<9<EJ9<;IF?Ci:?<  IBI8EBLE> MFE ;<E >IiGG8C<E $E=<BK<E\b DiK I<><C?8=K ;<LKCi:? DiC;<I<E 1<ICUL=<E 89QL\t>I<EQ<E\n \u001fi< T9<IKI8>LE> MFE (<EJ:? QL (<EJ:? <I=FC>K D<iJK X9<I /IWG=:?<E\t F;<I .:?Di<IiE=<BKiFE\b J<CK<E<I ;iI<BK X9<I .G<i:?<C\n \u001cL:? B8EE <iE< T9<IKI8>LE> MFE 2iIK F;<I 1<BKFI 8L= ;<E (<EJ:?<E X9<I &FK <I=FC><E\n \u001f8J 1iILJ X9<IC<9K LEK<I X9Ci:?<E /<DG<I8KLI<E J<?I C8E>< 8L= Mi<C<E *9<I=CU:?<E LE;    \u000bn$luenza  \n \u000f                \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??  88  \b\b'',,\"\"\u0018\u0018\u0019\u0019  \u001a\u001a,,''  \u0018\u0018\u0014\u0014((  \u0013\u0013\u0019\u0019''((\u0015\u0015++!!\u0019\u0019\"\"  --##\"\"  \n\n!!%%\u001a\u001a++\"\"\u001b\u001b\u0019\u0019\"\"44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \u0003\u0003\u0019\u0019**((\u0017\u0017\u001c\u001c  ;;  \u000f\u000f\u0017\u0017\u001c\u001c!!\u001d\u001d\u0018\u0018  \u0019\u0019**  \u0014\u0014  66  99FF44GG::    HH>>  DDiiee  sseellbbssttzzuu$$rriieeddeenneenn  \u000b\u000bggnnoorraanntteennCC\u0005\u0005oomm--llaacceenncc88DDFehlendes Bewusstsein f\u00fcr die Gef\u00e4hrlichkeit von impfpr\u00e4ventablen Erkrankungen und die Notwendigkeit von Impfungen22>>  DDiiee  \u000b\u000bmm--$$kkrriittiikkeerrCC\u0005\u0005oonn$$iiddeenncceeDDFehlendes Vertrauen in die Sicherheit von Impfungen, Impfkritik\n33>>  DDiiee  \u0010\u0010uuttzzeennaabbww\u00e4\u00e4ggeerrCC\u0005\u0005aallccuullaattiioonnDDNutzen-Risiko Abw\u00e4gungKK>>  DDiiee  bbee..uueemmeenn  \t\teessttrreesssstteennCC\u0005\u0005oonnvveenniieenncceeDDBequemlichkeit, VergesslichkeitIIMMPPFFMM\u00dc\u00dcDDIIGGKKEEIITT\u000bn$luenza  \n \u0010  D<?I<I< .KLE;<E 8CJ \u001c<IFJFC iE ;<I 'L=K\b N8J J<iE< ?F?< 1iILC<EQ LE; ;i< +FK<EQ QLI \u001cLJCWJLE> >IFY<I &I8EB?<iKJN<CC<E 9<;iE>K\n .iE; &I8EB?<iKJ<II<><I X9<I .:?C<iD?ULK< ;<J -<JGiI8KiFEJKI8BK<J F;<I ;i< \u001cL><E iE ;<E &WIG<I ><C8E>K\b 9<KIU>K ;i< $EBL98KiFEJQ<iK QNiJ:?<E <iE<D LE; Mi<I /8><E\n \u001f8J /I8><E <iE<J <iE=8\t:?<E (LE;J:?LKQ<J 9i<K<K B<iE< .i:?<I?<iK MFI \u001cEJK<:BLE>\b ;8 ;i< +8IKiB<C F=K QL BC<iE LE; ;i< \u001cL><E Ei:?K 9<;<:BK JiE;\n 6\r\u0010\b \r\u00117 11..22..22 \u0013\u0013\u001c\u001c\u000e\u000e\u0012\u0012TTOO\u000e\u000eEE\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001\u0005\u0005IIAAGG\u000f\u000fOO\u0015\u0015TTII\f\f  \u001fi< &I8EB?<iK 9<>iEEK iE ;<I -<><C GCWKQCi:? DiK ?F?<D !i<9<I\b 8LJ><GIU>K<D &I8EB?<iKJ><=X?C\b !8Ki>L<\b LEJG<Qi=iJ:?<D  OKI<DiKUK<EJ:?D<IQ LE; .:?XKK<C=IFJK 8CJ 8CC><D<iE<E .PDGKFD<E\n *I>8EJG<Qi=iJ:? =8CC<E F=K \u001e<G?8C>i<E\b \u001cGG<KiKCFJi>B<iK\b )8LJ<8\b  D<JiJ\b \u001fi8II?W<E JFNi< <iE LEGIF;LBKiM<I #LJK<E 8L=\n  6\r\u0010\b \r\u00117 \u001fi< 8BKL<CC< '<iKCiEi< ;<I $\u001f.\u001c \u0006$E=<:KiFLJ \u001fiJ<8J<J .F:i<KP F= \u001cD<Ii:8\u0007 JGIi:?K =XI ;i< \u001fi8>EFJKiB ;<I $E\t=CL<EQ8 =FC><E;<  DG=<?CLE><E 8LJ\u0016 \"ILE;C<><E; JFCCK< D<;iQiEiJ:?<J +<IJFE8C 9<i A<;<D +8Ki<EK<E DiK GCWKQCi:?<D  IBI8EBLE>J9<>iEE iE &FD9iE8KiFE DiK ?F?<D !i<9<I F;<I D8Ei=<JK<E I<JGiI8KFIiJ:?<E .PDG\tKFD<E <iE< DW>Ci:?< $E=CL<EQ8\t IBI8EBLE> iE \u001d<KI8:?K Qi<?<E\n  iE 8BKL<CC<I $DG=JK8KLJ J:?Ci<YK <iE<  I\tBI8EBLE> Ei:?K 8LJ\n \u001f<I  II<><IE8:?N<iJ 8LJ \u001c9JKIi:?<E ;<I )8J<E?W?C< F;<I '8M8><\t.<BI<K<E JFCCK< ELI 9<i K?<I8G<LKiJ:?<I F;<I FI>8EiJ8KFIiJ:?<I &FEJ<HL<EQ iD !8CC< <iE<J GFJiKiM<E  I><9EiJJ<J ;LI:?><=X?IK N<I;<E\n \u001d<iJGi<C< ?i<I=XI NUI<E ;i< $JFCi<ILE> ;<J  IBI8EBK<E QLD .:?LKQ< MFE (iKG8Ki<EK<E iD JK8KiFEUI<E \u001d<I<i:? F;<I ;i< K?<I8G<LKiJ:?< LE; GIFG?PC8BKiJ:?< \u001d<?8E;CLE> MFE +8Ki<EK LE; E8?<JK<?<E;<E +<IJFE<E DiK 8EKiMiI8C<E (<;iB8D<EK<E\n !UCCK ;i<  EKJ:?<i;LE> =XI <iE<E )8:?N<iJM<IJL:? iD '89FI\b JF iJK ;i< +\u001e- \u0006+FCPD<I8J< :?8iE I<8:KiFE\b +FCPD<I8J<\t&<KK<EI<8BKiFE\u0007 ;i< ?i<I=XI 9<MFIQL>K< (<K?F;<\n \u001f8 <iE< JG<Qi=iJ:?< /?<I8Gi< iE Mi<C<E !UCC<E Ei:?K EFKN<E;i> iJK\b B8EE F=K 8L= <iE<E  II<><IE8:?N<iJ M<IQi:?K<K N<I;<E\n 6\r\u00127 11..22..\u001f\u001f \u0014\u0014HHEE\u0014\u0014AA\u0012\u0012IIEE  \u001fi< /?<I8Gi< ;<I $E=CL<EQ8 <I=FC>K GIiDUI JPDGKFD8KiJ:?\n  iE< D<;iB8D<EKWJ< 8EKiMiI8C< \u001d<?8E;CLE> B8EE 9iJ JGUK<JK<EJ \u0010\u0014 .KLE;<E E8:? &I8EB?<iKJ9<>iEE <I=FC><E\b N<EE +8Ki<EK<E 8L=>ILE; ;<I .:?N<I< i?I<I  I\tBI8EBLE> ?FJGiK8CiJi<IK NLI;<E F;<I 9<i i?E<E MFE <iE<D ?F?<E &FDGCiB8KiFEJIiJiBF 8LJ><>8E><E N<I;<E DLJJ\n \u001f<EEF:? Ci<>K ;<I !FBLJ ;<I /?<I8Gi< iE ;<I -<><C 8L= !CXJJi>B<iKJJL9JKiKLKiFE LE; .K89iCiJi<ILE> MFE 1iK8CG8I8D<K<IE Ni< ;<I &WIG<IK<DG<I8KLI\n \u001cL:? ;8J iEJKiKLKiFE<CC< \u001cLJ9IL:?JD8E8><D<EK QLI 1<ID<i;LE> N<iK<I<I \u001cEJK<:BLE> DiK ;<D 1iILJ JGi<CK <iE< >IFY< -FCC<\n 6\r\u00127 \u001cL=>ILE; ;<I <iE><J:?IUEBK<E JG<Qi=iJ:?<E /?<I8Gi<DW>Ci:?B<iK<E <I?UCK ;i< +IUM<EKiFE ;<I  IBI8EBLE> ;LI:? $DDLEiJi<ILE> <iE< Q<EKI8C< \u001d<;<LKLE>\n 11..22..   PP\u0014\u0014OOGG\u000f\u000fOO\u0015\u0015EE\u0018\u0018\u0001\u0001\u0006\u0006\u0012\u0012II\u0006\u0006EE\u000e\u000eIIOOLLOOGGIIEE\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001GGLLOO\u0004\u0004AALLEE\u0001\u0001\u0003\u0003EE\u0006\u0006EE\u0017\u0017TT\u0017\u0017\u000f\u000fGG  0E><=U?I \u0011\f\u0003 ;<I $E=iQi<IK<E <I=8?I<E <iE< JPDGKFD8KiJ:?< (8Ei=<JK8KiFE\b MFE ;i<J<E ?i<I9<i \u0015\f\u0003 <iE<E DiC;<E LE; ELI \r\f\u0003 <iE<E J:?N<I<E &I8EB?<iKJM<IC8L=\n \u001cCC<I;iE>J iE=iQi<I<E Ji:? NU?I<E; <iE<I KPGiJ:?<E Die \u000bn$luenza-\u000bm-$ung  \n \u0011  $E=CL<EQ8\t.8iJFE 9iJ QL \u000e\f\u0003 ;<I \u001d<MWCB<ILE> DiK ;<D 1iILJ\b NF;LI:? iEJ><J8DK <iE< ?F?< 89JFCLK< 58?C  8E +8Ki<EK<E J:?N<I< 1<ICUL=< <I=U?IK\n 0EK<I 9<JFE;<IJ MLCE<I89C<E +FGLC8KiFE<E BFDDK <J QL <iE<I JF><\tE8EEK<E  OQ<JJDFIK8CiKUK\n 6\r\u00117 b\u001fi< ;LI:?J:?EiKKCi:?< J8iJFE8C< $E=CL<EQ8 M<ILIJ8:?K iE \u001f<LKJ:?C8E; QNi\tJ:?<E \u000e LE; \u000f (iCCiFE<E QLJUKQCi:?< \u001cIQKBFEJLCK8KiFE<E\b <KN8 \r\f\u0005\f\f\f 9iJ \u000e\f\u0005\f\f\f QLJUKQCi:?< #FJGiK8CiJi<ILE\t><E LE; ;LI:?J:?EiKKCi:? \u0014\u0005\f\f\f 9iJ \r\r\u0005\f\f\f QLJUKQCi:?< /F;<J=UCC<\n \u001fi<J< 58?C NiI; 9<i 8LY<I><NW?ECi:? JK8I\tB<I $E=CL<EQ8\t\u001cBKiMiKUK Ni< Q\n\u001d\n iE ;<I .8iJFE \r\u0015\u0015\u0011\u000b\u0015\u0012 ;<LKCi:? X9<IJ:?IiKK<E LE; B8EE 9iJ QL \u000f\f\u0005\f\f\f  OQ<JJ\t/F;<J=UCC< <II<i:?<E\n\u0002 6\r\u00117 \u001cCC<iE< iE \u001d<ICiE B8D <J NU?I<E; ;<I $E=CL<EQ8\t.8iJFE \u000e\f\r\u0013\u000b\r\u0014 QL D<?I 8CJ \ra\r\f\f  OQ<JJ\t/F;<J=UCC<E\b N8J <iE<I (FIK8CiKUK MFE \u000f\u000e GIF \r\f\fa\f\f\f  iENF?E<I <EKJGIi:?K 6\r\u00137\n *=K 9<KIi==K <iE >IFY<I \u001cEK<iC ;<I 5LJ8KQ9<C8JKLE> ;LI:? ;i< J8iJFE8C< $E=CL<EQ8 ;i< \u001cCC><D<iED<;iQiE\n \u001d<i\tJGi<CJN<iJ< BFEEK<E iE \"IFY9IiK8EEi<E MFE \r\u0015\u0015\u0011 9iJ \u000e\f\f\u0015 ;LI:?J:?EiKKCi:? X9<I \u0014\f\fa\f\f\f QLJUKQCi:?< \u001cCC><\tD<iE8IQK\t&FEJLCK8KiFE<E GIF .8iJFE DiK $E=CL<EQ8\t\u001d<QL> <I=8JJK N<I;<E 6\r\u00147\n  +8Ki<EK<E\b ;i< 8L=>ILE; :?IFEiJ:?<I  IBI8EBLE> ;<I #F:?IiJiBF>ILGG< 8E><?WI<E\b ?89<E NU?I<E; <iE<I $E\t=CL<EQ8\t$E=<BKiFE <iE ;<LKCi:? <I?W?K<J #FJGiK8CiJi<ILE>JIiJiBF\n  iE< .K<i><ILE> LD ;8J \u0014\n\u0015\t=8:?< NLI;< 9<i\tJGi<CJN<iJ< iE +8Ki<EK<E QNiJ:?<E \u0011\f LE; \u0012\u0010 %8?I<E =<JK><JK<CCK 6\r\u00157\n \u001fi< +IF>EFJ< NU?I<E; <iE<I #FJGiK8Ci\tJi<ILE> M<IJ:?C<:?K<IK Ji:? DiK QLE<?D<E;<D \u001cCK<I LE; QLE<?D<E;<I \u001cEQ8?C ;<I &FDFI9i;iKUK<E\n  iE< .KL;i< LEK<IJL:?K< +8Ki<EK<E iD \u001cCK<I X9<I \u0012\u0011 %8?I<E DiK ?F?<I :?IFEiJ:?<I  IBI8EBLE>JC8JK LE; #FJGiK8Ci\tJi<ILE> 8L=>ILE; <iE<I $E=CL<EQ8\t IBI8EBLE>\n \u001fi< #UC=K< ;<I +8Ki<EK<E DLJJK< 8L= <iE<I $EK<EJiMJK8KiFE 9<\t?8E;<CK LE; <iE \u001fIiKK<C D<:?8EiJ:? 9<8KD<K N<I;<E\b <iE 1i<IK<C ;<I +8Ki<EK<E JK8I9 NU?I<E; ;<J &I8EB<E\t?8LJ8L=<EK?8CK<J\n 6\u000e\f7 \u001fi< GFK<EKi<CC<E \u001cLJNiIBLE><E MFE >IFY<E $E=CL<EQ8\t Gi;<Di<E M<I8EJ:?8LCi:?K ;i< .G8EiJ:?< \"IiGG<\b N<C\t:?< iD %8?I \r\u0015\r\u0014 N<CKN<iK X9<I \u0010\f (iCCiFE<E /F;<JFG=<I =FI;<IK< 6\r\u00117\n $E Mi<C<E 'UE;<IE JK<i><E ;i< 58?C ;<I :?IFEiJ:?<E  IBI8EBLE><E LE; ;8J \u001cCK<I ;<I (<EJ:?<E J<iK %8?I<E BFEJK8EK 8E\b ;<I 0D=8E> MLCE<I89C<I +8Ki<EK<EGFGLC8KiFE<E EiDDK ;<D<EKJGI<:?<E; QL\n \u001cL:? =iE;<K iD 5L>< ;<I \"CF98CiJi<ILE> <iE<  IC<i:?K<\tILE> ;<I T9<IKI8>LE> JK8KK\n !FC>Ci:? DLJJ ;8MFE 8LJ><>8E><E N<I;<E\b ;8JJ $E=CL<EQ8\t+8E;<Di<E 8L:? iE ;<I ?<LKi><E 5<iK <iE< I<C<M8EK< \u001d<;IF?LE> =XI ;i< W==<EKCi:?< \"<JLE;?<iK ;8IJK<CC<E BWEE<E\n \u001fi< <iEQi>< \"<\t><ED8YE8?D< DiK 8LJI<i:?<E;<E HL8EKiK8KiM<E &8G8QiKUK<E iJK ;i< $DG=GIUM<EKiFE\n \u0019\u0019\u0015\u0015\u001b\u001b \u0004\u0004\u000b\u000bEE  II\u0010\u0010FFLLUUEE\u0010\u0010\u001d\u001d\u0002\u0002\u0016\u0016IIMM\u0012\u0012FFUU\u0010\u0010\t\t  11..\u001f\u001f..11 \u0007\u0007\u0017\u0017\u000f\u000f\f\fTTIIOO\u000f\u000f\u0015\u0015\u0012\u0012\u0014\u0014II\u000f\u000f\u001d\u001dII\u0012\u0012\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001\t\tEE\u0014\u0014\u0015\u0015TTEELLLL\u0017\u0017\u000f\u000fGG  1<IJL:?K <iE +8K?F><E X9<I ;i< E8KXICi:?<E \u001d8IIi<I<E iE ;8J $EE<I< ;<J D<EJ:?Ci:?<E &WIG<IJ <iEQL;IiE><E\b JF I<8>i<IK ;i<J<I DiK <iE<I $DDLE8EKNFIK\b N<C:?< Ji:? iE <iE<E 8E><9FI<E<E LE; <iE<E 8;8GKiM<E /<iC >Ci<\t;<IE CUJJK\n \u001fi< 8E><9FI<E< $DDLE8EKNFIK ><J:?i<?K LEJG<Qi=iJ:? LE; LEI<>LCi<IK\b <iE< 1<IUE;<ILE> ;<I EU:?JK<E -<8BKiFE 8L= ;8J >C<i:?< \u001cEKi><E =iE;<K Ei:?K JK8KK\n \u001f<I 8;8GKiM< /<iC I<8>i<IK 8EKi><E\tJG<Qi=iJ:? LE; B8EE Ji:? iE \u001c9?UE>i>B<iK M<IJ:?i<;<E<I !8BKFI<E I<>LCi<I<E\b 8LY<I;<D <I=FC>K E8:? &FEK8BK ;<J 8;8GKiM<E Die \u000bn$luenza-\u000bm-$ung  \n \u0012  .PJK<DJ DiK <iE<D \u001cEKi><E <iE< .G<i:?<ILE> MFE $E=FID8KiFE<E iD iDDLEFCF>iJ:?<E \"<;U:?KEiJ\n \u001d<iD EU:?JK<E &FEK8BK DiK <iE<D >C<i:?8IKi><E +8K?F><E ?iC=K ;i<J<J ;LI:? ;i< \u001cLJCWJLE> <iE<I ;<LKCi:? J:?E<CC<\tI<E LE; <==<BKiM<I<E $DDLE8EKNFIK\n 5i<C ;<I $DG=LE> iJK 8CJF\b ;8J 8;8GKiM< $DDLEJPJK<D iE !FID <iE<I \"<;U:?KEiJ9iC;LE> QLI <==<BKiM<E \u001c9N<?I <iE<I GFK<EQi<CC<E $E=CL<EQ8\t$E=<BKiFE QL <IDU:?Ki><E\n 6\u000e\r7 5L \u001d<>iEE <iE<I A<;<E $E=CL<EQ8\t.8iJFE <EKJ:?<i;<K ;i< 2#* \u00062FIC; #<8CK? *I>8EiQ8KiFE\u0007 X9<I ;i< 5LJ8D\tD<EJ<KQLE> ;<J $DG=JKF==<J LE; >i9K MFI \u001cEC8L= ;<I +IF;LBKiFE <EKJGI<:?<E; .88KMiI<E 8E #<IJK<CC<I 89\n 5LI #<IJK<CCLE> ;<J iE \u001f<LKJ:?C8E; QL><C8JJ<E<E iE8BKiMi<IK<E $E=CL<EQ8\t$DG=JKF==<J N<I;<E ;i< 1iI<E iE 9<9IXK<K<E #X?E<I<i<IE M<ID<?IK\n \u001fi<  II<><I N<I;<E 8EJ:?Ci<Y<E; 8LJ ;<E #X?E<I<i<IE <OKI8?i<IK LE; 89><KWK<K\b ;8J  OKI8BK NiI; ><I<iEi>K LE; GIFQ<JJi<IK\n \u001cD  E;< N<I;<E ;i< \u001d<JK8E;K<iC< ;<I <iEQ<CE<E 1iI<E QLD $DG=JKF== QLJ8DD<E><=X>K\n 6\r\u00117 #i<I9<i >i9K <J QN<i M<IJ:?i<;<E< &C8JJ<E\u0016 \u001fi< #<IJK<CCLE> MFE .G8C\tKiDG=JKF==<E 9<>iEEK DiK ;<I b\u001cL=JG8CKLE> ;<I 1iILJG8IKiB<C ;LI:? ><<i>E<K< -<8><EQi<E\b ;i< 1iILJ8EKi><E< N<I;<E MFE ;<E I<8BKF><E<E 'iGi;<E ;<I #XCC< 89><KI<EEK\n \u001cLY<I #8<D8>>CLKiEiE LE; )<LI8DiEi;8J< 9<\t=iE;<E Ji:? EF:? MiI8C< \u001cEKi><E< iE .G8CKiDG=JKF==<E\n` 6\r\u00117 !XI .L9LEiKiDG=JKF==< N<I;<E b;i< *9<I=CU:?< \u0006^\u0007 MFCCJKUE;i> 8L=><CWJK LE; ;i< JG<Qi=iJ:?<E &FDGFE<EK<E \u0006# LE; )\u0007 ?<I8LJ><I<iEi>K\n \u001fi<J< $DG=JKF==< <EK?8CK<E ELI EF:? ;i< 9<i;<E $E=CL<EQ8\t\u001cEKi><E< # LE; )\n` 6\r\u00117  \u001fi< #<IJK<CCLE> MFE I<BFD9iE8EK<E $E=CL<EQ8\t$DG=JKF==<E <I=FC>K LE89?UE>i> MFE #X?E<I<i<IE\b ?i<I9<i N<I;<E 1iILJ<C<D<EK< iE 5<CCBLCKLIK<:?EFCF>i< M<ID<?IK\n \u001fi<J <IDW>Ci:?K <iE< ;<LKCi:?< 1<IBXIQLE> ;<J #<IJK<CCLE>JGIFQ<JJ<J 9<i ;<LKCi:? ?W?<I<D K<:?EiJ:?<E \u001cL=N8E; =XI ;<E #<IJK<CC<I\n \"<<i>E<K iJK ;i<J< !FID =XI +8Ki<EK<E DiK T9<I<DG=iE;Ci:?B<iK<E ><><EX9<I #X?E<I<iN<iY<E LE;\b 8L=>ILE; ;<I J:?E<CC<E 1<I\t=X>98IB<iK\b =XI ;<E  iEJ8KQ NU?I<E; G8E;<DiJ:?<E \u001cLJ9IX:?<E\n 6\r\u0011\b \u000e\u000e7 '<9<E;iDG=JKF==<\b N<C:?< Ni< ;i< I<BFD9iE8EK<E $DG=JKF==< 9iJC8E> B<iE< 5LC8JJLE> iE \u001f<LKJ:?C8E; ?89<E\b <EK?8CK<E 89><J:?NU:?K< $E=CL<EQ8\t1iI<E M<IJ:?i<;<E<I .KUDD<\n \"IFY<I 1FIK<iC ;i<J<I $DG=JKF==< iJK ;i< (W>Ci:?B<iK <iE<I E8J8C<E \u001cGGCiB8KiFE 8CJ \u001cCK<IE8KiM< QLI $EA<BKiFE\b N8J Ji< ><<i>E<K =XI >IFY<\b LD=8E>I<i:?< $DG=B8DG8>E<E D8:?K\n /<iCN<iJ< iJK 8CC<I;iE>J ;i< 2iIBJ8DB<iK <iE><J:?IUEBK\b 8LY<I;<D ;XI=<E Ji< ELI >ILE;C<><E; \"<JLE;<E $E;iMi;L<E LEK<I \u001cLJJ:?CLJJ <iE<I .:?N8E><IJ:?8=K M<I89I<i:?K N<I;<E\n 6\u000e\u000f7 11..\u001f\u001f..22 \u0006\u0006\u000e\u000e\u0012\u0012\b\bEEHHLL\u0017\u0017\u000f\u000fGG  1.3.2.1 INDIKATIONEN !XI N<C:?< +FGLC8KiFE<E ;i< $E=CL<EQ8\t$DDLEiJi<ILE> <DG=F?C<E iJK LEK<ICi<>K I<>iFE8C<E 0EK<IJ:?i<;<E\b ;i< K<iCN<iJ< <Gi;<DiFCF>iJ:?\b K<iCN<iJ< BLCKLI<CC LE; GFCiKiJ:? 9<;iE>K JiE;\n \u001fi< ./$&* \u0006.KUE;i>< $DG=BFDDiJJiFE\u0007 8D -F9<IK\t&F:?\t$EJKiKLK <DG=i<?CK =XI \u001f<LKJ:?C8E; ;i< $E=CL<EQ8\t$DG=LE> =XI =FC><E;< +8Ki<EK<E F;<I .iKL8KiFE<E\u0016   b+<IJFE<E ] \u0012\f %8?I<\n \u001cCC< .:?N8E><I<E 89 \u000e\n /IiD<EFE\b 9<i <I?W?K<I ><JLE;?<iKCi:?<I \"<=U?I;LE> iE=FC>< Die \u000bn$luenza-\u000bm-$ung  \n \u0013  <iE<J \"ILE;C<i;<EJ 89 \r\n /IiD<EFE\n +<IJFE<E A<;<E \u001cCK<IJ DiK <I?W?K<I ><JLE;?<iKCi:?<I \"<=U?I;LE> iE=FC>< <iE<J \"ILE;C<i;<EJ \u0006\n\n\n\u0007\b \u001d<NF?E<I MFE \u001cCK<IJ\t F;<I +=C<><?<iD<E\b +<IJFE<E\b ;i< 8CJ DW>Ci:?< $E=<BKiFEJ\tHL<CC< iD J<C9<E #8LJ?8CK C<9<E;< F;<I MFE i?E<E 9<KI<LK< -iJiBFG<IJFE<E ><=U?I;<E BWEE<E\n \u0006\n\n\n\u0007 +<IJFE<E DiK <I?W?K<I \"<=U?I;LE>\b Q\n \u001d\n D<;iQiEiJ:?<J +<IJFE8C\b +<IJFE<E iE  iEIi:?KLE><E DiK LD=8E>I<i:?<D +L9\tCiBLDJM<IB<?I \u0006\n\n\n\u0007\b +<IJFE<E DiK <I?W?K<I \"<=U?I;LE> ;LI:? ;iI<BK<E &FEK8BK QL \"<=CX><C LE; 2iC;MW><CE\n !XI -<iJ<E;< 89 \u0012\f %8?I<E \u0006\n\n\n\u0007 iJK ;i< $DG=LE> ><E<I<CC <DG=<?C<EJN<IK\b \u0006\n\n\n\u0007\n 2<EE <iE< J:?N<I<  Gi;<Di< 8L=>ILE; MFE  I=8?ILE><E iE 8E;<I<E 'UE;<IE ;IF?K F;<I E8:? ;<LKCi:?<I \u001cEKi><E;Ii=K 9QN\n <iE<I \u001cEKi\t><EJ?i=K QL <IN8IK<E iJK \u0006\n\n\n\u0007\n`  6\u000e\u00107   \u001cCJ <iEQi>< \"ILGG< <I?8CK<E +<IJFE<E ] \u0012\f %8?I<E 8CJF ;i< $DDLEiJi<ILE> 8CJ .K8E;8I;iDG=LE>\b 8CC< 8E;<I<E &IiK<Ii<E =X?I<E QLI $E;iB8KiFEJiDG=LE> 8L=>ILE; D<;iQiEiJ:?<I &FE;iKiFE<E\b 9<IL=Ci:?<D -iJiBF F;<I -<i\tJ<E\n \u001f8J \u001c\u001e$+ \u0006\u001c;MiJFIP \u001eFDiK<< F= $DDLEiQ8KiFE +I8:Ki:<J\u0007 8D 8D<IiB8EiJ:?<E \u001e\u001f\u001e \u0006\u001e<EK<IJ =FI \u001fiJ<8J< \u001eFEKIFC\u0007 <DG=i<?CK ;i< $DG=LE> ><E<I<CC =XI 8CC< +<IJFE<E UCK<I 8CJ \u0012 (FE8K<\b N<C:?< B<iE< &FEKI8iE;iB8KiF\tE<E ><><E ;i< $DG=LE> 8L=N<iJ<E\n \u001d<i &E8GG?<iK ;<J $DG=JKF==<J LE; 9<i $DG=B8DG8>E<E JFCC< 8CC<I;iE>J ;<I !FBLJ 8L= 9<JKiDDK< -iJiBF>ILGG<E ><C<>K N<I;<E\b =XI N<C:?< <iE< 9<JFE;<I<  DG=<?CLE> ><KIF==<E NiI;\n 5L ;i<J<E ><?WI<E &iE;<I iD \u001cCK<I MFE \u0012 9iJ \u0011\u0015 (FE8K<E\b  IN8:?J<E< UCK<I 8CJ \u0011\f %8?I<\b &iE;<I LE;  IN8:?J<E< DiK :?IFEiJ:?<E GLCDFE8C<E\b B8I;iFM8JBLCUI<E\b I<E8C<E\b ?<G8KiJ:?<E\b E<LIFCF>iJ:?<E\b ?UD8KF\tCF>iJ:?<E F;<I D<K89FCiJ:?<E &I8EB?<iK<E JFNi< +8Ki<EK<E DiK  iEJ:?IUEBLE><E ;<J $DDLEJPJK<DJ\n \u001cL:? &iE;<I LEK<I \u001cJGiIiE\t F;<I .8Ci:PC8K\t?8CKi><I (<;iB8KiFE =iE;<E\b 8L=>ILE; ;<J -iJiBFJ <iE<J -<P<\t.PE;IFD<J\b M<IJKUIBK \u001d<8:?KLE>\n \u001d<JFE;<I<J \u001cL><ED<IB JFCC 8L:? 8L= .:?N8E><I< NU?I<E; ;<I $E=CL<EQ8\t.8iJFE\b \u001d<\tNF?E<I MFE JK8KiFEUI<E '8E>Q<iK9<KI<LLE>J<iEIi:?KLE><E\b 0I<iENF?E<I MFE \u001cD<IiB8 LE; \u001cC8JB8 LE; +8Ki\t<EK<E DiK \u001c;iGFJiK8J G<I D8>E8 ><C<>K N<I;<E\n \u001f<J 2<iK<I<E >i9K <J <iE<  DG=<?CLE> =XI 8CC< +<IJFE<E\b N<C:?< DiK (<EJ:?<E 8LJ ;<E F9i><E \"ILGG<E 8I9<iK<E F;<I QLJ8DD<EC<9<E\n 6\u000e\u0011\b \u000e\u00127 \u001cL:? MFE ;<I 2#* <OiJKi<IK <iE +FJiKiFEJG8Gi<I\b iE N<C:?<D  DG=<?CLE><E =XI I<>iFE8C< LE; CFB8C< -i:?K\tCiEi<E MFI><><9<E N<I;<E\n #W:?JK< +IiFIiKUK 8CC<I $DG=9<DX?LE><E JFCCK<E ;<DE8:? J:?N8E><I< !I8L<E ?89<E\b 8L= QN<iK<I  9<E< JK<?<E QLJ8DD<E &iE;<I iD \u001cCK<I QNiJ:?<E \u0012 LE; \u0011\u0015 (FE8K<E\b  IN8:?J<E< UCK<I 8CJ \u0012\u0011 %8?I<\b +<IJFE<E DiK :?IFEiJ:?<E  IBI8EBLE><E LE; D<;iQiEiJ:?<J +<IJFE8C 6\u000e\u00137\n  1.3.2.2 \u000bONT\u0011AINDIKATIONEN $E /89<CC< \r =iE;<K Ji:? <iE< T9<IJi:?K X9<I ;i< &FEKI8iE;iB8KiFE<E QLI $E=CL<EQ8\t$DG=LE> E8:? \u001cIK ;<J $DG=JKF==<J\b =I<i X9<IJ<KQK 8LJ <iE<I +L9CiB8KiFE ;<J \u001c\u001e$+\n  &FEKI8iE;iB8KiFE<E ><><E ;i< $DG=LE> DiK ;<D\b iE \u001f<LKJ:?C8E; QL><C8JJ<E<E\b iE8BKiMi<IK<E $DG=JKF== JiE; QLJ8DD<E><=8JJK C<;i>Ci:? 8BLK<  IBI8EBLE><E LE; iE ;<I 1<I>8E><E?<iK <I=FC>K< F;<I 9<=XI:?K<K< G8K?FCF\t>iJ:?< $DDLEI<8BKiFE<E 8L= ;<E $DG=JKF==\n \u001cL:? ;i< \u001cGGCiB8KiFE ;<J I<BFD9iE8EK<E $DG=JKF==<J B8EE iE ;<E D<iJK<E !UCC<E 9<;<EB<ECFJ ;LI:?><=X?IK N<I;<E\n \u001fLI:? J<iE< LD=8E>I<i:?<E &FEKI8iE;iB8KiFE<E iJK  Die \u000bn$luenza-\u000bm-$ung  \n \u0014               \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  ??  88  \u000b\u000b##\"\"**''\u0014\u0014\u001d\u001d\"\"\u0018\u0018\u001d\u001d\u001f\u001f\u0014\u0014**\u001d\u001d##\"\"\u0019\u0019\"\"  \u0018\u0018\u0019\u0019''  \n\n\"\"\u001a\u001a  ++\u0019\u0019\"\"11\u0014\u001477\n\n!!%%\u001a\u001a++\"\"\u001b\u001b  \u001d\u001d\"\"  \u0002\u0002\u0016\u0016\u001c\u001c\u0015\u0015\"\"\u001b\u001b\u001d\u001d\u001b\u001b\u001f\u001f\u0019\u0019\u001d\u001d**  \u0018\u0018\u0019\u0019''  \n\n!!%%\u001a\u001a((**##\u001a\u001a\u001a\u001a\u0014\u0014''77**\u0019\u0019\"\"44  !!##\u0018\u0018\u001d\u001d\u001a\u001a\u001d\u001d11\u001d\u001d\u0019\u0019''**  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \b\b''##\u001c\u001c((\u001f\u001f##%%\u001a\u001a  \u0019\u0019**  \u0014\u0014  66  99@@CC::  \u0002\u0002((**  \u001c\u001c\u001d\u001d))  II$$''\u001e\u001e22))**&&\u001e\u001e\u001e\u001e\u001d\u001d))  \u000b\u000b&&%%**((\u0018\u0018!!%%\u001c\u001c!!\"\"\u0018\u0018**!!&&%%\u001d\u001d%%  \u0003\u0003\u001d\u001d))&&%%\u001c\u001c\u001d\u001d((\u001d\u001d  \u0002\u0002\u001a\u001a--\u0019\u0019\u001f\u001f++%%\u001f\u001f  \u001c\u001c\u001d\u001d((  \u0012\u0012!!**++22\u0018\u0018**!!&&%%  %%&&**--\u001d\u001d%%\u001c\u001c!!\u001f\u001f  Inaktiviert - Schwere allergische Reaktion auf einen Bestandteil der Impfung oder nach einer applizierten Influenza-Imp-fung in der Vorgeschichte - Moderate oder schwere, akute Erkran-kung mit oder ohne Fieber - Entwicklung eines Guillain-Barr\u00e9e-Syn-droms innerhalb von 6 Wochen nach applizierter Influenza-Impfung in der Vorgeschichte Rekombinant - Schwere allergische Reaktion auf einen Bestandteil der Impfung in der Vorgeschichte \nLebend-abge-schw\u00e4cht - Schwere allergische Reaktion auf einen Bestandteil der Impfung oder nach einer applizierten Influenza-Imp-fung in der Vorgeschichte - Therapie mit Aspirin- oder Salicylat-haltiger Medikation f\u00fcr Kinder und Jugendliche (Reye-Syndrom) - Kinder im Alter von 2-4 Jahren mit Hinweisen auf eine bestehende asthmatische Erkrankung - Patienten mit Einschr\u00e4nkungen der Immunabwehr durch Medikamente oder Erkrankungen - Menschen mit engem Kontakt zu Patienten mit Ein-schr\u00e4nkungen der Immunabwehr - Schwangerschaft - Einnahme von antiviraler Influenza-Medikation inner-halb der letzten 48 Stunden - Moderate oder schwere, akute Erkran-kung mit oder ohne Fieber - Entwicklung eines Guillain-Barr\u00e9e-Syn-droms innerhalb von 6 Wochen nach applizierter Influenza-Impfung in der Vorgeschichte - Patienten \u00e4lter als 5 Jahre mit Hinwei-sen auf bestehende asthmatische Grun-derkrankung - Alle Patienten mit zugrundeliegenden chronischen Erkrankungen, welche das Komplikationsrisiko bei einer In-fluenza-Infektion vom Wildtyp ma\u00df-geblich erh\u00f6hen w\u00fcrden    Die \u000bn$luenza-\u000bm-$ung  \n \u0015  ;<I '<9<E;iDG=JKF== =XI Mi<C< +8Ki<EK<E\b iEJ9<JFE;<I< =XI ;i< LEK<IJL:?K< 5i<CGFGLC8KiFE ;<I :?IFEiJ:? &I8EB<E\b Ei:?K ><<i>E<K\n 11..\u001f\u001f..\u001f\u001f \u0013\u0013II\u0005\u0005HHEE\u0014\u0014HHEEIITT\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001\u0017\u0017II\u0014\u0014\f\f\u0015\u0015AA\u000e\u000e\f\fEEIITT  b$E=CL<EQ8\t$DG=JKF==< JiE; iE ;<I -<><C >LK M<IKIU>Ci:?\n \u001cCJ \u001cLJ;IL:B ;<I EFID8C<E \u001cLJ<iE8E;<IJ<KQLE> ;<J *I>8EiJDLJ DiK ;<D $DG=JKF== B8EE <J ><C<><EKCi:? iEE<I?8C9 MFE \r 9iJ \u000f /8><E 8E ;<I $DG=JK<CC< QL C<i:?K<E .:?D<IQ<E\b -WKLE><E LE; .:?N<CCLE><E BFDD<E\b F;<I 8L:? QL \u001cCC><D<iEJPDGKFD<E Ni< !i<9<I\b !IWJK<CE\b T9<CB<iK\b 0ENF?CJ<iE\b (X;i>B<iK\b .:?NiKQ<E\b &FG=\t\b (LJB<C\t LE; \"<C<EBJ:?D<IQ<E\n $E ;<I -<><C JiE; ;i<J< 'FB8C\t LE; \u001cCC><D<iEI<8BKiFE<E MFIX9<I><?<E;<I )8KLI LE; BCiE><E I8J:? LE; =FC><ECFJ Ni<;<I 89\n .<?I J<CK<E N<I;<E 8CC<I>iJ:?< -<8BKiFE<E 8E #8LK \u0006\n\n\n\u0007 LE; \u001dIFE:?i8CJPJK<D 9<F98:?K<K\u0017 X9<I 8CC<I>iJ:?< .F=FIK\tI<8BKiFE<E \u0006\n\n\n\u0007 NLI;< ELI iE  iEQ<C=UCC<E 9<Ii:?K<K\n \u0006\n\n\n\u0007  9<E=8CCJ J<?I J<CK<E B8EE <J QL <iE<I 18JBLCiKiJ F;<I <iE<I MFIX9<I><?<E;<E /?IFD9FQPKFG<Ei< BFDD<E\b 8CJ ;<I<E !FC>< \u001dCLKLE><E 8L=KI<K<E BWEE<E\n` 6\r\u00117  iE< \u001cJJFQi8KiFE ;<J \"LiCC8iE\t\u001d8IIV<\t.PE;IFDJ LE; ;<I )8IBFC<GJi< DiK 9<JKiDDK<E /PG<E ;<J $E=CL<EQ8\t$DG=\tJKF==<J B8EE ;<IQ<iK Ei:?K 8LJ><J:?CFJJ<E N<I;<E\b ;i< DW>Ci:?< -iJiBF<I?W?LE> iJK 8CC<I;iE>J 8CJ ><IiE> <iE\tQLJ:?UKQ<E 6\u000e\u0014\b \u000e\u00157\n  b\u001fi< $DDLEiKUK ?UE>K MFD \u001cCK<I ;<J +8Ki<EK<E\b ;8J ?<iYK MFE ;<I \u001cEQ8?C LE; \u001cIK ;<I MFI8E><>8E><E<E  OGFJiKiFE<E ><><EX9<I ;<E $E=CL<EQ8\t\u001cEKi><E<E 89\n \u001fi< 2iIBJ8DB<iK ;<I $DG=JKF==< NiI; MFD \"I8; ;<I T9<I<iEJKiDDLE> ;<I \u001cEKi><EQLJ8DD<EJ<KQLE> QNiJ:?<E $DG=JK8DD LE; 8BKL<CC QiIBLCi<I<E;<D  Gi;<\tDi<JK8DD 9<JKiDDK\n   \"<JLE;< &iE;<I LE;  IN8:?J<E< BWEE<E iE \u0013\f 9iJ \u0015\f\u0003 ;<I !UCC< MFI <iE<I  IBI8EBLE> ><J:?XKQK N<I;<E\n \u0006\n\n\n\u0007 $E <iE<I GIFJG<BKiM<E .KL;i< iE \u0014\u0012\f +8Ki<EK<E \u001a \u0012\u0011 %8?I<E NLI;< 9<i D<?I 8CJ \u0013\f\u0003 <iE< 8LJI<i:?<E;< .:?LKQI8K< <IQi<CK\n   $E <iE<I (<K88E8CPJ< MFE \u000e\f !8CC\t&FEKIFCC\t.KL;i<E <I>89 ;i< \u001d<I<:?ELE>\b A< E8:?  E;GLEBK LE; +FGLC8KiFE\b <iE< QLJ8DD<E><J<KQK< 2iIBJ8DB<iK ;<I $E=CL<EQ8\t$DG=LE> MFE \u0011\u0012\u0003 =XI ;i< +IUM<EKiFE <iE<I \u001cK<DN<>J<I\tBI8EBLE> 6LE;7 \u0011\f\u0003 =XI ;i< 1<ID<i;LE> <iE<I #FJGiK8CiJi<ILE> F;<I /F; ;LI:? +E<LDFEi<\n \u0006\n\n\n\u0007 2<iK<I?iE 6Ni<J<E7 ><iDG=K< <iE< -iJiBFDiE;<ILE> =XI B8I;i8C< Q<I<9IFM8JBLCUI<  I<i>EiJJ< MFE \r\u0015 9QN\n \r\u0012\u0003 8L=\n` 6\r\u00117 !XI ;i< JG<Qi=iJ:?< +FGLC8KiFE ;<I :?IFEiJ:? &I8EB<E >i9K <J J<G8I8K< \u001f8K<E\b N<C:?< ;i< 2iIBJ8DB<iK ;<I $DG=LE> 9<JKUKi><E 6\u000f\f7\n 0EK<I &iE;<IE DiK \u001cJK?D8 9IFE:?i8C< BFEEK< ;i< $DG=LE> ;i< 58?C ;<I &I8EB\t?<iKJ<GiJF;<E LE; \u001cJK?D8\t8JJFQii<IK<E  I<i>EiJJ< I<;LQi<I<E 6\u000f\r7\n \u001e*+\u001f\t+8Ki<EK<E iDDLEiJi<IK< ;i< $DG\t=LE> <==<BKiM\b 8L:? BFEEK< ;i< \u001cEQ8?C MFE  O8Q<I98KiFE<E\b #FJGiK8CiJi<ILE><E LE; \u001cIQK9<JL:?<E M<IIiE><IK N<I;<E 6\u000f\u000e7\n $E +8Ki<EK<E DiK K<IDiE8C<I )i<I<EiEJL==iQi<EQ I<;LQi<IK< Ji< \"<J8DKDFIK8CiKUK\b 58?C ;<I #FJ\tGiK8CiJi<ILE><E\b $EK<EJiMJK8KiFEJ8L=<EK?8CK< LE; >IiGG8C<I $E=<BK< 6\u000f\u000f7\n \u001cL:? ;i< -<;LBKiFE MFE \u001f<BFDG<E\tJ8KiFE<E <iE<I MFI9<JK<?<E;<E #<IQiEJL==iQi<EQ BFEEK< 8CJ 2iIBLE> iE <iE<I .KL;i< 9<F98:?K<K N<I;<E 6\u000f\u00107\n \u001fi< ><J8DK< -iJiBF\t)LKQ<E\t\u001diC8EQ =UCCK 8CJF =XI 8CC< iE !I8>< BFDD<E;<E \"ILGG<E\b iEJ9<JFE;<I< 89<I =XI +8Ki<EK<E DiK :?IFEiJ:?<E 1FI<IBI8EBLE><E\b BC8I GFJiKiM 8LJ\n  \u001dielsetzungen der \u0002rbeit  \n \r\f  11..\u001f\u001f..   \u0002\u0002\f\f\u001d\u001dEE\u0012\u0012TTAA\u000f\u000f\u001d\u001d\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001\u0015\u0015\u000e\u000e\u0015\u0015EETT\u001d\u001d\u0017\u0017\u000f\u000fGG\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\u0006\u0006\u000e\u000e\u0012\u0012\b\bEEHHLL\u0017\u0017\u000f\u000fGGEE\u000f\u000f\u0001\u0001II\u000f\u000f\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\u0003\u0003EE\u0019\u0019\u0011\u0011LL\f\fEE\u0014\u0014\u0017\u0017\u000f\u000fGG\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\u000f\u000f\u0006\u0006\u0004\u0004\u0005\u0005\u0001\u0001\u001a\u001a\u0001\u0001\f\f\u0003\u0003\u000f\u000f  \u0006\u0006EE\u0014\u0014  \u001d<I<:?ELE><E ><?<E ;8MFE 8LJ\b ;8JJ =XI ;i< 8E><JKI<9K< #<I;<EiDDLEiKUK ><><E $E=CL<EQ8 <iE< $DDLEiJi<\tILE>JI8K< MFE 9iJ QL \u0014\f\u0003 iE ;<I \u001cCC><D<iE9<MWCB<ILE> LE; \u0015\f\u0003 iE -iJiBF>ILGG<E EFKN<E;i> iJK 6\u000f\u00117\n /IFKQ 9I<iK<I  Mi;<EQ =XI 2iIBJ8DB<iK LE; .i:?<I?<iK M<I9C<i9<E ;i< $DG=HLFK<E iE ;<I \u001d<MWCB<ILE> Mi<C<I * \u001e\u001f \t'UE;<I \u0006*I>8EiJ8KiFE =FI  :FEFDi: \u001eFFG<I8KiFE 8E; \u001f<M<CFGD<EK\u0007 ;<EEF:? 8L= LE9<=Ii<;i><E;<D )i\tM<8L\n   $E \u001f<LKJ:?C8E; C8> ;i< $E=CL<EQ8\t$DG=I8K< 9<i :?IFEiJ:? &I8EB<E iE ;<I .8iJFE \u000e\f\r\f\u000b\u000e\f\r\r QNiJ:?<E \u0010\r LE; \u0010\u0014 \u0003\b 9<i  +8Ki<EK<E LEK<I \u0012\f %8?I<E JF>8I ELI QNiJ:?<E \u000e\u0014 LE; \u000f\u000f\u0003 6\u000f\u00127\n $E &FI<8 N8I<E \u000e\f\r\u0012 \u000f\u0015\b\u0014\u0003 ;<I :?IFEiJ:? &I8EB<E (UEE<I QNiJ:?<E \u0011\f LE; \u0012\u0010 %8?I<E ><iDG=K\b ;8IX9<I N8I<E <J \u0014\u0012\b\u0014\u0003 6\u000f\u00137\n $E <iE<I GFC\tEiJ:?<E 0D=I8>< N8I<E \u000e\f\r\u0011 LEK<I ;<E +8Ki<EK<E DiK 'LE><E<IBI8EBLE><E \u0011\u0014\u0003\b LEK<I #UDF;i8CPJ< \u000f\u0010\u0003\b DiK B8I;iFM8JBLCUI<E  IBI8EBLE><E \u000f\u000e\u0003 LE; DiK .:?iC;;IXJ<EB8IQiEFD ELI \u0015\u0003 ><><E $E=CL<EQ8 iDDLEi\tJi<IK 6\u000f\u00147\n   \u001fi< $DG=HLFK<E 9<i :?IFEiJ:? &I8EB<E JiE; 8CJF ><E<I<CC D8E><C?8=K 9iJ J:?C<:?K\b N8J 8L= D8E><CE;< \u001cB\tQ<GK8EQ LE; 0DJ<KQLE> ;<I iDGC<D<EKi<IK<E -i:?KCiEi<E JFNF?C iE ;<I \u001d<MWCB<ILE> 8CJ 8L:? LEK<I !8:?BIU=\tK<E ?iEN<iJ<E BWEEK<\n  iE 9<JFE;<I<J (8Y 8E 0EK<IM<IJFI>LE> Q<i>K Ji:? 9<i AXE><I<E +8Ki<EK<E DiK :?IF\tEiJ:?<E  IBI8EBLE><E 6\u000f\u0012\b \u000f\u0013\b \u000f\u00157\n \u0019\u0019\u0015\u0015\u001c\u001c \u0013\u0013\u000b\u000bEELL\u0015\u0015EE\u0016\u0016\u001d\u001dUU\u0010\u0010\t\tEE\u0010\u0010  DDEE\u0014\u0014  \u0002\u0002\u0014\u0014BBEE\u000b\u000b\u0016\u0016  +8Ki<EK<E DiK :?IFEiJ:?<E  IBI8EBLE><E C<i;<E F=K LEK<I <iE<I ?F?<E &I8EB?<iKJC8JK LE; M<I9IiE><E Mi<C 5<iK iE D<;iQiEiJ:?<I \u001d<?8E;CLE>\b iEJ9<JFE;<I< 9<i #8LJUIQK<E 6\u0010\f7\n $EJ9<JFE;<I< AXE><I< +8Ki<EK<E ;i<J<I +FGLC8KiFE <I?8CK<E\b KIFKQ BC8I<I $E;iB8KiFE\b ?UL=i> B<iE< $E=CL<EQ8\t$DG=LE> \u0006Ji<?< \r\n\u000f\n\u0010\u0007\n  9<EJF iJK E8?<\tCi<><E;\b ;8JJ Ji:? ;i<  ==<BKiMiKUK MFE $EK<IM<EKiFE<E iE ;<I +FGLC8KiFE ;<I :?IFEiJ:? &I8EB<E LE; iE >IW\tY<I<E\b ;LI:?J:?EiKKCi:? ><JXE;<I<E +FGLC8KiFE<E LEK<IJ:?<i;<E BWEEK<E\n \u001fi<J<  IB<EEKEiJJ< LEK<IJKI<i:?<E iE ?F?<D (8Y< ;i< )FKN<E;i>B<iK MFE 8;8GKi<IK<E $EK<IM<EKiFE<E =XI LEJ<I< 5i<C>ILGG<\n \u001fLI:? ;<E ?F?<E \u001cEK<iC ;<I #8LJ8IQK9<JL:?< 8E ;<E ><J8DK<E \u001cIQKBFEK8BK<E LEK<I :?IFEiJ:? &I8EB<E iJK ;i< \u001cCC><D<iED<\t;iQiE =XI JFC:?< $EK<IM<EKiFE<E GIU;<JKiEi<IK\n  !FBLJ ;<J -<Mi<NJ N8I ;<D<EKJGI<:?<E; ;i<  M8CL8KiFE M<IJ:?i<;<E<I .KI8K<>i<E QLI .K<i><ILE> ;<I $DG=\tHLFK<E ><><E ;i< J8iJFE8C< $E=CL<EQ8 LEK<I :?IFEiJ:? &I8EB<E iD .<KKiE> ;<I \u001cCC><D<iED<;iQiE\n \u001cL:? JFCCK< ;i< \u001c9?UE>i>B<iK ;<I 2iIBJ8DB<iK MFE -8?D<E9<;iE>LE><E\b 9<iJGi<CJN<iJ< ;<J \"<JLE;?<iKJJPJK<DJ\b LEK<I\tJL:?K N<I;<E\n Der s8stematische \u0014eview  \n \r\r  \u0017\u0017 MMEE\u0012\u0012\t\t\u000f\u000f\u0005\u0005EENN  \u001a\u001a\u0015\u0015\u0019\u0019 \u0004\u0004EE\u0014\u0014  \u0015\u0015\u001c\u001c\u0015\u0015\u0016\u0016EEMM\u0002\u0002\u0016\u0016\u000b\u000b\u0015\u0015\u0005\u0005\n\nEE  \r\rEE\u0019\u0019\u000b\u000bEE\u001a\u001a   iE< >IFY< #<I8LJ=FI;<ILE> =XI  EKJ:?<i;LE>JKIU><I iD \"<JLE;?<iKJN<J<E B8EE ;8J T9<I9Ci:B<E\b .FIKi<I<E LE; \u001d<N<IK<E ;<I LD=8E>I<i:?<E\b iD !8:?><9i<K GL9CiQi<IK<E \u001f8K<ED<E><E J<iE\n $E \u001c99iC;LE> \u000e =iE;<K Ji:? <iE< T9<IJi:?K ;<I .:?IiKK<\b ;i< \u001eF:?I8E< \u001f<LKJ:?C8E; QLI <Mi;<EQ98Ji<IK<E \u001d<8EKNFIKLE> <iE<I BCiEiJ:?<E !I8><JK<CCLE> <DG=i<?CK\n  iE< ><<i>E<K< (<K?F;< QLI 0DJ<KQLE> ;i<J<I .KI8K<>i< ;LI:? Q<EKI8C< \u001cLKF\tI<EK<8DJ iJK ;<I JPJK<D8KiJ:?< -<Mi<N\n  \u001f<I JPJK<D8KiJ:?< -<Mi<N iJK <iE< (<K?F;< QLI Qi<C><I<:?K<E LE; ;LI:?;8:?K<E 5LJ8DD<E=8JJLE> LE; \u001d<\tN<IKLE> ;<I  I><9EiJJ< M<IJ:?i<;<E<I .KL;i<E\n .:?FE (LCIFN <DG=8?C \r\u0015\u0015\u0010 iD \u001d(% ;<JJ<E (<K?F;iB 8CJ QLM<ICUJJi><J .PJK<D QLI BFEQ<EKIi<IK<E 2iJJ<EJM<IDiKKCLE> =XI RIQK< LE; 8E;<I<J +<IJFE8C iD \"<JLE;?<iKJ\tN<J<E 6\u0010\r7\n \u001fi< \u001eF:?I8E< \u001eFCC89FI8KiFE\b N<C:?< Ji:? ;<D \"<E<Ii<I<E MFE  Mi;<EQ LE; ;<I 1<I=X>98IB<iKJ\tJK<i><ILE> ;i<J<I M<IJ:?Ii<9<E ?8K 6\u0010\u000e7\b <DG=i<?CK =FC><E;<J 1FI><?<E QLI  IJK<CCLE> <iE<J JPJK<D8KiJ:?<E -<Mi<NJ\u0016 \u0006\r\u0007 1FI;<=iEiKiFE MFE BC8I<E 5i<C<E LE;  iEJ:?CLJJBIiK<Ii<E =XI .KL;i<E\b \u0006\u000e\u0007 1<IN<E;LE> <iE<I I<\tGIF;LQi<I98I< (<K?F;iB\b \u0006\u000f\u0007 \u001fLI:?=X?ILE> <iE<I .L:?JKI8K<>i< DiK ;<D 5i<C\b 8CC< QLD /?<D8 <OiJKi<I<E;<E .KL;i<E QL i;<EKi=iQi<I<E\b \u0006\u0010\u0007 \u001cEN<E;LE> <iE<I (<K?F;< QLI ,L8CiKUKJ9<N<IKLE> JFNi< <iE< \u0006\u0011\u0007 JPJK<D8KiJ:?< +IUJ<EK8KiFE ;<I  I><9EiJJ< 6\u0010\u000f7\n .PJK<D8KiJ:?< -<Mi<NJ ;i<E<E 8CJ  EKJ:?<i;LE>J?iC=<E LE; \u001d8JiJ =XI ;i< JGUK<I< '<iKCiEi<E<IJK<CCLE> LE; E<?D<E JFDiK <iE< Ni:?Ki>< -FCC< iE ;<I $E=FID8KiFEJM<I8I9<iKLE> <iE\n \u001a\u001a\u0015\u0015\u001a\u001a VV\u0011\u0011\u0014\u0014\u0014\u0014EE\u0005\u0005\n\nEE\u0014\u0014\u0005\u0005\n\nEE  5L \u001d<>iEE ;<J +IFA<BKJ NLI;<E LD=8E>I<i:?< 1FII<:?<I:?<E ;LI:?><=X?IK\b LD ;i< 8BKL<CC< \u001f8K<EC8>< QL JFE;i<I<E LE; <iE< .:?UI=LE> ;<J /?<D8J MFIE<?D<E QL BWEE<E\n #i<I9<i =i<C <iE !FBLJ ;<I 9iJ?<I GL9Ci\tQi<IK<E -<Mi<NJ 8L= >IFY< +FGLC8KiFE<E\b N<C:?< F=K 8CC<iE< ;LI:? ;8J &IiK<IiLD b'<9<EJ8CK<I` ;<=iEi<IK NLI\t;<E\b 8L=\n \u001cL:? =8E; iE ;<I -<><C B<iE< !FBLJJi<ILE> 8L= 9<JKiDDK< D<;iQiEiJ:?< !8:?9<I<i:?< JK8KK\n (<?I<I< >IFY< +L9CiB8KiFE<E DiK ><NiJJ<I R?ECi:?B<iK QL LEJ<I<D +IFA<BK BFEEK<E i;<EKi=iQi<IK LE; QLI *Ii<EKi<ILE> M<IN<E;<K N<I;<E 6\u0010\u0010_\u0010\u00137\n %<;F:? N8I LEJ N8I LEJ QL \u001d<>iEE ;<J +IFA<BK<J B<iE< +L9CiB8KiFE 9<B8EEK\b ;i< <iE< M<I>C<i:?98I< +FGLC8KiFE iE <EKJGI<:?<E;<I 0D><9LE> LEK<IJL:?K<\n \u001a\u001a\u0015\u0015\u001b\u001b \u000e\u000e\u0016\u0016UUDD\u000b\u000bEE\u0010\u0010\u0012\u0012\u0014\u0014\u0011\u0011\u0016\u0016\u0011\u0011KK\u0011\u0011LLLL  UU\u0010\u0010DD  EE\u000b\u000b\u0010\u0010\u0015\u0015\u0005\u0005\n\nLLUU\u0015\u0015\u0015\u0015KK\u0014\u0014\u000b\u000b\u0016\u0016EE\u0014\u0014\u000b\u000bEE\u0010\u0010  22..\u001f\u001f..11 PP\u0014\u0014OOTTOO\f\fOOLLLL  .KL;i<EGIFKFBFCC< JiE; <iE &<IE8JG<BK =XI ;i< ,L8CiKUKJJi:?<ILE> MFE JPJK<D8KiJ:?<E -<Mi<NJ\b ;8 JF ;i< ><\tNiJJ<E?8=K< 0DJ<KQLE> ;<J ><GC8EK<E .:?<D8J X9<IGIX=K N<I;<E B8EE\n  iE 8LJ=X?ICi:?<J .KL;i<EGIFKFBFCC NLI;< MFI \u001d<>iEE ;<I 'iK<I8KLIJL:?< <IJK<CCK LE; X9<I +-*.+ -* \u0006\u001e-\u001f\u0010\u000e\f\r\u0014\r\r\u0010\r\u0012\u000f\u0002 GL9CiQi<IK 6\u0010\u00147\n \u0015tudien-rotokoll und Einschlusskriterien  \n \r\u000e     \n\u00dcbersetzung des klinischen Problems in eine Fragestellung, die durch wissenschaftliche Untersuchungen zu beantworten istSystematische Literaturrecherche nach geeigneten StudienKritische Evidenzbewertung der identifizierten StudienAnwendung der gewonnenen Einsichten in Abw\u00e4gung der konkreten klinischen SituationEvaluation und ggf. Anpassung des bisherigen Verhaltens\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  @@  88  \u0005\u0005\u001d\u001d\u0019\u0019  \u001a\u001a,,\"\"\u001a\u001a  \u000f\u000f\u0017\u0017\u001c\u001c''\u001d\u001d****\u0019\u0019  \u0018\u0018\u0019\u0019''  \u0006\u0006\u0016\u0016\f\f44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \u000e\u000e66  \f\f$$\u001c\u001c  \u0019\u0019''  99??::    \u0015tudien-rotokoll und Einschlusskriterien  \n \r\u000f  22..\u001f\u001f..22 \u0013\u0013TT\u0017\u0017\u0006\u0006IIEE\u000f\u000f  5LI 28?ILE> <iE<J ?F?<E ,L8CiKUKJJK8E;8I;J NLI;<E ELI I8E;FDiJi<IK<\b BFEKIFCCi<IK< .KL;i<E iE LEJ<I -<\tMi<N <iE><J:?CFJJ<E\b ;i< 8LY<I;<D JUDKCi:?< ;<I E8:?=FC><E;<E &IiK<Ii<E \u0006Ji<?< \u000e\n\u000f\n\u000f \t \u000e\n\u000f\n\u0012\u0007 <I=XCCK<E\n \u001eCLJ\tK<I\t-8E;FDiJi<ILE> N8I B<iE \u001cLJJ:?CLJJ>ILE;\n (W>Ci:?< .GI8:?<E ;<I +L9CiB8KiFE<E N8I<E \u001f<LKJ:? LE;  E>CiJ:?\b <iE<  iEJ:?IUEBLE> ?iEJi:?KCi:? +L9CiB8KiFEJA8?I =8E; Ei:?K JK8KK\n 6\u0010\u00147 22..\u001f\u001f..\u001f\u001f PPAATTIIEE\u000f\u000fTTEE\u000f\u000f  -iJiBF<IBI8EBLE><E 8E8CF> QLI $DG=<DG=<?CLE> =XI $E=CL<EQ8 ;<J -F9<IK\t&F:?\t$EJKiKLKJ BWEE<E DLJK<I?8=K b\u0006\n\n\n\u0007 :?IFEiJ:?< &I8EB?<iK<E ;<I \u001cKDLE>JFI>8E< \u0006\n\n\n\u0007\b :?IFEiJ:?< #<IQ\t&I<iJC8L=\t\b '<9<I\t LE; )i<I<EBI8EB\t?<iK<E\b \u0006\n\n\n\u0007 .KF==N<:?J<CBI8EB?<iK<E\b :?IFEiJ:?< E<LIFCF>iJ:?< &I8EB?<iK<E 6LE;7 \u0006\n\n\n\u0007 8E><9FI<E<6\n\n\n7 F;<I <INFI9<E<6\n\n\n7 $DDLE;<=iQi<EQ \u0006\n\n\n\u0007 9QN\n $DDLEJLGGI<JJiFE` 6\u000e\u00107 J<iE\n \"UE>i>< \u001d<iJGi<C< =XI BFEBI<K<  I\tBI8EBLE><E JK<CC<E ;<DE8:? LEK<I 8E;<I<D ;<I \u001fi89<K<J D<CCiKLJ \u0006\u001f(\u0007\b ;i< BFIFE8I< #<IQBI8EB?<iK \u0006B#&\u0007\b ;8J :?IFEiJ:?< F;<I K<IDiE8C< )i<I<EM<IJ8><E \u0006:)1 9QN\n K)1\u0007\b ;8J \u001cJK?D8 9IFE:?i8C<  F;<I ;i< :?IFEiJ:? F9JKILBKiM< GLCDFE8C< 'LE><E<IBI8EBLE> \u0006\u001e*+\u001f\u0007 ;8I\n \"<<i>E<K =XI LEJ<I -<Mi<N N8I<E 8CC< +8Ki<EK<E DiK BWIG<ICi:?<E F;<I GJP:?iJ:?<E :?IFEiJ:?<E  IBI8EBLE\t><E 8LJ 'UE;<IE DiK <iE<D DiKKC<I<E 9iJ ?F?<E  iEBFDD<EJJ:?EiKK F?E<  iEJ:?IUEBLE> MFE \u001cCK<I F;<I \"<J:?C<:?K\n +8Ki<EK<E iE  EKNi:BCLE>JCUE;<IE NLI;<E Ei:?K iE LEJ<I< \u001cI9<iK <iE><J:?CFJJ<E\n \u001f<I JFQiFWBF\tEFDiJ:?< .K8KLJ <iE<J '8E;<J NLI;< 8E?8E; ;<I \u001f<=iEiKiFE<E ;<I 0EiK<; )8KiFEJ .K8KiJKi:J \u001fiMiJiFE \u00060).\u001f\u0007 =<JK><C<>K 6\u0010\u00157\n \"<E<I<CC 8LJ><J:?CFJJ<E N8I<E ;8L<I?8=K< \u001d<NF?E<I MFE JK8KiFEUI<E \u001d<KI<LLE>J<iEIi:?KLE\t><E Ni< \u001cCK<E\t LE; +=C<><?<iD<E F;<I +8Ki<EK<E iE &CiEiB<E LE; &I8EB<E?ULJ<IE\b ;8 ;i< 1<I>C<i:?98IB<iK QL :?IFEiJ:? &I8EB<E ;<I 8D9LC8EK<E 1<IJFI>LE> LEJ<I<I (<iELE> E8:? ELI J<?I <iE><J:?IUEBK DW>Ci:? iJK\n 6\u0010\u00147 22..\u001f\u001f..   \n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f  )8:? /?FD8J <K 8C\n C8JJ<E Ji:? ;I<i $EK<IM<EKiFEJ9<I<i:?< <iEK<iC<E\u0016 \u0006\r\u0007  I?W?LE> ;<I )8:?=I8>< E8:? $DG\t=LE><E iE ;<I \"<J<CCJ:?8=K\b \u0006\u000e\u0007 1<I9<JJ<ILE> ;<J 5L>8E>J MFE $EK<I<JJi<IK<E QLI $DG=LE> LE; \u0006\u000f\u0007 8E9i<K<I\t LE; JPJK<D98Ji<IK< $EK<IM<EKiFE<E 6\u0010\u00107\n \u001fi< 5LFI;ELE> <iE<I (8YE8?D< QL D<?I<I<E \"ILGG<E iJK ?i<I9<i DW>Ci:?\n 0D ;i< T9<IKI8>98IB<iK 8L= ;i< \u001cCC><D<iED<;iQiE QL <I?W?<E\b NLI;<E ELI $EK<IM<EKiFE<E DiK 8E\t9i<K<I\t F;<I JPJK<D98Ji<IK<E &FDGFE<EK<E <iE><J:?CFJJ<E\b ;i< ;i< 0DJ<KQLE> ;LI:? <iE<E #8LJ8IQK iE J<i\tE<I 8D9LC8EK<E +I8OiJ <IC8L9<E\n 5i<C 8CC<I $EK<IM<EKiFE<E DLJJK< ;i< \u001cE?<9LE> ;<I $DG=HLFK<E ><><E ;i< J8iJFE8C< $E=CL<EQ8 J<iE\n $DG=B8DG8>E<E DiK !FBLJJi<ILE> 8L= ;<E  II<><I ;<I .:?N<iE<>IiGG< \u0006#\r)\r\u0007 =iE;<E iD )FID8C=8CC GIiDUI iD &FEK<OK ;<I LEI<><CDUYi><E \u001cLJ9IX:?< JK8KK LE; NLI;<E 8L=>ILE; ;<I D8E><CE;<E 1<I>C<i:?98IB<iK Ei:?K <iE><J:?CFJJ<E\n 6\u0010\u00147 Literatursuche  \n \r\u0010  22..\u001f\u001f..!! \u000f\u000f\u0017\u0017TT\u0005\u0005OO\u000e\u000eEE\u0015\u0015  !XI LEJ<I -<Mi<N N8I<E <iEQi> ;i< $E=CL<EQ8\t$DG=HLFK<E E8:? \u001fLI:?=X?ILE> ;<I (8YE8?D< iE $EK<IM<E\tKiFEJ\t LE; &FEKIFCC>ILGG<E MFE $EK<I<JJ< 6\u0010\u00147\n $DG=HLFK<E N<I;<E 8LJ ;<D ,LFKi<EK MFE ><iDG=K<E LE; iEJ><J8DK I8E;FDiJi<IK<E +8Ki<EK<E QL <iE<D 9<JKiDDK<E 5<iKGLEBK 9<I<:?E<K\n  iE< JG<Qi=iJ:?<  iEJ:?IUE\tBLE> ?iEJi:?KCi:? ;<I )8:?M<I=FC>LE>J;8L<I ;<I +8Ki<EK<E N8I 8LJ LEJ<I<I .i:?K Ei:?K EFKN<E;i>\b ;8 Ji:? ;i< $DGC<D<EKi<ILE> LE;  I=FC>JD<JJLE> MFE $DG=9<DX?LE><E E8:? ;<D J8iJFE8C<E 1<IC8L= ;<I $E=CL<EQ8 Ii:?K<K\n 22..\u001f\u001f..\"\" \u0013\u0013EETTTTII\u000f\u000fGG  )LI .KL;i<E ;i< iD !8:?9<I<i:? ;<I \u001cCC><D<iED<;iQiE ;LI:?><=X?IK NLI;<E\b NLI;<E iE ;i< T9<IJi:?KJ8I9<iK <iE><J:?CFJJ<E\n 2iI ;<=iEi<IK<E ;8J .<KKiE> <EKJGI<:?<E; ;<I \u001c\u001c!+ \u0006\u001cD<Ii:8E \u001cJJF:i8KiFE F= !8DiCP +?PJi\t:i8EJ\u0007\u0016 \u001cCC><D<iED<;iQiE <I=FC>K ;LI:? <iE<E\b =XI LEJG<Qi=iJ:?<E  IJKBFEK8BK DiK +8Ki<EK<E 8LJ><9iC;<K<E LE; HL8Ci=iQi<IK<E\b \u001cIQK\n \u001fi<J<I 9<?8E;<CK +8Ki<EK<E DiK LEBC8I<E \u001cEQ<i:?<E <iE<I  IBI8EBLE>\b \"<JLE;?<iKJ\t9<;<EB<E F;<I .PDGKFD<E LE; 9<KI<LK Ji< X9<I <iE<E CUE><I<E 5<iKI8LD\n  iEJ:?IUEBLE><E ;LI:? #<IBLE=K <iE<J .PDGKFDJ\b <iE<I \u001fi8>EFJ< F;<I <iE<J *I>8EJPJK<DJ 9<JK<?<E Ei:?K\n 6\u0011\f7   \u001f8 ;i< \u001cCC><D<iED<;iQiE N<CKN<iK iE LEK<IJ:?i<;Ci:?<E !FID<E LE; \u001cLJGIU>LE><E JK8KK=iE;<K\b NLI;<E 9<i\tJGi<CJN<iJ< (\u001e*J \u0006(8E8><; \u001e8I< *I>8EiQ8KiFE\u0007\b #(*J \u0006#<8CK? (8iEK<E8E:< *I>8EiQ8KiFE\u0007 LE; M<I>C<i:?\t98I< 9<KIi<9Ci:?< 1<IJFI>LE>JJPJK<D< >C<i:?<ID8Y<E Ni< BC8JJiJ:?<\b 8CC><D<iED<;iQiEiJ:?< +I8O<E iE LEJ<I -<Mi<N 8L=><EFDD<E\n (8Y><9Ci:? N8I =XI LEJ ;i< C<KQK<E;Ci:?< 1<I8EKNFIKCi:?B<iK =XI ;<E +8Ki<EK<E\b ;i< 9<i <iE<D \u001cCC><D<iE8IQK Ci<><E DLJJK<\n  OGCiQiK 8LJ><J:?CFJJ<E N8I<E JUDKCi:?< JK8KiFEUI<E 1<IJFI>LE>J<iE\tIi:?KLE><E Ni< &I8EB<E?ULJ<I F;<I \u001cCK<E\t LE; +=C<><?<iD<\b GU;i8KIiJ:?< +I8O<E LE; \u001fi8CPJ<Q<EKI<E\n 6\u0010\u00147 \u001a\u001a\u0015\u0015\u001c\u001c \t\t\u000b\u000b\u0016\u0016EE\u0014\u0014\u0002\u0002\u0016\u0016UU\u0014\u0014\u0015\u0015UU\u0005\u0005\n\nEE  22..  ..11 \u0002\u0002LLGGOO\u0014\u0014IITTHH\u000e\u000e\u0017\u0017\u0015\u0015  \u001fi< \u001cLJ8I9<iKLE> ;<J .L:?8C>FIiK?DLJ <I=FC>K< LEK<I *Ii<EKi<ILE> 8E /?FD8J <K 8C\n 6\u0010\u00107\b LD <iE< DW>Ci:?JK JL==iQi<EK< \u001c9;<:BLE> ><E<Ii<I<E QL BWEE<E\n \u001cLY<I;<D <I=FC>K< ;i< 18Ci;i<ILE> ;LI:? <iE<E \u001di9CiFK?<B8I\n 5LI  EKNi:BCLE> ;<I .L:?JKI8K<>i< NLI;<E M<IJ:?i<;<E< &8K<>FIi<E ;<=iEi<IK\b N<C:?< LEJ<I< !FIJ:?LE>J\t=I8>< I<GIUJ<EKi<I<E JFCCK<E \u0006/89<CC< \u000e\u0007\n $EE<I?8C9 ;i<J<I &8K<>FIi<E NLI;<E \u001d<>Ii==< LE; .PEFEPD< =<JK><\tC<>K LE; DiK /ILEBi<ILE><E M<IJ<?<E\n \u001cLJ A<;<I .G8CK< DLJJK< DiE;<JK<EJ <iE \u001d<>Ii== iE ;<E .L:?=<C;<IE QL =iE;<E J<iE\b LD <iE<E /I<==<I QL ><E<Ii<I<E\n  !XI ;i< /?<J8LILJ\t.L:?< NLI;< ;i< \u001cEQ8?C ;<I &8K<>FIi<E I<;LQi<IK \u0006/89<CC< \u000f\u0007\b ;8 ;i< T9<IE8?D< ;<I &<PNFI;\t&8K<>FIiJi<ILE> <iE< iEJL==iQi<EK< /I<==<IQ8?C ><E<Ii<IK<\n  Literatursuche  \n \r\u0011  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  @@  88  \u0013\u0013\u0019\u0019''..\u0019\u0019\"\"\u0018\u0018\u0019\u0019**\u0019\u0019  \u000f\u000f++\u0017\u0017\u001c\u001c\u0016\u0016\u0019\u0019\u001b\u001b''\u001d\u001d\u001a\u001a\u001a\u001a\u0019\u0019  \u001d\u001d\"\"  \u0018\u0018\u0019\u0019''  \u000b\u000b\u0019\u001900..##''\u0018\u001877\u000f\u000f++\u0017\u0017\u001c\u001c\u0019\u001966    \u0004\u0004  ((&&%%!!\u001b\u001b  \u001c\u001c!!))\u001d\u001d\u0018\u0018))\u001d\u001d  II%%\u001e\u001e##++\u001d\u001d%%//\u0018\u0018  II%%**\u001d\u001d((,,\u001d\u001d%%**!!&&%%  \u0015\u0015\u0018\u0018\u001b\u001b\u001b\u001b!!%%\u0018\u0018**!!&&%%  \u0011\u0011\u0018\u0018**\u001d\u001d  \u0012\u0012**++\u001c\u001c..  \u001c\u001c\u001d\u001d))!!\u001f\u001f%%  chronic\u0004, longterm, condition\u0004, multiple, persist\u0004, ongoing, de-generat\u0004, high risk, disab\u0004, illn\u0004, diseas\u0004, congential, incurab\u0004, defect\u0004, disorder\u0004, sick\u0004, syndrom\u0004, dis-position\u0004, disabil\u0004, failure, asthma, copd, cir-rhos\u0004, hepatit\u0004, renal insuff\u0004, diabet\u0004, im-munodefic\u0004, immuno-suppr\u0004, scleros\u0004, HIV, human immuno-defi-ciency virus, AI\u0019S, aBuired immuno-defi-ciency syndrome, can-cer\u0004, malign\u0004, tumor\u0004 influenza\u0004, flu system\u0004, strateg\u0004, pro-gram\u0004, campaign\u0004, ed-ucat\u0004, participat\u0004, re-mind\u0004 system\u0004, re-call\u0004, postcard\u0004, let-ter\u0004, \u0004phone cam-paign\u0004, \u0004phone call\u0004, financial incentiv\u0004, en-couragement, motiva-tion, buisness hour\u0004, opening hour\u0004, home visit\u0004, house call\u0004, bu-reaucracy, transfer\u0004, responsib\u0004, compe-ten\u0004, liabil\u0004, inform\u0004, remind\u0004, commendat\u0004 immun\u0004, vaccin\u0004, unvaccin\u0004, unimmun\u0004, in-oculat\u0004 rate, uptake, cov-erage, target, per-centage randomized con-trolled trial, controlled clinical trial, random-ized, placebo, drug therapy, randomly, trial, groups, double blind, rct, controlled \nW\u00f6rter innerhalb einer Spalte wurde mit \u201eOR\u201c, Spalten untereinander mit \u201eAND\u201c verkn\u00fcpft.  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  AA  88  \u0013\u0013\u0019\u0019''..\u0019\u0019\"\"\u0018\u0018\u0019\u0019**\u0019\u0019  \u000f\u000f++\u0017\u0017\u001c\u001c\u0016\u0016\u0019\u0019\u001b\u001b''\u001d\u001d\u001a\u001a\u001a\u001a\u0019\u0019  \u001d\u001d\"\"  \u0018\u0018\u0019\u0019''  \u0010\u0010\u001c\u001c\u0019\u0019((\u0014\u0014++''++((77\u000f\u000f++\u0017\u0017\u001c\u001c\u0019\u001966    \u0010\u0010\u0018\u0018**!!\u001d\u001d%%**))  II%%\u001e\u001e##++\u001d\u001d%%//\u0018\u0018  II%%**\u001d\u001d((,,\u001d\u001d%%**!!&&%%  \u0015\u0015\u0018\u0018\u001b\u001b\u001b\u001b!!%%\u0018\u0018**!!&&%%  chronic disease, congenital disorder, asthma, chronic obstructive lung disease, cardiomyopa-thies, immunosuppression, diabetes mellitus, neoplasms, human immunodeficiency virus, acBuired immune deficiency syndrome influenza preventive health service, house call, medical staff, atti-tude to health immunity, vaccines W\u00f6rter innerhalb einer Spalte wurde mit \u201eOR\u201c, Spalten untereinander mit \u201eAND\u201c verkn\u00fcpft.  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  BB  88  \u0002\u0002\"\"\u001b\u001b\u0014\u0014\u0016\u0016\u0019\u0019\"\"  11++''  \u0018\u0018++''\u0017\u0017\u001c\u001c\u001b\u001b\u0019\u0019\u001a\u001a,,\u001c\u001c''**\u0019\u0019\"\"  \u000f\u000f++\u0017\u0017\u001c\u001c((**''\u0014\u0014**\u0019\u0019\u001b\u001b\u001d\u001d\u0019\u0019  \u0005\u0005\u0018\u0018**++$$  \u001c\u001c\u001d\u001d((  \u0012\u0012++\u001b\u001b  \u001d\u001d  \u0005\u0005\u0018\u0018**\u001d\u001d%%\u001a\u001a\u0018\u0018%%\"\"  \u000b\u000b\u001d\u001d..--&&((\u001c\u001c))++22\u001b\u001b  \u001d\u001d  ,,!!\u0018\u0018  \u0013\u0013  \u001d\u001d))\u0018\u0018++((++))))++22\u001b\u001b  \u001d\u001d  ,,!!\u0018\u0018  \u0002\u0002\u001a\u001a\u001f\u001f\u001d\u001d\u001c\u001c\u001d\u001d\u001b\u001b\"\"**\u001d\u001d((  \u0010\u0010++\u001a\u001a##!!\"\"\u0018\u0018**!!&&%%))//\u001d\u001d!!**((\u0018\u0018++$$  26\u0007\n\t\u00072\t\n8 EMBASE $vid 05\n1 \n\u0012\u00104 Y 2\t\n8, Woche 42 2\u0012\u0007\n\t\u00072\t\n8 ME\u0019!I#E $vid PubMed 0521 \n\u001246 Y $ktober 2\t\n8 ,Woche \f 2\u0012\u0007\n\t\u00072\t\n8 \u0018E#TRA! \u0018ochrane !ibrary 05\f1 Bis Issue \n\t\b2\t\n8 2\u0012\u0007\n\t\u00072\t\n8 ERI\u0018 ERI\u0018 0541 - Keine Einschr\u00e4nkungen  \u0015tudienselektion  \n \r\u0012  1FI \u001fLI:?=X?ILE> ;<I .L:?< <I=FC>K<E ;i<  M8CL8KiFE ;<I .KI8K<>i< DiK <iE<D \u001di9CiFK?<B8I JFNi< D<?I<I< \u001c;8GK8KiFEJJ:?IiKK<\b LD ;i< T9<IKI8>98IB<iK ;<J \u001cC>FIiK?DLJ 8L= ;i< M<IJ:?i<;<E<E \u001f8K<E98EB<E LE; .L:?\tD8J:?iE<E QL ><NU?IC<iJK<E\n  22..  ..22 \u0005\u0005\u0017\u0017\u0014\u0014\u0005\u0005HH\b\b\u0018\u0018HH\u0014\u0014\u0017\u0017\u000f\u000fGG  2iI =X?IK<E LEJ<I< -<:?<I:?< Ni< F9<E 9<J:?Ii<9<E iE ;I<i D<;iQiEiJ:?<E LE; <iE<I C<?INiJJ<EJ:?8=KCi:?<E \u001f8K<E98EB ;LI:?\n \u001fLI:?JL:?K NLI;<E  (\u001d\u001c. \b ( \u001f'$) \b \u001e )/-\u001c' LE;  -$\u001e\n \u001f<K8iCJ JiE; iE /8\t9<CC< \u0010 QL =iE;<E\n \u001f<J 2<iK<I<E JL:?K<E NiI E8:? 8BKL<CC C8L=<E;<E F;<I LEGL9CiQi<IK<E .KL;i<E 8L= :CiEi:8CKIi8CJ\n>FM 6\u0011\u00117 LE; :CiEi:8CKIi8CJI<>iJK<I\n<L 6\u0011\u00127\n 5L >LK<I '<KQK =X?IK<E NiI <iE< D8EL<CC< .L:?< iE ;<E -<=<I<EQ<E 8E;<I<I JPJK<\tD8KiJ:?< -<Mi<NJ QL M<I>C<i:?98I<E /?<D<E ;LI:?\n \u001fi< .L:?GIFKFBFCC< =XI ;i< A<N<iCi><E \u001f8K<E98EB<E =iE\t;<E Ji:? iD \u001cE?8E> \u0006Ji<?<  $\u0007\n  )8:? \u001dI8D<I <K 8C\n CUJJK Ji:? M<IDLK<E\b ;8JJ NiI 8CC<iE< ;LI:? LEJ<I< \u001f8K<E98EB8LJN8?C DiE;<JK<EJ \u0015\f\u0003 ;<I I<C<M8EK<E .KL;i<E i;<EKi=iQi<I<E BFEEK<E 6\u0011\u00137\n \u001a\u001a\u0015\u0015\u001d\u001d \u000e\u000e\u0016\u0016UUDD\u000b\u000bEE\u0010\u0010\u0015\u0015EELLEEKK\u0016\u0016\u000b\u000b\u0011\u0011\u0010\u0010  22..!!..11 \u0014\u0014IITTEELL\u001a\u001a\u0002\u0002\u0004\u0004\u0015\u0015TT\u0014\u0014AA\u0005\u0005TT\u001a\u001a\u0013\u0013EELLEE\f\fTTIIOO\u000f\u000f  \u001fi< iE ;<I .L:?< ><=LE;<E<E -<=<I<EQ<E NLI;<E ><JG<i:?<IK LE; iE  E;)FK< iDGFIKi<IK\n #i<I 9<N<IK<K<E QN<i -<Mi<N<I \u0006'. \u0004Dr. rer. nat. Linda Sanftenberg\u0005 LE; !\u001d \u0004Felix Brombacher\u0005\u0007 LE89?UE>i> MFE<iE8E;<I /iK<C LE; \u001c9JKI8:K ;<I .KL;i<E iE \u001d<QL> 8L= LEJ<I<  iEJ:?CLJJBIiK<Ii<E LE; FI;E<K<E Ji< iE ;i< &8K<>FIi<E Included\b Excluded LE; Unsure <iE\n \u001cCC< -<=<I<EQ<E\b 9<i N<C:?<E ;i< &8K<>FIiJi<ILE><E 9<i;<I -<Mi<N<I Ei:?K X9<I<iE\tJKiDDK<E\b NLI;<E 8CJ &FE=CiBK< 9<?8E;<CK\n \u001cCC< -<=<I<EQ<E iE ;<I ;IiKK<E &8K<>FIi< NLI;<E ><D<iEJ8D DiK ;<D A<N<iCJ 8E;<I<E -<Mi<N<I 9<N<IK<K LE; 9<i \u001d<;8I= <9<EJF 8CJ &FE=CiBK< ><=X?IK\n \u001fi<J< NLI;<E ><E<I<CC ;LI:? &FEJ<EJ ><CWJK\n &FEEK< B<iE<  iEi>LE> ><KIF==<E N<I;<E\b =UCCK< <iE ;IiKK<I -<Mi<N<I \u0006%\" \u0004Prof. Dr. med. Dipl.-P\u00e4d. Jochen Gensichen, MPH\u0005\u0007 ;i<  EKJ:?<i;LE>\n $D 5N<i=<C NLI;<E .KL;i<E iE ;i< 1FCCK<OK\t.<C<BKiFE <iE><J:?CFJJ<E\b LD ;<E 1<ICLJK MFE ><<i>E<K<E .KL;i<E 8L= ;<I /iK<C\t\u001c9JKI8:K\t 9<E< QL M<ID<i;<E\n 22..!!..22 \u0016\u0016OOLLLLTTEE\u001b\u001bTT\u001a\u001a\u0003\u0003EE\u0015\u0015\u0005\u0005HHAA\b\b\b\b\u0017\u0017\u000f\u000fGG   iE 1<IJL:? ;<I 1FCCK<OK9<J:?8==LE> NLI;< =XI 8CC< .KL;i<E ;LI:?><=X?IK\b N<C:?< MFE 9<i;<E -<Mi<N<IE F;<I E8:? \u001c9J:?CLJJ <iE<J &FE=CiBK<J 8CJ GFK<EQi<CC <iEJ:?CLJJ=U?i> 9<N<IK<K NFI;<E N8I<E\n #i<IQL NLI;< <iE D<?IJKL=i><J 1<I=8?I<E 8E><N8E;K\n \u0006\r\u0007 1<IJL:? X9<I ;i< 8LKFD8KiJ:?< 1FCCK<OK9<J:?8==LE>J=LEBKiFE MFE  E;)FK<\b \u0006\u000e\u0007 .L:?< E8:?  iEKIU><E iE +L9(<;\b \u0006\u000f\u0007 .L:?< X9<I \"FF>C<\b \u0006\u0010\u0007 .L:?< X9<I \"FF>C< .:?FC8I\b \u0006\u0011\u0007 .L:?< X9<I *Mi;\n 2<EE 9iJ ?i<I?iE B<iE 1FCCK<OK i;<EKi=iQi<IK N<I;<E BFEEK<\b NLI;< \u0006\u0012\u0007 <EKN<;<I <iE< \u001d<\tJK<CCLE> 9<iD 'i<=<I;i<EJK .0\u001d$/* \u0006SUBITO P Dokumente aus Bibliotheken e.-., Berliner Strasse \u0010\u000e, \f\u000b\u0012\f\u000e Berlin\u0005 \u0013ualit\u00e4tsbewertung  \n \r\u0013  iE \u001cL=KI8> ><><9<E\b iD +IUJ<EQ9<JK8E; MFE \u001di9CiFK?<B<E ><JL:?K F;<I <iE< BFJK<EG=Ci:?K< *GKiFE 8L= $EK<I\tE<KGIUJ<EQ<E MFE 1<IC8><E iE \u001cEJGIL:? ><EFDD<E\n $E ;<I EU:?JK<E .KL=< NLI;<E \u0006\u0013\u0007 \u001cLKFI<E G<I  \t(8iC BFEK8BKi<IK\b iEJF=<IE &FEK8BKiE=FID8KiFE<E M<I=X>98I N8I<E\n 28I ;LI:? 8CC< ;i<J< (8YE8?D<E B<iE< \u001d<\tJ:?8==LE> ;<J 1FCCK<OK<J DW>Ci:?\b NLI;< ;i< .KL;i< 8LJ><J:?CFJJ<E LE; Kein -olltext verfNgbar 8CJ \"ILE; 8E\t><><9<E\n 22..!!..\u001f\u001f \u0016\u0016OOLLLLTTEE\u001b\u001bTT\u001a\u001a\u0013\u0013EELLEE\f\fTTIIOO\u000f\u000f  (iK #iC=< <iE<J (i:IFJF=K\t\u001c\u001e\u001e ..Z\t.?<<KJ \u0004\r\u000b\f\u0011 MSO \u0004\f\u0011.\u000b.\u000f\u0012\u000e\u0013.\f\u000b\u000b\u000b\u0005 \u000e\r-bit\u0005 <I=FC>K< <iE< \u001d<N<IKLE> ;<I GFK<EQi<CC ><<i>E<K<E  1FCCK<OK< 9<QX>Ci:? LEJ<I<I  iEJ:?CLJJBIiK<Ii<E \u0006\u000e\n\u000f\n\u000f\t\u000e\n\u000f\n\u0012\u0007 ;LI:? <iE<E \u001cLKFI \u0006!\u001d\u0007\n  iE< QN<iK< \u001cLKFIiE X9<IGIX=K< ;i< \u001cLJN8?C JKi:?GIF9<E8IKi> LE; JK8E; 9<i 0EBC8I?<iK<E QLI 1<I=X>LE> \u0006'.\u0007\n &FE=CiBK< NLI;<E iD &FEJ<EJ ><CWJK\n 28I B<iE<  iEi>LE> DW>Ci:?\b <EKJ:?i<; <iE ;IiKK<I \u001cLKFI \u0006%\"\u0007\n \u001f<I C<KQK<E;Ci:?< .KL;i<E<iEJ:?CLJJ iE LEJ<I -<Mi<N <I=FC>K< 8L= ;i<J<D '<M<C\n \u001a\u001a\u0015\u0015\u001e\u001e \f\fUU\u0002\u0002LL\u000b\u000b\u0016\u0016\u0003\u0003\u0016\u0016\u0015\u0015BBEE\u001a\u001aEE\u0014\u0014\u0016\u0016UU\u0010\u0010\t\t  22..\"\"..11 \u0004\u0004OO\u0005\u0005HH\u0014\u0014AA\u000f\u000fEE\u0001\u0001\u0012\u0012II\u0015\u0015\f\f\u0001\u0001OO\b\b\u0001\u0001\u0003\u0003IIAA\u0015\u0015\u0001\u0001\u0014\u0014OOOOLL  \u001fi< \u001d<N<IKLE> ;<I JPJK<D8KiJ:?<E !<?C<I8E=UCCi>B<iK ;<I .KL;i<E <I=FC>K< DiK ;<D \u001eF:?I8E< -iJB F= \u001di8J /FFC 6\u0011\u00147\n \u001fi<J<J <EK?UCK iEJ><J8DK Ji<9<E &8K<>FIi<E LE; 9<N<IK<K ;i<J< DiK A<N<iCJ Ei<;Ii><D\b LE9<B8EE\tK<D F;<I ?F?<D 1<IQ<IILE>JIiJiBF\u0016  b\r\u0007 \"<E<Ii<ILE> ;<I -8E;FDiJi<ILE>JJ<HL<EQ \u0006\n\n\n\u0007\b \u000e\u0007 \"<?<iD?8CKLE> LE; 0EMFI?<IJ<?98IB<iK ;<I \"ILGG<E\tQLK<iCLE> \u0006\n\n\n\u0007\b \u000f\u0007 1<I9CiE;LE> MFE .KL;i<EG<IJFE8C\u000b\tK<iCE<?D<IE NU?I<E; ;<I \u001d<?8E;CLE> \u0006\n\n\n\u0007\b \u0010\u0007 1<I9CiE\t;LE> 9<i ;<I  E;GLEBK<I?<9LE>\u000b\t9<N<IKLE> \u0006\n\n\n\u0007\b \u0011\u0007 !<?C<E;< \u001f8K<E 9<i ;<I  E;GLEBK<I?<9LE> \u0006\n\n\n\u0007\b \u0012\u0007 .<\tC<BKiM<J \u001d<Ii:?K<E MFE  E;GLEBK<E \u0006\n\n\n\u0007\b \u0013\u0007 \u001cE;<I< 0IJ8:?<E =XI \u001di8J\n` 6\u0011\u00147\n   \u001fi< \u001d<N<IKLE> <I=FC>K< DiKK<CJ <iE<J iD \u001f8K<E<OKI8BKiFEJJ?<<K iEK<>Ii<IK<E !FIDLC8IJ ;LI:? <iE<E \u001cLKFI \u0006!\u001d\u0007\b <iE< \u001d<>IXE;LE> DLJJK< =XI A<;<  EKJ:?<i;LE> 8E><><9<E N<I;<E\n  iE< QN<iK< \u001cLKFIiE \u0006'.\u0007 GIX=K< ;i< \u001d<N<IKLE><E 8E?8E; ;<I ;FBLD<EKi<IK<E \u001d<>IXE;LE><E LE; =X?IK< 9<i \u001d<;8I= \u001cEG8JJLE><E ;LI:?\n &FE\t=CiBK< NLI;<E ;LI:? &FEJ<EJ ><CWJK\n &FEEK< B<iE<  iEi>LE> ><=LE;<E N<I;<E\b KI8= <iE ;IiKK<I \u001cLKFI \u0006%\"\u0007 ;i<  EKJ:?<i;LE>\n 22..\"\"..22 PP\u0012\u0012\n\n\u0013\u0013\r\r\u0002\u0002\u001a\u001a\f\fEEIITTLLII\u000f\u000fIIEE  \u001f8J +-$.(\u001c\t.K8K<D<EK \u0006/I8EJG8I<EK -<GFIKiE> F= .PJK<D8Ki: -<Mi<NJ 8E; (<K8\t\u001cE8CPJiJ\u0007 6\u0011\u00157 iJK <iE< '<iK\tCiEi< =XI \u001cLKFI<E MFE +L9CiB8KiFE<E QL JPJK<D8KiJ:?<E -<Mi<NJ LE; 9<J:?I<i9K\b N<C:?< $E=FID8KiFE<E <iE JFC:?<I \u001cIKiB<C <EK?8CK<E JFCCK<\b LD ;<D '<J<I ;i< MFCCLD=UE>Ci:?<  I=8JJLE> ;<I  I><9EiJJ< LE; ;i<  iE\tJ:?UKQLE> ;<J \u001di8J\t-iJiBFJ QL <IC8L9<E\n \u001f8J ><J8DK< 1FI><?<E 9<i ;i<J<D +IFA<BK\b ;i<J<I \u001fiJJ<IK8KiFE LE; 8CC<E ;8I8L= 9<IL?<E;<E +L9CiB8KiFE<E NLI;< E8:? +-$.(\u001c ><GC8EK LE; ><GIX=K\n  iE< \u001cL=JK<CCLE> ;<I <DG\t=F?C<E<E  C<D<EK< DiK 1<IN<iJ<E 8L= ;<E A<N<iCi><E *IK B8EE iD \u001cE?8E> \u0006Ji<?<   $$$\b /89<CC< \u0015\u0007 <iE><J<?<E \u0013ualit\u00e4tsbewertung  \n \r\u0014  N<I;<E\n 22..\"\"..\u001f\u001f \u0011\u0011\u0017\u0017AALLIITT\u0003\u0003TT\u0015\u0015\b\bAA\f\fTTOO\u0014\u0014  5LI 1<I9<JJ<ILE> ;<I 1<I>C<i:?98IB<iK QNiJ:?<E ;<E .KL;i<E NLI;< QLJUKQCi:? <iE ,L8CiKUKJ=8BKFI \u0006,!\u0007 8LJ ;<E <iEQ<CE<E &8K<>FIi<E ;<J -iJB\tF=\t\u001di8J\t/FFCJ <II<:?E<K\n !XI A<;< &8K<>FIi< NLI;< <iE Ei<;Ii><J DiK ;I<i\b <iE LE9<B8EEK<J DiK <iE<D LE; <iE ?F?<J -iJiBF DiK ELCC +LEBK<E 9<N<IK<K\n \u001f8E8:? NLI;< =XI A<;< .KL;i< ;i< .LDD< 8LJ ;<E <iEQ<CE<E \u001d<GLEBKLE><E ><9iC;<K LE; 8E><><9<E\n \ud835\udc44\ud835\udc44\ud835\udc44\ud835\udc44=\ud835\udc5b\ud835\udc5b!\"#$%\"&#'\t)\"'\"*+\u00d73+\ud835\udc5b\ud835\udc5b,!-#*.!!/#'\t)\"'\"*+\u00d71+\ud835\udc5b\ud835\udc5b0+0#'\t)\"'\"*+\u00d70 #i<I9<i <EKJGI8:?<E  I><9EiJJ< QNiJ:?<E \f LE; \r\f +LEBK<E <iE<I Ei<;Ii><E\b QNiJ:?<E \r\r LE; \r\u0010 +LEBK<E <iE<I DiKK<CDUYi><E LE; MFE DiE;<JK<EJ \r\u0011 +LEBK<E <iE<I ?F?<E ,L8CiKUK\n 22..\"\"..   \u0015\u0015\u000e\u000eGGAA\u000f\u000fGG\u0001\u0001\u000e\u000eIITT\u0001\u0001\u0004\u0004LL\u0017\u0017\u0015\u0015TTEE\u0014\u0014\u001a\u001a\u0012\u0012AA\u000f\u000f\u0006\u0006OO\u000e\u000eII\u0015\u0015IIEE\u0014\u0014\u0017\u0017\u000f\u000fGG  \u001eCLJK<I\t-8E;FDiJi<ILE> iJK =XI .KL;i<E iD .<KKiE> ;<I 8D9LC8EK<E +8Ki<EK<EM<IJFI>LE> >LK ><<i>E<K LE; NiI; ?i<I F=K 8E><N8E;K\n .FDiK N8I ;i< 28?IJ:?<iECi:?B<iK ;<J \u001cL=KI<K<EJ JFC:?<I -8E;FDiJi<ILE>JD<:?8EiJD<E iE LEJ<I<D +IFA<BK J<?I ?F:?\n \u001d<i ;i<J<I (<K?F;< <I=FC>K ;i< 5LK<iCLE> QL \"ILGG<E 8L= <iE<I 8E;<I<E  9<E< 8CJ ;i< (<JJLE> ;<J *LK:FD<J\n \u001fi<J B8EE QL <iE<D 0EiK\tF=\t8E8CPJiJ\t<IIFI =X?I<E\b N<C:?<I ;8EE 8IKi=iQi<CC BC<iE< &FE=i;<EQiEK<IM8CC< \u0006\u001e$\u0007 LE; G\t2<IK< ><E<Ii<IK 6\u0012\f\b \u0012\r7\n 5LI &FDG<EJ8KiFE ;i<J<J  ==<BK<J iJK ;i< \u001cEN<E;LE> MFE 8LJ>C<i:?<E;<E (<K?F;<E NU?I<E; ;<I  I><9EiJ8LJN<IKLE> EFKN<E;i>\b 8CC<I;iE>J =iE;<K ;i<J JG<Qi<CC iE UCK<I<E .KL;i<E ?UL=i> Ei:?K F;<I Ei:?K JL==iQi<EK JK8KK 6\u0012\u000e7\n   5LI (iEiDi<ILE> ;<J DW>Ci:?<E !<?C<IJ 9<ELKQK<E NiI =XI LEJ<I -<Mi<N JL==iQi<EK 8E><G8JJK<  I><9EiJJ< 6\u0012\u000f7\b iEJF=<IE ;i<J< M<I=X>98I N8I<E\n \u001fi< (W>Ci:?B<iK <iE<I \u001cE>C<i:?LE> ;LI:? LEJ<I \u001cLKFI<EK<8D N8I ?W:?JK LEN8?IJ:?<iECi:?\b ;8 ;i< ?i<I=XI EFKN<E;i><E \u001f8K<E iE ;<I -<><C Ei:?K 9<Ii:?K<K N<I;<E\n 5LI (8Oi\tDi<ILE> ;<I /I8EJG8I<EQ 9<Ii:?K<K<E NiI iE LEJ<I<E  I><9EiJK89<CC<E ;i< \u001cEQ8?C ;<I \u001eCLJK<I\b DW>Ci:?<IN<iJ< 8E><N<E;<K< .KI8Ki=iQi<ILE><E NU?I<E; ;<I -8E;FDiJi<ILE> LE; F9 <iE< \u001cEG8JJLE> ;<I C<KQK<E;Ci:? M<IN<E\t;<K<E \u001f8K<E ;LI:? ;i< \u001cLKFI<E ;<I .KL;i< DiK <iE<I ><<i>E<K<E JK8KiJKiJ:?<E (<K?F;< <I=FC>K N8I\n 22..\"\"..!! \u0016\u0016EE\u0014\u0014\u001d\u001dEE\u0014\u0014\u0014\u0014\u0017\u0017\u000f\u000fGG\u0015\u0015\u0014\u0014II\u0015\u0015II\f\fOO\u0001\u0001\u0018\u0018\u0004\u0004EE\u0014\u0014\u0001\u0001\u0006\u0006IIEE\u0001\u0001\u0013\u0013TT\u0017\u0017\u0006\u0006IIEE\u000f\u000f\u0001\u0001HHII\u000f\u000f\u001a\u001aEEGG  5LI \u001c9J:?UKQLE> ;<J 1<IQ<IILE>JIiJiBFJ X9<I ;i< .KL;i<E ?iEN<> NLI;< ;<I ,L8CiKUKJ9<I<i:? ;<I .KL;i<E E8II8KiM <iE9<QF><E\n \u001cLY<I;<D <I=FC>K< ;i< \u001c9J:?UKQLE> ;<J +L9CiB8KiFEJ\t\u001di8J DiK #iC=< MFE !LEE<C +CFKJ\n Datensammlung  \n \r\u0015  \u001a\u001a\u0015\u0015\u001f\u001f \u0004\u0004\u0002\u0002\u0016\u0016EE\u0010\u0010\u0015\u0015\u0002\u0002MMMMLLUU\u0010\u0010\t\t  22..##..11 \u0005\u0005AATTEE\u000f\u000fEE\u001b\u001bTT\u0014\u0014AA\f\fTTIIOO\u000f\u000f  2.;.1.1 \u0015O\u0011\u0015\u0003E\u0011\fE\b\u0014N\bEN \u001f8J \u001e*).*-/\t.K8K<D<EK 6\u0012\u00107 iJK <iE< '<iKCiEi< =XI ;i< \u001cLKFI<E MFE +L9CiB8KiFE<E QL I8E;FDiJi<IK<E\b BFE\tKIFCCi<IK<E .KL;i<E LE; 9<J:?I<i9K ;i< $E=FID8KiFE<E\b ;i< <iE JFC:?<I \u001cIKiB<C <EK?8CK<E JFCCK<\b ;8DiK ;<I '<J<I  I><9EiJJ< iE MFCC<D 0D=8E> M<IJK<?<E LE; 'iDiK8KiFE<E <I=8JJ<E B8EE\n \u001cCC< iE ;<I <EKJGI<:?<E;<E \u001e?<:B\tCiJK< 6\u0012\u00117 <EK?8CK<E<E  C<D<EK< NLI;<E =XI LEJ<I< \u001f8K<E<OKI8BKiFE 8LJ><NU?CK\n  iE< \u001cL=JK<CCLE> ;<I <OKI8\t?i<IK<E $K<DJ\b <9<EJF 9<Ii:?K<K iE LEJ<I<D +IFKFBFCC 6\u0010\u00147\b =iE;<K Ji:? iD \u001cE?8E> \u0006Ji<?<   $$\b /89<CC< \u0014\u0007\n  2.;.1.2 \u0005\u0014\u0011\u0004\t\u0007\u0015\t\u0011\u0014N\b \u001cCJ \u001f8K<E<OKI8BKiFEJJ?<<K NLI;< <iE< I<C8KiFE8C< \u001f8K<E98EB DiK (i:IFJF=K \u001c\u001e\u001e ..Z <IJK<CCK \u0006!\u001d\u0007\n \u001fi<J< <EK?i<CK <iE<  iE>89<D8JB< iE !FID <iE<J !FIDLC8IJ JFNi< ;i< (W>Ci:?B<iK QLI \u001cLJ>89< MFE \u001d<Ii:?K<E QL ;<E <iEQ<CE<E .KL;i<E LE;  OKI8BKiFEJiK<DJ\n $E ;i<J< \u001f8K<E98EB NLI;<E ;i< +8I8D<K<I E8:? \u001e*).*-/ =XI 8CC< <iE><J:?CFJJ<E<E .KL;i<E <iE><G=C<>K \u0006!\u001d\u0007\n  iE< QN<iK< \u001cLKFIiE =X?IK< JKi:?GIF9<E8IKi>< T9<IGIX\t=LE><E ;LI:? LE; JK8E; =XI !I8><E QLI 1<I=X>LE> \u0006'.\u0007\n !XI N<iK<I< \u001d<I<:?ELE><E <I=FC>K< QLJUKQCi:? ;i<  I=8JJLE> MFE +8Ki<EK<EQ8?C<E LE; *LK:FD<\t+8I8D<K<IE iE JK8E;8I;iJi<IK<E (i:IFJF=K\t 3\u001e 'Z\t.?<<KJ \u0004\r\u000b\f\u0011 MSO \u0004\f\u0011.\u000b.\u000f\u0012\u000e\u0013.\f\u000b\u000b\u000b\u0005 \u000e\r-bit\u0005 \u0006!\u001d\u0007\n 22..##..22 \u0013\u0013TTAATTII\u0015\u0015TTII\u0015\u0015\u0005\u0005HHEE\u0001\u0001\r\rEETTHHOO\u0006\u0006EE\u000f\u000f  +8Ki<EK<EQ8?C<E\b $DG=HLFK<E\b  ==<BK>IWY<E\b &FE=i;<EQiEK<IM8CC< LE;  I><9EiJJ< MFE .i>Ei=iB8EQK<JKJ NLI\t;<E ><E<I<CC DiK ;<I D8OiD8C DW>Ci:?<E \"<E8Li>B<iK <I=8JJK\n 28I<E iE <iE<I +L9CiB8KiFE B<iE<  I><9EiJJ< =XI LEJ<I< JG<Qi=iJ:?< +8Ki<EK<EGFGLC8KiFE 9<Ii:?K<K\b JF NLI;<E 9<i JFEJK 8LJI<i:?<E;<I \u001f8K<EC8>< ;i<  I\t><9EiJJ< =XI ><<i>E<K< .L9>ILGG<E ;LI:? <iE=8:?< \u001c;;iKiFE LE; .L9KI8BKiFE iE (i:IFJF=K  3\u001e 'Z 9<I<:?\tE<K\n \u001cLJ>8E>JGLEBK N8I<E ?i<I=XI ><iDG=K< LE; ><J8DK< +8Ki<EK<EQ8?C GIF \"ILGG< LE; .L9GFGLC8KiFE\n &FEEK< <iE< T9<IJ:?E<i;LE> QNiJ:?<E .L9>ILGG<E F;<I \tGFGLC8KiFE<E Ei:?K 8LJ><J:?CFJJ<E N<I;<E F;<I N8I ;i< \u001f8K<EC8>< Ei:?K 8LJI<i:?<E;\b JF NLI;<E ;i<  I><9EiJJ< J<G8I8K ;8I><JK<CCK\n $D \u001cEJ:?CLJJ ;8I8E NLI;<E\b N<EE DW>Ci:?\b -iJB -8KiFJ \u0006--\u0007 LE; &FE=i;<EQiEK<IM8CC< 8L= \u001d8JiJ MFE +8Ki<E\tK<EQ8?C LE;  M<EKJ GIF \"ILGG< DiK -<M(8E \u0004-ersion \u0010.\u000e. Copenhagen\u0015 The Nordic Cochrane Centre, The Cochrane Collaboration, \r\u000b\f\u000f\u0005  JK8E;8I;iJi<IK 9<I<:?E<K\n \u001cCJ \"ILE;C8>< ;i<EK<E ;i< (8<EK<C\t#8<EQ<C\t.K8KiJKiB\b <iE &FE\t=i;<EQEiM<8L MFE \u0015\u0011\u0003 LE; ;8J -8E;FD  ==<:KJ (F;<C\b =XI N<C:?<J NiI LEJ 8L=>ILE; ;<I\b QL <IN8IK<E;<E\b ?F?<E #<K<IF><EiKUK QNiJ:?<E ;<E .KL;i<E <EKJ:?i<;<E\n \u001f<J 2<iK<I<E NLI;<E DiK (i:IFJF=K  3\u001e 'Z K<iC\tN<iJ< $DG=HLFK<E 8LJ +8Ki<EK<EQ8?C<E J<C9JK 9<I<:?E<K LE; iE ;<E .KL;i<E 8E><><9<E<  ==<BKJKUIB<E iE --J BFEM<IKi<IK\n Datens8nthese  \n \u000e\f  \u001a\u001a\u0015\u0015   \u0004\u0004\u0002\u0002\u0016\u0016EE\u0010\u0010\u0015\u0015\u001c\u001c\u0010\u0010\u0016\u0016\n\nEE\u0015\u0015EE  22..$$..11 \u000b\u000bOO\u000f\u000fTT\u0014\u0014OOLLLLGG\u0014\u0014\u0017\u0017\u0012\u0012\u0012\u0012EE\u000f\u000f  \u001fi< K8KJU:?Ci:?< 0DJ<KQLE> MFE &FEKIFCC>ILGG<E\b ;i< iE ;<I .KL;i< 8CJ keine Intervention F;<I Nbliche -ersorgung \u0006<E>C\n usual care\u0007 9<KiK<CK N<I;<E\b M8Iii<IK K<iCJ JK8IB QNiJ:?<E +L9CiB8KiFE<E 6\u0012\u0012\b \u0012\u00137\n \u001c9?UE>i>B<iK<E 9<JK<?<E ?i<I 9<QX>Ci:? ;<J \"<JLE;?<iKJJPJK<DJ\b ;<J .<KKiE>J LE; ;<I 1FCCJKUE;i>B<iK ;<I \u001cE>89<E iE ;<I .KL;i<\n 2<EE Ei:?K 8E;<IJ 8E><><9<E\b JF NLI;<E  ==<BK>IWY<E JK<KJ 8LJ ;<D 1<I>C<i:? MFE $EK<IM<EKiFE LE; &FEKIFCC\t>ILGG< DiK X9Ci:?<I 1<IJFI>LE> 9<I<:?E<K\n  iE< ><NiJJ< $EK<IGI<K8KiFEJ=I<i?<iK E8?D<E NiI LEJ 9<i .KL;i<E\b N<C:?< JFNF?C iE &FEKIFCC\t 8CJ 8L:? iE $EK<IM<EKiFEJ>ILGG< ;i< >C<i:?<E 5LJ8KQD8YE8?D<E 8EN8E;K<E\b iE ;i<J<D !8CC NLI;< 9<i .iEE?8=Ki>B<iK ;i< 5LJ8KQiEK<IM<EKiFE i>EFIi<IK LE; ;<I 0EK<IJ:?i<; QNiJ:?<E 9<i;<E \"ILGG<E 8CJ \u001cEJ8KQ M<IN<E;<K\b ;<I 1<I>C<i:? =8E; ;8EE <EKJGI<:?<E; $EK<IM<EKiFE ><><E B<iE< $EK<IM<EKiFE JK8KK\n 22..$$..22 \u0002\u0002\u0017\u0017\u0015\u0015\u001a\u001aAAHHLL\u0001\u0001\u0006\u0006EE\u0015\u0015\u0001\u0001\u0006\u0006\b\b\b\bEE\f\fTT\u000e\u000eAA\u001e\u001eEE\u0015\u0015  \u001cCJ  ==<BKD8Y NU?CK<E NiI ;i< -iJB -8KiF\b ;8 Ji< ;LI:? i?I< \u001cEJ:?8LCi:?B<iK ;i< &FDG8I8KiFE <IC<i:?K<IK\n  iE 1<I>C<i:? QNiJ:?<E $EK<IM<EKiFEJ\t LE; &FEKIFCC>ILGG<E\b ;i< )FID8CM<IJFI>LE> F?E< $EK<IM<EKiFE <I?i<CK<E\b NLI;< ?i<I9<i 9<MFIQL>K\n  EK?i<CK <iE< +L9CiB8KiFE <iE< JFC:?< \"ILGG< Ei:?K\b NLI;<E --J QNiJ:?<E M<IJ:?i<\t;<E<E $EK<IM<EKiFEJ>ILGG<E 9<I<:?E<K LE; ;i<  I><9EiJJ< ><B<EEQ<i:?E<K\n 1FIK<iC< ;<I -- JiE; ;i< (W>\tCi:?B<iK ;<I \u001d<I<:?ELE> 8LJ 8CC<E .KL;i<E\b ;i< $DG=HLFK<E 9<Ii:?K<E LE; ;i< iEKLiKiM< $EK<IGI<K8KiFE\n 22..$$..\u001f\u001f \b\b\u0014\u0014\u0017\u0017\u0012\u0012\u0012\u0012IIEE\u0014\u0014\u0017\u0017\u000f\u000fGG\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f  2.<.3.1 \b\u0011\u0014\u0010\u0010IE\u0011\u0014N\b\u0001NA\u0004\t\u0001\u0002\u0011T\u0001DE\u0011\u0001INTE\u0011\u0016ENTION \u001fi< $EK<IM<EKiFE<E ;<I <iE><J:?CFJJ<E<E .KL;i<E NLI;<E iE \u001cI<8C<\b &8K<>FIi<E JFNi< E8:? \"I8; ;<I &FD\tGC<OiKUK LE; QLJUKQCi:?<E $E?8CK<E >ILGGi<IK\n \u001f<J 2<iK<I<E >Ci<;<IK<E NiI E8:? ><JLE;?<iKJGFCiKiJ:?<D -8?\tD<E\n 5LI  EKNi:BCLE> ;i<J<I .PJK<D8KiB =8E; <iE< *Ii<EKi<ILE> 8E ;<I  +*\u001e\t/8OFEFDi< \u0006\u001eF:?I8E<  ==<:\tKiM< +I8:iKi:< 8E; *I>8EiQ8KiFE F= \u001e8I< \"IFLG\u0007 6\u0012\u00147\b 8E <iE<I /8OFEFDi< M<IJ:?i<;<E<I \"<JLE;?<iKJJPJK<D< 6\u0012\u00157 LE; 8E QLMFI GL9CiQi<IK<E -<Mi<NJ 6\u0010\u0013\b \u0010\u00127 JK8KK\n 5LD <IJK<E ;i==<I<EQi<IK<E NiI LEJ<I< \u001cI<8C< E8:? \u0006\r\u0007 $EK<IM<EKiFE<E DiK ;<D !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C LE; \u0006\u000e\u0007 (8YE8?D<E DiK ;<D !FBLJ 8L= +8Ki<EK<E\n  IJK<I<J \u001cI<8C BFEEK< 8E?8E; <iE<I  +*\u001e\t+IX=CiJK< =XI ;i< \u001f8K<E<OKI8BKiFE 6\u0013\f7 <iE><K<iCK N<I;<E\b NF9<i ;<I iD 1FI;<I>ILE; JK<?<E;< $EK<IM<EKiFEJ8EK<iC 8LJJ:?C8>><9<E; N8I \u0006\u001c99iC;LE> \u0010\u0007\n \u001cCJ \u0006\r8\u0007 '<?IM<I8E\tJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ 9<KiK<CK<E NiI \u001d<JL:?< MFE <OK<IE<E  OG<IK<E iE +I8O<E\b NU?I<E; N<C\t:?<E <iE< $E=FID8KiFEJ9<I<iKJK<CCLE> QLD 5N<:B ;<I \u001d<<iE=CLJJLE> ;<I 8CCKU>Ci:?<E +I8OiJ JK8KK=8E;\n \u001fi< '<?IM<I8EJK8CKLE> BFEEK< <9<EJF !<<;98:B\t(8YE8?D<E <EK?8CK<E\n 6\u0013\f7 5i<C>ILGG< N8I<E JK<KJ +I8OiJK<8DJ\b  Datens8nthese  \n \u000e\r      \nFokus auf medizinischem PersonalArt der Intervention, nach EPOC Lehrveranstaltungen f\u00fcr medizinische TeamsErinnerungssysteme f\u00fcr \u00c4rzteRevision der beruflichen RollenverteilungenGrad der Komplexit\u00e4tEinfachKomplexFokus auf PatientenForm der BereitstellungSMS-Nachrichten BriefPostkarteEdukative Brosch\u00fcreFinanzieller AnreizZus\u00e4tzlicher InhaltPersonalisierungEdukativer Anteil\n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  AA  88  \b\b''++%%%%\u001d\u001d\u0019\u0019''++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \n\n\"\"**\u0019\u0019''77--\u0019\u0019\"\"**##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  \r\r\u0014\u0014**\u001d\u001d\u0019\u0019\"\"**\u0019\u0019\"\"  \u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  BB  88  \b\b''++%%%%\u001d\u001d\u0019\u0019''++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \n\n\"\"**\u0019\u0019''77--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  !!\u0019\u0019\u0018\u0018\u001d\u001d11\u001d\u001d\"\"\u001d\u001d77((\u0017\u0017\u001c\u001c\u0019\u0019!!  \r\r\u0019\u0019''((##\"\"\u0014\u0014    Datens8nthese  \n \u000e\u000e  8CJF 8CC< D<;iQiEiJ:?<E (iK8I9<iK<I <iE<I +I8OiJ\b <iEJ:?Ci<YCi:? ;<I RIQK< LE; !8:?8E><JK<CCK<E\n \u0006\r9\u0007 \u001cLKFD8\tKiJ:?<  IiEE<ILE>JJPJK<D< =XI RIQK< iEBCL;i<IK<E G8Ki<EK<EJG<Qi=iJ:?< $E=FID8KiFE<E\b N<C:?< M<I98C F;<I J:?Ii=KCi:? 8L= +8Gi<I F;<I \u001eFDGLK<I\t\u001diC;J:?iID<E 9<I<iK><JK<CCK NLI;<E\n 5i<C N8I <iE< 5LIX:B<IiEE<ILE> ;<J \u001cIQK<J 8E 9<I<iKJ MFI?8E;<E<J 2iJJ<E LE; ;<D<EKJGI<:?<E; <iE< \u001d<<iE=CLJJLE> ;<J UIQKCi:?<E  EKJ:?<i\t;LE>JGIFQ<JJ<J QLD 1FIK<iC ;<I $E=CL<EQ8\t$DG=LE>\n 6\u0013\f7  \u001fi< \u0006\r:\u0007 -<MiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> 9<iE?8CK<K< iE LEJ<I<D +IFA<BK MFI 8CC<D ;i<  IN<iK<ILE> MFE /UKi>B<iKJ=<C;<IE iE !FID ;<I T9<IKI8>LE> MFE \u001cL=>89<E9<I<i:?<E 8L= D<;iQiEiJ:?<J \u001cJJiJK<EQG<IJFE8C 6\u0013\f7\n \u001fi<J BFEEK< iD  iEQ<C=8CC 9<iJGi<CJN<iJ< ;i< <i><EJKUE;i>< $E;iB8KiFEJJK<CCLE> F;<I \u001fLI:?=X?ILE> ;<I $DG=LE> ;LI:? D<;iQiEiJ:?<J !8:?G<IJFE8C J<iE\n   \u001cLY<I;<D NLI;< ;i<J< \"ILGG< E8:? 58?C ;<I M<IJ:?i<;<E<E M<IN<E;<K<E (<K?F;<E iE \u0006\r;\u0007 <iE=8:?< \u0006\r\t\u000e M<IJ:?i<;<E< (<K?F;<E\u0007 LE; \u0006\r<\u0007 BFDGC<O< \u0006\u001a\u000e M<IJ:?i<;<E< (<K?F;<E\u0007 (8YE8?D<E >ILGGi<IK\n 5N<iK<I<I \u001d<I<i:? NLI;<E E8:? !FID ;<I \u001d<I<iKJK<CCLE> LE; E8:? QLJUKQCi:?<E $E?8CK<E <iE><K<iCK \u0006\u001c99iC;LE> \u000f\u0007\n #i<I9<i LEK<IJ:?i<;<E NiI LEK<I ;<E +8Ki<EK<E<IiEE<ILE>JJPJK<D<E \u0006\u000e8\u0007 .(.\t)8:?Ii:?K<E\b \u0006\u000e9\u0007 \u001dIi<=< LE; \u0006\u000e:\u0007 +FJKB8IK<E\n 2<iK<I DW>Ci:?< &8K<>FIi<E N8I<E \u0006\u000e;\u0007 <;LB8KiM< \u001dIFJ:?XI<E LE; \u0006\u000e<\u0007 =iE8EQi<CC< \u001cE\tI<iQ<\n  IiEE<ILE><E\b iE N<C:?<E M<I;<LKCi:?K NLI;<\b ;8JJ ;<I #8LJ8IQK ;<E <IiEE<IK<E +8Ki<EK<E iE <iE<D iE;iMi;L<CC<E 1<I=8?I<E 8CJ iDG=G=Ci:?Ki> <iE><J:?UKQK ?8KK< <EK?i<CK<E <iE< \u0006\u000e=\u0007 +<IJFE8CiJi<ILE> LE; JK8E;<E iD \"<><EJ8KQ QL ><E<IiJ:?<E .PJK<D<E\n \u001cCC< !FID<E\b ;i< ;<E +8Ki<EK<E QLJUKQCi:? X9<I $E;iB8KiFE<E\b -iJiB<E LE; )<9<ENiIBLE><E MFE $DG=LE> LE;  IBI8EBLE> 8L=BCUIK<E\b Ni<J<E <iE<E \u0006\u000e>\u0007 <;LB8KiM<E \u001cEK<iC 8L=\n 2.<.3.2 \b\u0011\u0014\u0010\u0010IE\u0011\u0014N\b\u0001NA\u0004\t\u0001\bE\u0012\u0014ND\tEIT\u0012\u0012\u0017\u0012TE\r\u0001\u0014ND\u0001\u0012ETTIN\b 0D ;<E  iE=CLJJ ;<I -8?D<E9<;iE>LE><E 8L= ;i< 2iIBJ8DB<iK MFE $EK<IM<EKiFE<E QL LEK<IJL:?<E\b NLI;<E ;i< \u001cEJUKQ< QLJUKQCi:? 8E?8E; ;<D '8E; i?I<I \u001fLI:?=X?ILE> E8:? \u001dW?D <K 8C\n 6\u0012\u00157 iE M<IJ:?i<;<E<E \"<\tJLE;?<iKJJPJK<D<E >ILGGi<IK\u0016 $\u0007 .K88KCi:?<I \"<JLE;?<iKJ;i<EJK\b $$\u0007 .K88KCi:?< &I8EB<EM<IJi:?<ILE>\b $$$\u0007 .FQi\t8C< &I8EB<EM<IJi:?<ILE>\b $1\u0007 +IiM8K<J \"<JLE;?<iKJJPJK<D LE; 1\u0007 .K88KCi:? I<>LCi<IK< JFQi8C< &I8EB<EM<IJi\t:?<ILE>\n  iE< ><E8L<I< \u001cL=JK<CCLE> ;<I #8LGKKPG<E\b X9<IJ<KQK E8:? \u001dW?D <K 8C\n\b =iE;<K Ji:? iE /89<CC< \u0011\n 22..$$..   \u0005\u0005AA\u0014\u0014\u0015\u0015TTEELLLL\u0017\u0017\u000f\u000fGG\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\u0005\u0005AATTEE\u000f\u000f  2U?I<E; LEJ<I<I 1FII<:?<I:?< JK<CCK<E NiI <iE >IFY<J (8Y 8E BCiEiJ:?<I LE; D<K?F;iJ:?<I #<K<IF><EiKUK 9<QX>Ci:? .KL;i<EKPG<E\b $EK<IM<EKiFE<E\b +8Ki<EK<E LE; .<KKiE>J =<JK\n )8:?;<D #<K<IF><EiKUK <iE JK8IB<J \u001cI\t>LD<EK ><><E ;8J +FFCiE> MFE .KL;i<E;8K<E iJK 6\u0013\r7\b N8I ;i< 28?IJ:?<iECi:?B<iK QLI \"<C<><E?<iK =XI <iE< (<K8\t\u001cE8CPJ< J<?I ><IiE>\n  2iI <EKJ:?i<;<E LEJ ;<J?8C9 =XI ;i< \u001f8IJK<CCLE> MFE  ==<BKJKUIB<E LE; &FE=i;<EQiEK<IM8CC<E iE !FI<JK +CFKJ\b LEK<I \u001d<IX:BJi:?Ki>LE> ;<I F9<E ><E8EEK<E &8K<>FIiJi<ILE><E\n !XI +L9CiB8KiFE<E\b iE N<C:?<E Ei:?K ><EL> \u001f8K<E QLI \u001d<I<:?ELE> MFE &FE=i;<EQiEK<IM8CC<E MFI?8E;<E N8I<E\b NLI;<E  ==<BK>IWY< LE; .i>Ei=iB8EQ8E\t>89<E 8LJ ;<E .KL;i<E iD !FI<JK +CFK ;8I><JK<CCK LE; >I8G?iJ:? J<G8I8K D8IBi<IK\n \u001fi< C<KQK<E;Ci:?< .PEK?<J<  Datens8nthese  \n \u000e\u000f                      \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  CC  88  \t\t\u0014\u0014++%%****00%%\u0019\u0019\"\"  --##\"\"  \b\b\u0019\u0019((++\"\"\u0018\u0018\u001c\u001c\u0019\u0019\u001d\u001d**((((00((**\u0019\u0019!!\u0019\u0019\"\"  !!##\u0018\u0018\u001d\u001d\u001a\u001a\u001d\u001d11\u001d\u001d\u0019\u0019''**  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \u0003\u0003$$\u001c\u001c!!  \u0019\u0019**  \u0014\u0014  66  99DDGG::  \nAbk\u00fcr5un\u001f,bedeutun\u001fen9 @RAe\u001fulati'n, @\u0007Ainan5ierun\u001f, \u0016er,'r\u001fun\u001f,@bAereit,tellun\u001f. @StAaat, @S'A5iale Akteure, @\u0010rAi>vate Akteure.    55  \u0013\u0013\u0016\u0016\u0010\u0010  \u0011\u0011  \u0007\u0007  \u0003\u0003  \u0003\u0003\u0006\u0006II\u0012\u0012\u0010\u0010II\u0006\u0006\f\f\u0006\u0006  \n Staatlicher Gesundheitsdienst St St St \u0019\u00e4nemark, Finnland, Island, #orwegen, Schweden, Por-tugal, Spanien, Gro\u00dfbritannien 2 Staatliche Krankenversicherung St St Pr Australien, Kanada, Irland, #euseeland, Italien \f Soziale Krankenversicherung So So Pr Osterreich, \u0019eutschland, !uIemburg, Schweiz 4 Privates Gesundheitssystem Pr Pr Pr *SA 5 Staatlich regulierte soziale Kranken-versicherung St So Pr Belgien, Estland, Frankreich, Tschechien, *ngarn, #ie-derlande, Slovakei, Israel, Japan, Korea Datens8nthese  \n \u000e\u0010  ;<I \u001f8K<E <I=FC>K< ;<D<EKJGI<:?<E; GIiDUI E8II8KiM\b 8CJ  EKJ:?<i;LE>JBIiK<Ii<E NLI;<E BC8I< MiJL<CC< 0E\tK<IJ:?i<;< QNiJ:?<E &8K<>FIi<E JFNi< ;<I \u001cEK<iC ;<I .KL;i<E DiK Ji>Ei=iB8EK GFJiKiM<D  ==<BK GIF &8K<>FIi< M<IN<E;<K\n \u0002uswahl-rozess  \n \u000e\u0011  \u0018\u0018 EE\u0010\u0010GGEE\u0003\u0003NN\n\nSSSSEE  \u001b\u001b\u0015\u0015\u0019\u0019 \u0002\u0002UU\u0015\u0015\u001a\u001a\u0002\u0002\n\nLL\u0012\u0012\u0014\u0014\u0011\u0011\u001d\u001dEE\u0015\u0015\u0015\u0015   iE< T9<IJi:?K QLD \u001cLJN8?CGIFQ<JJ ;<I .KL;i<E =iE;<K Ji:? iE \u001c99iC;LE> \u0011\n 2iI <I?i<CK<E \u000e\u0014\u0015\u0011  I><9EiJJ< ;LI:? LEJ<I< \u001f8K<E98EBJL:?<\n T9<I D8EL<CC< .L:?< iE ;<E -<=<I<EQ<E 8E\t;<I<I -<Mi<NJ BFEEK<E \r\u000e\u0011 N<iK<I< /I<==<I <IQi<CK N<I;<E\b <iE <iEQ<CE<J +IFA<BK NLI;< iE <iE<D .KL;i<EI<\t>iJK<I i;<EKi=iQi<IK\n 2U?I<E; ;<I /iKC<\t\u001c9JKI8:K\t.<C<BKiFE NLI;<E \r\u0015\u0011\u0015 -<=<I<EQ<E 8LJ><J:?CFJJ<E\n #UL=i>< \"IXE;< N8I<E ?i<I <iE< \u001d<J:?U=Ki>LE> DiK ;<I $DG=LE> ><><E #UDFG?iCLJ iE=CL<EQ8< LE; <iE \u001f<Ji>E 8CJ \u001d<F98:?KLE>JJKL;i< F;<I <Gi;<DiFCF>iJ:?< \u001c9?8E;CLE> F?E< \u001cEN<E;LE> MFE $EK<IM<EKiFE<E\n \u001cL:? .KL\t;i<E QL $DG=LE><E ><><E #\r)\r NLI;<E iE LEJ<I<D .L:?8C>FI?PK?DLJ <IB8EEK LE; DLJJK<E ?UL=i> 8LJ><\tJ:?CFJJ<E N<I;<E\n  iE< 1FCCK<OK8E8CPJ< B8D =XI \r\r\u0011 ;i<J<I .KL;i<E iE !I8><\b ?i<IMFE N8I<E =XI 8:?K -<=<I<EQ<E <EKN<;<I B<iE< 1FCCK<OK< F;<I B<iE< 8LJI<i:?<E;<E \u001f8K<E QL>UE>Ci:?\n \u001cD ?UL=i>JK<E NLI;<E .KL;i<E 8L= ;i<J<I  9<E< 8L=\t>ILE; MFE LEG8JJ<E;<D .KL;i<E;<Ji>E 8LJ><J:?CFJJ<E \u0006E \u0019 \u000f\u0014\u0007\n  !XI iEJ><J8DK \r\u000f .KL;i<E <I=FC>K<E &FEK8BKM<IJL:?< QL \u001cLKFI<E\b ;8MFE NLI;<E Ji<9<E (8C 1FCCK<OK< LE; Ji<9<E (8C QLJUKQCi:?< \u001f8K<E 8E><=I8>K\n !XI QN<i \u001cLKFI<E BFEEK<E B<iE< JL==iQi<EK<E &FEK8BK;8K<E ><=LE;<E N<I;<E\b MFE J<:?J \u001cLKFI<E KI8= iEE<I?8C9 MFE QN<i (FE8K<E E8:? &FEK8BKM<IJL:? B<iE< \u001cEKNFIK <iE\n !XE= \u001cLKFI<E 9<8EKNFIK<K<E LEJ<I< \u001cE=I8><\b MFE ;i<J<E BFEEK< <iE <iEQ<CE<I \u001cLKFI 1FCCK<OK LE; QLJUKQCi:?< \u001f8\tK<E QLI 1<I=X>LE> JK<CC<E\n \u001cCC< 8E;<I<E .KL;i<E NLI;<E C<KQK<E;Ci:? 8LJ ;<D -<Mi<N 8LJ><J:?CFJJ<E\n \u001b\u001b\u0015\u0015\u001a\u001a \u0011\u0011BBEE\u0014\u0014LL\u000b\u000b\u0005\u0005KK  \u0018\u0018BBEE\u0014\u0014  EE\u000b\u000b\u0010\u0010\t\tEE\u0015\u0015\u0005\u0005\n\nLL\u0011\u0011\u0015\u0015\u0015\u0015EE\u0010\u0010EE  \u000e\u000e\u0016\u0016UUDD\u000b\u000bEE\u0010\u0010  \u001f\u001f..22..11 \u0002\u0002LLLLGGEE\u000e\u000eEEII\u000f\u000fEE\u0015\u0015  $EJ><J8DK N8I<E \r\u0011 .KL;i<E 6\u0013\u000e_\u0014\u00127 =XI ;<E  iEJ:?CLJJ iE LEJ<I -<Mi<N ><<i>E<K\n  iE< <iEQ<CE< .KL;i< 6\u0013\u000e7 <EK?i<CK 8LJJ:?Ci<YCi:? $EK<IM<EKiFEJ>ILGG<E LE; BFEEK< ;<D<EKJGI<:?<E; ELI =XI JG<Qi=iJ:?< !I8><JK<CCLE\t><E M<IN<E;<K N<I;<E\n 5N<i .KL;i<E 6\u0013\u000f\b \u0013\u00117 9<Ii:?K<K<E =XI ;i< ><<i>E<K<E +FGLC8KiFE<E ELI $DG=HLFK<E LE; G\t2<IK<\b 89<I B<iE< ><E8L<I<E HL8EKiK8KiM<E +FGLC8KiFEJ9<J:?I<i9LE><E F;<I &FE=i;<EQiEK<IM8CC<\n \"<\tE8L< $E=FID8KiFE<E QL LEJ<I<E <iE><J:?CFJJ<E<E .KL;i<E JiE; iE ;<E /89<CC<E \u0012 LE; \u0013 M<I=X>98I\n \u001f<I -8E;FDiJi<ILE>JGIFQ<JJ =8E; iE LEJ<I<E .KL;i<E ?UL=i> 8L= ;<D '<M<C ;<I +I8OiJ F;<I ;<J \u001cIQK<J JK8KK \u0006E \u0019 \u0013\u0007\b N8J iE \u001cE9<KI8:?K ;<I $EK<IM<EKiFEJ=FID<E JiEEMFCC N8I\n \u001fi< ><E<I<CC< .KL;i<EHL8CiKUK N8I DF;<I8K DiK <iE<D DiKKC<I<E ,L8CiKUKJ=8BKFI MFE \r\u000f\n\u000f 8LJ \u000e\r\n  iEi>< .KL;i<E LEK<IJL:?K<E M<IJ:?i<;<E< $EK<IM<EKiF\tE<E >C<i:?Q<iKi>\b ;I<i .KL;i<E K<JK<K<E JF>8I ;I<i M<IJ:?i<;<E< \u001cEJUKQ< 6\u0013\u000e\b \u0013\u000f\b \u0014\f7\n \u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000e\u0012  \u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  CC  88  \u0012\u0012\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**  11++''  \u000f\u000f**++\u0018\u0018\u001d\u001d\u0019\u0019\"\"\u0014\u0014++((..\u0014\u0014\u001c\u001c  44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \r\r\u000e\u000e\n\n\u000f\u000f\f\f\u0002\u0002  99CCGG::66  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe. \n\u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000e\u0013   \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  DD  88  \u0006\u0006''\u001b\u001b\u0019\u0019\u0016\u0016\"\"\u001d\u001d((,,\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**55  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  !!\u0019\u0019\u0018\u0018\u001d\u001d11\u001d\u001d\"\"\u001d\u001d((\u0017\u0017\u001c\u001c\u0019\u0019!!  \r\r\u0019\u0019''((##77\"\"\u0014\u0014    \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.     \n\u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000e\u0014  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  EE  88  \u0006\u0006''\u001b\u001b\u0019\u0019\u0016\u0016\"\"\u001d\u001d((,,\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**55  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  \r\r\u0014\u0014**\u001d\u001d\u0019\u0019\"\"**\u0019\u0019\"\"  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe. \n\u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000e\u0015   \u001f\u001f..22..22 \b\bEE\u0015\u0015\u0017\u0017\u000f\u000f\u0006\u0006HHEEIITT\u0015\u0015\u0012\u0012OOLLIITTII\u0015\u0015\u0005\u0005HHEE\u0014\u0014\u0001\u0001\u0012\u0012AAHH\u000e\u000eEE\u000f\u000f  $EJ><J8DK E<LE .KL;i<E NLI;<E iE ;<E 0.\u001c \u0006+IiM8K<J \"<JLE;?<iKJJPJK<D\u0007\b QN<i .KL;i<E iE \"IFY9IiK8EEi<E \u0006.K88KCi:?<I \"<JLE;?<iKJ;i<EJK\u0007\b ;I<i .KL;i<E iE \u001cLJKI8Ci<E \u0006.K88KCi:?< &I8EB<EM<IJi:?<ILE>\u0007 LE; <iE< .KL;i< iE ;<I .:?N<iQ \u0006.FQi8C< &I8EB<EM<IJi:?<ILE>\u0007 ;LI:?><=X?IK\n \u001fi<  IJ:?<iELE>JA8?I< I<i:?K<E MFE \r\u0015\u0014\u0013\t\u000e\f\r\u0014\n  \u001cCC< .KL;i<E =8E;<E iE ;<I \u001cCC><D<iED<;iQiE JK8KK\n 0EJ<I< ><F>I8G?iJ:?<E .:?8LGCUKQ< I<i:?K<E MFE CUE;Ci:? 9iJ LI98E\b LE; Mi<C< M<IJ:?i<;<E< 1<IJFI>LE>J=FID<E Ni< +IiM8KGI8O<E\b LEiM<IJiKUI< 8CC><D<iED<;iQiEiJ:?< &CiEiB<E LE; (\u001e*J BFEEK<E iE LEJ<I -<Mi<N <iE><J:?CFJJ<E N<I;<E\n \u001f\u001f..22..\u001f\u001f PPAATTIIEE\u000f\u000fTTEE\u000f\u000f  0EJ<I< .KL;i<E ;<:BK<E <iE 9I<iK<J .G<BKILD 8E +8Ki<EK<E DiK :?IFEiJ:?<E  IBI8EBLE><E 89\n  iE< T9<IJi:?K X9<I ;i< M<IJ:?i<;<E<E \u001cCK<IJ>ILGG<E iJK iE \u001c99iC;LE> \u0012 QL J<?<E\b <iE< T9<IJi:?K X9<I ;i< ;iM<IJ<E  IBI8E\tBLE>J>ILGG<E iE \u001c99iC;LE> \u0013\n \u001fi< 8D ?UL=i>JK<E M<IKI<K<E< +8Ki<EK<E>ILGG< N8I<E ;i< LEK<I \u0012\u0011\tAU?Ii><E \u0006E \u0019 \u0012\u0007\b N8J ;<D \u001cLJJ:?CLJJ ;<I F=K <9<EJF LEK<IJL:?K<E X9<I \u0012\u0011\tAU?Ii><E 8LJ Mi<C<E .KL;i<E ;LI:? LEJ ><\tJ:?LC;<K N8I\n 0EK<IJL:?K< <iE< .KL;i< 8CC< +8Ki<EK<E\b ;i< <iE< $E=CL<EQ8\t$DG=LE> <I?8CK<E JFCCK<E \u0006F=K :?IF\tEiJ:? &I8EB< LE; X9<I \u0012\u0011\tAU?Ii><\u0007\b JF BFEEK<E E8:? \u001cLJJ:?CLJJ ;<I UCK<I<E +FGLC8KiFE ;i< :?IFEiJ:? &I8E\tB<E iJFCi<IK 9<KI8:?K<K N<I;<E\n 0EJ<I< UCK<JK<E +8Ki<EK<E N8I<E \u0014\f %8?I< \u0006E \u0019 \r\u0007 6\u0013\u00127\b LEJ<I< AXE>JK<E +8Ki<E\tK<E \u0012 (FE8K< \u0006E \u0019 \r\u0007 6\u0014\u000e7 8CK\n \u001fi< (<?I?<iK LEJ<I<I .KL;i<E LEK<IJL:?K< +8Ki<EK<E DiK :?IFEiJ:?<E GLCDFE8C<E \u0006E \u0019 \r\u000f\u0007\b B8I;iFM8JBLCUI<E \u0006E \u0019 \r\r\u0007 LE; I<E8C<E \u0006E \u0019 \u0014\u0007  IBI8EBLE><E\n (8E:?< .KL;i<E =FBLJJi<IK<E Ji:? <9<EJF 8L= <iE< <iEQ<CE< :?IFEiJ:?<  IBI8EBLE> Ni< QLD \u001d<iJGi<C ;i< \u001e*+\u001f \u0006E \u0019 \u0010\u0007 6\u0013\u0012\b \u0013\u0014\b \u0014\u0011\b \u0014\u00127\n +JP:?iJ:?< F;<I GJP:?i8KIiJ:?<  IBI8EBLE><E NLI;<E iE B<iE<I <iE><J:?CFJJ<E<E .KL;i< LEK<IJL:?K\n   \u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000f\f      \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  DD  88  \u0012\u0012\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**  ,,\u0016\u0016\u0019\u0019''  \u0019\u0019\u001d\u001d\"\"\u001b\u001b\u0019\u0019((\u0017\u0017\u001c\u001c  ##((((\u0019\u0019\"\"\u0019\u0019  \u0002\u0002  **\u0019\u0019''((\u001b\u001b''++%%%%\u0019\u0019\"\"  \u0006in\u001fe,\u001bhl',,ener Alter,berei\u001bh pr' Studie, 3>A\u001bh,e9 Alter in \u000bahren \nKardiovaskul\u00e4r73;Pulmonal87;\u0003\u000bP\u000427;\u0007\u00e4matologisch41;\bmmunologisch41;\u0004iabetes mellitus67;\renal53;0%20%40%60%80%100%\n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  EE  88  \u0012\u0012\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**  ,,\u0016\u0016\u0019\u0019''  \u0018\u0018\u001d\u001d\u0019\u0019  \u001b\u001b''$$))**\u0019\u0019\"\"  \u0019\u0019\u001d\u001d\"\"\u001b\u001b\u0019\u0019((\u0017\u0017\u001c\u001c  ##((((\u0019\u0019\"\"\u0019\u0019\"\"  \u0006\u0006''\u001f\u001f''\u0014\u0014\"\"\u001f\u001f++\"\"\u001b\u001b((\u001b\u001b''++%%%%\u0019\u0019\"\"  An\u001fabe in \u0010r'5ent der ein\u001fe,\u001bhl',,enen Studien \u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000f\r  \u001f\u001f..22..   \n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f\u0001\u0001  3.2.:.1 INTE\u0011\u0016ENTIONEN\u0001\rIT\u0001\u0007OK\u0014\u0012\u0001A\u0014\u0007\u0001\rEDI\u0018INI\u0012\u0004\tE\r\u0001\u0010E\u0011\u0012ONA\f $EJ><J8DK BFEEK<E 8L= ;i<J<D '<M<C Ji<9<E +L9CiB8KiFE<E i;<EKi=iQi<IK N<I;<E\n  #i<IMFE K<JK<K<E ;I<i .KL;i<E '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ\n (8IBLE <K 8C\n \u0006\u000e\f\r\u0014\u0007 LE; 5N8I <K 8C\n \u0006\u000e\f\r\u0012\u0007 6\u0013\u0014\b \u0014\u00127 iDGC<D<EKi<IK<E (8YE8?D<EG8B<K< QLI 1<I9<JJ<ILE> ;<I 1<IJFI>LE> MFE +8Ki<EK<E DiK \u001e*+\u001f\n \u001fi< 5i<C>ILGG< 9<i;<I .KL;i<E N8I<E A<N<iCJ \u001cCC><D<iEUIQK< LE; !8:?G<IJFE8C\b <iE< 5i<CJ<KQLE> N8I ;i< *GKiDi<ILE> ;<I K<8D98Ji<IK<E +8Ki<EK<EM<IJFI>LE>\n \u001d<JFE;<I?<iK 9<i;<I .KL;i<E N8I <iE< 1FIC8L=\tG?8J<\b iE N<C:?<I ><=U?I;<K< +8Ki<EK<E ;LI:? !8:?G<IJFE8C E8:? MFI?<Ii><I .:?LCLE> 8L= \u001e*+\u001f ><J:I<<EK NLI;<E\n )LI +8Ki<EK<E DiK <iE<D G8K?FCF>iJ:?<E .GiIFD<KIi<<I><9EiJ NLI;<E <iE><J:?CFJJ<E\n  .iIiN8I;<E8 <K 8C\n \u0006\u000e\f\f\u000e\u0007 6\u0014\u000f7 LEK<IJL:?K<E <iE< '<?IM<I8EJK8CKLE>\b ;<I<E !FBLJ 8L= ;<I $E=CL<EQ8\t$DG=LE> C8>\n #i<I9<i LEK<IIi:?K<K<E ;i< \u001fFQ<EK<E ;i< +I8OiJK<8DJ <Mi;<EQ98Ji<IK X9<I $E;iB8KiFE<E\b 2iIBJ8DB<iK LE; -iJiB<E ;<I $DG=LE> LE; >89<E <iE=8:?< #8E;CLE>J<DG=<?CLE><E QLI 0DJ<KQLE> ;<J 2iJJ<EJ iE ;<I 8CCKU>\tCi:?<E +I8OiJ\n  5N<i .KL;i<E N<E;<K<E 8LKFD8KiJi<IK<  IiEE<ILE>JJPJK<D<E =XI RIQK< iD +I8OiJ8CCK8> 8E\n \u001e?8D9<IJ <K 8C\n \u0006\r\u0015\u0015\r\u0007 6\u0013\u00117 ;IL:BK<E \u001cED<IBLE><E QLI $E=CL<EQ8\t$DG=LE> 8L= \u001fFBLD<EK8KiFEJ=FIDLC8I<\b LEK<IJ:?i<;<E NLI;< GIF \u001cIQK 8L:? QNiJ:?<E  IiEE<ILE><E =XI 8CC< F;<I ELI =XI ;i< #UC=K< ;<I ><<i>E<K<E +8Ki<EK<E\n  /i<IE<P <K 8C\n \u0006\u000e\f\f\u0011\u0007 6\u0014\u00117 >89<E DiK <iE<D 8LKFD8KiJ:?<E \u001eFDGLK<IJPJK<D (<C;LE><E 9<QX>Ci:? ><<i>E<K<I +IUM<EKiFEJD8YE8?D<E 8L= \u001eFDGLK<I8I9<iKJGCUKQ<E iE ;<E \u001d<?8E;CLE>JIULD<E 8LJ\n  5N<i .KL;i<E K<JK<K<E -<MiJiFE<E ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE>\n \u001fi< 1<IJFI>LE> ;<I +8Ki<EK<E <I=FC>K< 9<i \u001d<:B <K 8C\n \u0006\r\u0015\u0015\u0013\u0007 6\u0013\u00107 iD -8?D<E MFE I<><CDUYi><E \"ILGG<E9<JL:?<E iE ;<I +I8OiJ\n #i<I9<i NLI;<E 2FIBJ?FGJ LE; (W>Ci:?B<iK<E QLI JFQi8C<E /<iC?89< ><9FK<E\b NU?I<E; ;i< 0EK<IJL:?LE> ;<I +8Ki<EK<E 8L= \u001d<?8E;CLE>JiE;iB8KiFE<E <iEJ:?Ci<YCi:? ;<I  I?<9LE> ;<J $DG=JK8KLJ LE; <M<EKL<CC<I \u001fLI:?=X?ILE> MFE EWKi><E $DG=LE><E MFE D<;iQiEiJ:?<D !8:?G<IJFE8C X9<IEFDD<E NLI;<\n \u001d<i \u001d<;8I= BFEEK<E ;i< +8Ki<EK<E <iE  iEQ<C><JGIU:? DiK ;<D \u001cIQK =X?I<E\n #<IDiQ <K 8C\n \u0006\u000e\f\f\u000e\u0007 6\u0013\u00127 9FK<E \u001e*+\u001f\t+8Ki<EK<E E8:?  EKC8JJLE> 8LJ ;<I &CiEiB )8:?JFI><9<JL:?< ;LI:? <iE<E \"<D<iE;<BI8EB<EG=C<><I 8E\n \u001fi<J<I <I=8JJK< ;i< 8BKL<CC< .iKL\t8KiFE LE; LEK<IJL:?K<\b F9 \u001d<;8I= =XI N<iK<I< (8YE8?D<E Ni< (<;iB8D<EK<E8EG8JJLE><E\b $DDLEiJi<ILE><E F;<I )iBFKiE<EKNW?ELE> 9<JK8E;\n \u001fi<  I><9EiJJ< NLI;<E 8E ;<E QLJKUE;i><E \u001cCC><D<iE8IQK N<iK<I><C<iK<K LE; JUDKCi:?< (8YE8?D<E DiK i?D 9<JGIF:?<E LE; 89><JKiDDK\n !XE= +L9CiB8KiFE<E M<IN<E;<K<E <iE=8:?< 6\u0013\u0011\b \u0013\u0014\b \u0014\u000f\b \u0014\u0011\b \u0014\u00127 LE; QN<i .KL;i<E BFDGC<O< 6\u0013\u0010\b \u0013\u00127 \u001cEJUKQ<\n 3.2.:.2 INTE\u0011\u0016ENTIONEN\u0001\rIT\u0001\u0007OK\u0014\u0012\u0001A\u0014\u0007\u0001\u0010ATIENTEN $EJ><J8DK BFEEK<E 8L= ;i<J<D '<M<C 8:?K +L9CiB8KiFE<E i;<EKi=iQi<IK N<I;<E\n  \u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000f\u000e  5N<i .KL;i<E M<IJ<E;<K<E X9<I +CL>iEJ iE ;<I A<N<iCi><E +I8OiJD8E8><D<EKJF=KN8I<  IiEE<ILE><E 8E ><<i>\tE<K< +8Ki<EK<E G<I .(.\n #<II<KK <K 8C\n \u0006\u000e\f\r\u0012\u0007 6\u0013\u00137 Q<i:?E<K<E Ji:? iEJ9<JFE;<I< ;LI:? i?I< ?F?< +8Ki<EK<EQ8?C \u0006E \u001a \r\f\fa\f\f\f\u0007 8LJ\n -<>8E <K 8C\n \u0006\u000e\f\r\u0013\u0007 6\u0014\u000e7 J:?CFJJ<E DiK :?IFEiJ:? &I8EB<E +8Ki<EK<E 89 \u0012 (FE8K<E LEJ<I< AXE>JK<E +8Ki<EK<E iE ;i< .KL;i< <iE\n  \u001fI<i .KL;i<E DiK =XE= $EK<IM<EKiFE<E M<IJ<E;<K<E +FJKB8IK<E\n \u001c?D<; <K 8C\n \u0006\u000e\f\f\u0010\u0007 6\u0013\u000e7 LEK<IJL:?K<E B<iE< &FEKIFCC>ILGG< F?E< $EK<IM<EKiFE\b <IDW>Ci:?K<E 89<I ;<E 1<I>C<i:? QNiJ:?<E <iE<I LE; QN<i +FJKB8IK<E\n \u001d8B<I <K 8C\n \u0006\r\u0015\u0015\u0014\u0007 6\u0013\u000f7 LE; .G8LC;iE> <K 8C\n \u0006\r\u0015\u0015\r\u0007 6\u0014\u00107 ELKQ<E JFC:?< &FEKIFCC>ILGG<E\n   \u001fI<i .KL;i<E DiK Mi<I $EK<IM<EKiFE<E M<IJ<E;<K<E \u001dIi<=<\n (FI8E <K 8C\n \u0006\r\u0015\u0015\u000e\u0007 6\u0013\u00157 <IDW>Ci:?K<E ;<E 1<I>C<i:? QNiJ:?<E <iE<D LE; QN<i \u001dIi<=<E\b \u001d8B<I <K 8C\n \u0006\r\u0015\u0015\u0014\u0007 6\u0013\u000f\b \u0014\r7 LE; (LCCFFCP \u0006\r\u0015\u0014\u0013\u0007 6\u0014\r7 M<IJ<E;<K<E A<N<iCJ ELI <iE<E \u001dIi<=\n (FI8E <K 8C\n \u0006\r\u0015\u0015\u0012\u0007 6\u0014\f7 M<IJ:?i:BK<E <;LB8KiM< \u001dIFJ:?XI<E DiK LD=8E>I<i:?<D (8K<Ii8C X9<I 2iIBLE>\b -i\tJiB<E LE; )<9<ENiIBLE><E MFE  IBI8EBLE> LE; $DG=LE>\b N<C:?< 8LY<I;<D \u001diC;D8K<Ii8C <EK?i<CK<E\n \u001f<J 2<iK<I<E 9FK<E Ji< DiK ;<I 1<ICFJLE> MFE '<9<EJDiKK<C>LKJ:?<iE<E LEK<I +8Ki<EK<E\b ;i< <iE< $DG=LE> iE \u001cEJGIL:? E8?D<E\b <iE<E =iE8EQi<CC<E \u001cEI<iQ LE; LEK<IJL:?K<E ;i< &FD9iE8KiFE 8LJ 9<i;<E (8YE8?D<E\n  $E <iEi><E !UCC<E NLI;<E  IiEE<ILE><E QLI 2iIBJ8DB<iKJJK<i><ILE> QLJUKQCi:?< $E?8CK< 9<i><=X>K\n !XE= MFE E<LE  IiEE<ILE><E 6\u0013\u000f\b \u0013\u0015\b \u0014\r\b \u0014\u00107 <EK?i<CK<E <iE< +<IJFE8CiJi<ILE> LE; \u0012 MFE \u0015 \u001cEJUKQ<E 6\u0013\u000f\b \u0013\u0015_\u0014\r\b \u0014\u00107 <iE<E <;LB8KiM<E \u001cEK<iC\n \u001f\u001f..22..!! \u0016\u0016EE\u0014\u0014\u001d\u001dEE\u0014\u0014\u0014\u0014\u0017\u0017\u000f\u000fGG\u0015\u0015\u0014\u0014II\u0015\u0015II\f\fOO  $E \u001c99iC;LE> \u0014 =iE;<K Ji:? <iE< T9<IJi:?K ;<I -iJB\tF=\t\u001di8J\t\u001d<N<IKLE> LEJ<I<I <iE><J:?CFJJ<E<E .KL;i<E\n \u001fi<  I=8JJLE> MFE  E;GLEBK<E <I=FC>K< iE ;<E D<iJK<E !UCC<E F9A<BKiM 8LJ <C<BKIFEiJ:?<E \u001f8K<E98EB<E LE; BFEEK< ;<D<EKJGI<:?<E; DiK <iE<D Ei<;Ii><E \u001di8J\t-iJiBF 9<N<IK<K N<I;<E\n \u001fi< \"<E<Ii<ILE> ;<I -8E;FDi\tJi<ILE>JJ<HL<EQ <I=FC>K< iE Mi<C<E !UCC<E DiK JL==iQi<EK<E (<:?8EiJD<E Ni< QL=8CCJ98Ji<IK<E \u001eFDGLK<IJPJK<\tD<E\n \u001f8J GFK<EQi<CC< 1<IQ<IILE>JIiJiBF ;LI:? CX:B<E?8=K< 1<I9CiE;LE> MFE +<IJFE8C LE; .KL;i<EK<iCE<?\tD<IE NLI;< ?UL=i> 8L=>ILE; ;<I F9A<BKiM<E  E;GLEBK<I=8JJLE> 8CJ 9<>I<EQK <iE><FI;E<K\n \u001d<i;< &8K<>FIi<E <I?i<CK<E ;<D<EKJGI<:?<E; iE ;<I (<?IQ8?C ;<I !UCC< <iE< Ei<;Ii>< \u001di8J\t-iJiBF\t\u001d<N<IKLE>\n !XI ;i< D<iJK<E .KL;i<E N8I 8LJJ:?Ci<YCi:? ;i< \u001cLJNiIBLE> ;<I $EK<IM<EKiFE 8L= ;i< $DG=HLFK<E MFE $EK<I<JJ<\b 8CC<I;iE>J N8I<E iE ;<E D<iJK<E !UCC<E B<iE< .KL;i<EGIFKFBFCC< M<I=X>98I\n \u001f8J -iJiBF MFE =<?C<E;<E \u001f8K<E 9<i ;<I  E;GLEBK<I?<9LE> LE; J<C<BKiM<D \u001d<Ii:?K<E MFE  I><9EiJJ<E NLI;< =FC>Ci:? ><DiJ:?K 9<N<IK<K\n +IF9C<D8\tKiJ:? N8I MFI 8CC<D ;i< 0EMFI?<IJ<?98IB<iK ;<I \"ILGG<EQLK<iCLE>\b N<C:?< iE Mi<C<E !UCC<E Ei:?K 9<N<IK<K N<I;<E BFEEK<\n \u001cE;<I< 0IJ8:?<E =XI \u001di8J NLI;<E iE ;<E D<iJK<E !UCC<E 8CJ LEN8?IJ:?<iECi:? 8E><J<?<E\n  $D \u001cCC><D<iE<E Ni<J<E ;i< .KL;i<E DiK !FBLJJi<ILE> 8L= D<;iQiEiJ:?<J +<IJFE8C D<?I Ei<;Ii>< LE; N<Ei><I LE9<B8EEK< F;<I ?F?< 2<IKLE><E 8L=\b N8J <iE< K<E;<EQi<CC ?W?<I< .KL;i<EHL8CiKUK iDGCiQi<IK\n \u0018berlick \u00fcber eingeschlossene \u0015tudien  \n \u000f\u000f    \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  FF  88  \u0012\u0012\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**  ,,\u0016\u0016\u0019\u0019''  \u0018\u0018\u001d\u001d\u0019\u0019  \u000e\u000e\u001d\u001d((\u001f\u001f77##\u001a\u001a77\u0016\u0016\u001d\u001d\u0014\u0014((77\u0003\u0003\u0019\u0019..\u0019\u0019''**++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \u0019\u0019\u001d\u001d\"\"\u001b\u001b\u0019\u0019((\u0017\u0017\u001c\u001c  ##((((\u0019\u0019\"\"\u0019\u0019\"\"  \u000f\u000f**++\u0018\u0018\u001d\u001d\u0019\u0019\"\"  \f\faattee\u001f\u001f''rriieenn  ff\u00fc\u00fcrr  ddiiee  \u0003\u0003eewweerrttuunn\u001f\u001f99  RS\b P \benerierun\u001f der Rand'mi,ierun\u001f,,e*uen58 A\u0004 P \beheimhaltun\u001f und \u0015nv'r>her,ehbarkeit der \bruppen5uteilun\u001f8 \u0003 P \u0016erblindun\u001f v'n Studienper,'nal=>teilnehmern w\u0019hrend der \u0003ehandlun\u001f8 OA P \u0016erblindun\u001f bei der \u0006ndpunkterhebun\u001f=>bewertun\u001f8 \nOD P \u0007ehlende Daten bei der \u0006ndpunkterhebun\u001f8 SR P Selektive, \u0003eri\u001bhten v'n \u0006ndpunkten8 O\u0003 P Andere \u0015r,a\u001bhen f\u00fcr \u0003ia,. \u0003\u0003eewweerrttuunn\u001f\u001f  mmiitt99  niedri\u001f, unbekannt, h'\u001bh8 Na\u001bh dem \u0004'\u001bhrane Ri,k 'f \u0003ia, \u0014''l G.F BKMC. \u0003\u0003eerree\u001b\u001bhhnnuunn\u001f\u001f  ddeerr  dduurr\u001b\u001bhh,,\u001b\u001bhhnniittttllii\u001b\u001bhheenn  \u0011\u0011uuaalliitt\u0019\u0019tt pr' \fate\u001f'rie anal'\u001f un,ere, \u0011ualit4 S\u001b're mit F \u0010unkten f\u00fcr h'he,, G \u0010unkt f\u00fcr unbekannte, und I \u0010unkten f\u00fcr niedri\u001fe, Ri,ik'. \r'difi5iert na\u001bh BGHHC mit \u0006rlaubni, de, \u0016erla\u001f,. E$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0010  \u001b\u001b\u0015\u0015\u001b\u001b EEFFFFEEKK\u0016\u0016\u000b\u000b\u0019\u0019\u000b\u000b\u0016\u0016\u0003\u0003\u0016\u0016  DDEE\u0014\u0014  II\u0010\u0010\u0016\u0016EE\u0014\u0014\u0019\u0019EE\u0010\u0010\u0016\u0016\u000b\u000b\u0011\u0011\u0010\u0010EE\u0010\u0010  \u001f\u001f..\u001f\u001f..11 \u0006\u0006\b\b\b\bEE\f\fTTII\u0019\u0019IITT\u0003\u0003TT\u0001\u0001\u000e\u000eAA\u0005\u0005HH\u0001\u0001\u000b\u000bAATTEEGGOO\u0014\u0014IIEE\u000f\u000f  3.3.1.1 INTE\u0011\u0016ENTIONEN\u0001\rIT\u0001\u0007OK\u0014\u0012\u0001A\u0014\u0007\u0001\rEDI\u0018INI\u0012\u0004\tE\r\u0001\u0010E\u0011\u0012ONA\f\u0001 0EK<I ;<E '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ BFEEK<E (8IBLE <K 8C\n \u0006\u000e\f\r\u0014\u0007 LE; 5N8I <K 8C\n \u0006\u000e\f\r\u0012\u0007\b N<C:?< Ji:? 8L= ;i< 1<IJFI>LE> MFE +8Ki<EK<E DiK \u001e*+\u001f BFEQ<EKIi<IK<E\b Ji>Ei=iB8EK GFJiKiM<  ==<BK< E8:?\tN<iJ<E 6\u0013\u0014\b \u0014\u00127\n .iIiN8I;<E8 <K 8C\n \u0006\u000e\f\f\u000e\u0007\b ;<I<E 1<I8EJK8CKLE> Ji:? iD \u001cCC><D<iE<D DiK ;<I $E=CL<EQ8\t$DG\t=LE> 9<=8JJK<\b <IQi<CK<E iE B<iE<I ;<I LEK<IJL:?K<E +FGLC8KiFE<E <iE<E Ji>Ei=iB8EK<E  ==<BK\n \u001fi< ><E<I<CC< ,L8CiKUK ;<I .KL;i<E N8I DiKK<CDUYi> 9iJ ?F:? <iEQLJ:?UKQ<E\n \u001f<K8iCJ QLI  ==<BKiMiKUK ;<I $EK<IM<EKiFE<E DiK !FBLJ 8L= D<;iQiEiJ:?<D +<IJFE8C =iE;<E Ji:? iE \u001c99iC;LE> \u0015\n   IiEE<ILE>JJPJK<D< =XI RIQK< ;<DFEJKIi<IK<E M<IJ:?i<;<E<  I><9EiJJ<\n 2U?I<E; \u001e?8D9<IJ <K 8C\n \u0006\r\u0015\u0015\r\u0007\b N<C:?< $DG=\t IiEE<ILE><E 8L= \u001fFBLD<EK8KiFEJ=FIDLC8I< 8L=;IL:BK<E\b <iE<E Ji>Ei=iB8EK GFJiKiM<E  ==<BK Q<i>K<E 6\u0013\u00117\b <IQi<CK<E /i<IE<P <K 8C\n \u0006\u000e\f\f\u0011\u0007 DiK )8:?Ii:?K<E 8L= \u001eFDGLK<I8I9<iKJGCUKQ<E B<iE Ji>Ei=iB8EK<J -<JLCK8K 6\u0014\u00117\n 2LI;<E iE <IJK<I<I .KL;i< 6\u0013\u00117  IiEE<ILE><E ELI =XI ;i< #UC=K< ;<I iDG=G=Ci:?Ki><E +8Ki<EK<E ><E<Ii<IK\b JF KI8K =XI ;i< Ei:?K <I=8JJK<E +8Ki<EK<E <iE Ji>Ei=iB8EK E<>8KiM<I  ==<BK \u0006-- \f\n\u000e\u0015\b G \u0018 \f\n\f\u0011\u0007 8L=\n $E ;<I QN<iK<E .KL;i< NLI;<E  IiEE<ILE><E QLI $E=CL<EQ8\t$DG=LE> <9<EJF ><E<I<CC ELI =XI :8\n \u0011\f\u0003 ;<I +FGL\tC8KiFE <IJK<CCK\b ;i< ><E8L<E \"IXE;< NLI;<E Ei:?K 8E><><9<E\n \u001fi< ,L8CiKUK ;<I .KL;i<E N8I DiKK<CDUYi> 9iJ ?F:?\n  \u001fi< -<MiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> <IQi<CK< <9<EJF iE;i==<I<EK<  ==<BK<\n \u001fi< 1<IJFI>LE> ;<I +8Ki\t<EK<E NU?I<E; \"ILGG<E9<JL:?<E iE ;<I +I8OiJ I<JLCKi<IK< 9<i \u001d<:B <K 8C\n \u0006\r\u0015\u0015\u0013\u0007 iE <iE<D Ji>Ei=iB8EK GFJiKiM<E  ==<BK 6\u0013\u00107\b NU?I<E; )8:?JFI><9<JL:?< ;LI:? \"<D<iE;<BI8EB<EG=C<><I =XI \u001e*+\u001f\t+8Ki<EK<E E8:?  EKC8J\tJLE> 8LJ ;<D &I8EB<E?8LJ 9<i #<IDiQ <K 8C\n \u0006\u000e\f\f\u000e\u0007 B<iE Ji>Ei=iB8EK<J -<JLCK8K <I>89<E 6\u0013\u00127\n \u001fi< iEJ><J8DK< .KL;i<EHL8CiKUK N8I Ei<;Ii> 9iJ DiKK<CDUYi>\b ;i< .Ki:?GIF9<E>IWY<E <?<I BC<iE\n 1FE =XE= .KL;i<E DiK <iE=8:?<E $EK<IM<EKiFE<E 6\u0013\u0011\b \u0013\u0014\b \u0014\u000f\b \u0014\u0011\b \u0014\u00127 Ci<=<IK<E ;I<i +L9CiB8KiFE<E Ji>Ei=iB8EK GFJiKiM<  I><9EiJJ<\b NU?I<E; <iE< MFE QN<i .KL;i<E DiK BFDGC<O<E $EK<IM<EKiFE<E 6\u0013\u0012\b \u0013\u00107 <iE JFC:?<J -<\tJLCK8K <II<i:?<E BFEEK<\n    E$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0011            \n  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.     \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  GG  88  \u0007\u0007##''\u0019\u0019((**  \r\r  ##**55  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001d\u001d--\u001d\u001d**\u0015\u0015**  --##\"\"  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  !!\u0019\u0019\u0018\u0018\u001d\u001d11\u001d\u001d\"\"\u001d\u001d((\u0017\u0017\u001c\u001c\u0019\u0019!!  \r\r\u0019\u0019''((##\"\"\u0014\u0014      E$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0012   3.3.1.2 INTE\u0011\u0016ENTIONEN\u0001\rIT\u0001\u0007OK\u0014\u0012\u0001A\u0014\u0007\u0001\u0010ATIENTEN \u001f<K8iCJ QLI  ==<BKiMiKUK MFE $EK<IM<EKiFE<E DiK ;<D !FBLJ 8L= +8Ki<EK<E =iE;<E Ji:? iE ;<E \u001c99iC;LE><E \r\f LE; \r\r\n .(.\t)8:?Ii:?K<E BFEEK<E 9<i -<>8E <K 8C\n \u0006\u000e\f\r\u0013\u0007 <iE<E Ji>Ei=iB8EK GFJiKiM<E  ==<BK E8:?N<iJ<E 6\u0014\u000e7\n #<II<KK <K 8C\n \u0006\u000e\f\r\u0011\u0007 Q<i>K<E 8CJ >IWYK< .KL;i< iE LEJ<I<D -<Mi<N C<i;<I ELI <iE<E C<i:?K<E\b Ei:?K Ji>Ei=iB8EK GFJiKiM<E  ==<BK 6\u0013\u00137\n \u001cCC< .KL;i<E Ni<J<E <iE< ?F?< ,L8CiKUK 8L=\n   +FJKB8IK<E =X?IK<E 9<i \u001d8B<I <K 8C\n \u0006\r\u0015\u0015\u0014\u0007 LE; .G8LC;iE> <K 8C\n \u0006\r\u0015\u0015\r\u0007 QL Ji>Ei=iB8EK GFJiKiM<E 6\u0013\u000f\b \u0014\u00107 LE; iE <iE<I 8E;<I<E $EK<IM<EKiFEJ>ILGG< ;<I <IJK<E .KL;i< QL <iE<D Ei:?K Ji>Ei=iB8EK<E  ==<BK 6\u0013\u000f7\n 5NiJ:?<E 9<i\t;<E .L9>ILGG<E MFE \u001d8B<I <K 8C\n \u0006\r\u0015\u0015\u0014\u0007 Q<i>K<E Ji:? B<iE< 0EK<IJ:?i<;<\n \u001fi< \"XK< ;<I .KL;i<E N8I iEJ><J8DK DiKK<CDUYi>\n  \u001dIi<=< <II<i:?K<E 9<i (LCCFFCP \u0006\r\u0015\u0014\u0013\u0007 <iE<E Ji>Ei=iB8EK GFJiKiM<E  ==<BK 6\u0014\r7\b \u001d8B<I <K 8C\n \u0006\r\u0015\u0015\u0014\u0007 BFEEK< <iE Ji>Ei=iB8EK<J -<JLCK8K ELI =XI +8Ki<EK<E LEK<I \u0012\u0011 %8?I<E E8:?N<iJ<E 6\u0013\u000f7\n (FI8E <K 8C\n \u0006\r\u0015\u0015\u000e\u0007 ;<DFEJKIi<IK< JF>8I <iE<E Ei:?K Ji>Ei=iB8EK<E\b C<i:?K E<>8KiM<E  ==<BK 6\u0013\u00157\n  iE< <;LB8KiM< \u001dIFJ:?XI< LE; <iE =iE8EQi<CC<I \u001cEI<iQ Q<i>K<E 9<i (FI8E <K 8C\n \u0006\r\u0015\u0015\u0012\u0007 6\u0014\f7 >IFY<\b Ji>Ei=iB8EK GFJiKiM<  ==<BK<\n  iE< &FD9iE8KiFE 8LJ 9<i;<E (8YE8?D<E <I>89 1FIK<iC< ><><EX9<I ;<I 8CC<iEi><E \u001cEN<E\t;LE> ;<I \u001dIFJ:?XI<\b Ei:?K 89<I ><><EX9<I ;<I 8CC<iEi><E \u001cEN<E;LE> ;<J =iE8EQi<CC<E \u001cEI<iQ<J\n  \u001f8J EF:?D8Ci>< 1<IJ<E;<E <iE<I J:?Ii=KCi:?<E  IiEE<ILE> iE <iE<D (FE8K \u001c9JK8E; QLI <IJK<E Q<i>K< 9<i \u001c?D<; <K 8C\n \u0006\u000e\f\f\u0010\u0007 6\u0013\u000e7 B<iE<E\b 9<i (FI8E <K 8C\n \u0006\r\u0015\u0015\u000e\u0007 6\u0013\u00157 <iE<E Ei:?K Ji>Ei=iB8EK<E E<>8KiM<E  ==<BK\n \u001fI<i ;<I =XE=  IiEE<ILE><E DiK +<IJFE8CiJi<ILE> Q<i>K<E <iE<E Ji>Ei=iB8EK GFJiKiM<E  ==<BK 6\u0013\u000f\b \u0014\r\b \u0014\u00107\b <iE< $EK<IM<EKiFE <I>89 <iE JFC:?<J -<JLCK8K ELI iE +8Ki<EK<E LEK<I \u0012\u0011 %8?I<E\n \u001cEJUKQ< F?E< +<IJFE8CiJi<ILE> Q<i>\tK<E iE QN<i MFE Mi<I !UCC<E <iE Ji>Ei=iB8EK GFJiKiM<J  I><9EiJ 6\u0013\u0013\b \u0014\f\b \u0014\u000e7\b iE <iE<I .KL;i< DiK D<?I<I<E $EK<I\tM<EKiFE<E BFEEK<E 8LJJ:?Ci<YCi:? G<IJFE8CiJi<IK< \u001cEJUKQ< Ji>Ei=iB8EK<  I><9EiJJ< <II<i:?<E 6\u0013\u000f7\n  \u001fI<i ;<I J<:?J  IiEE<ILE><E DiK <;LB8KiM<D \u001cEK<iC BFEEK<E iE i?I<I ><J8DK<E +FGLC8KiFE <iE<E Ji>Ei=iB8EK GFJiKiM<E  ==<BK LEK<I \u001d<N<iJ JK<CC<E 6\u0013\u000f\b \u0013\u0015_\u0014\r7\b NU?I<E; 8CC< ;I<i .KL;i<E DiK .PJK<D<E F?E< <;LB8KiM<E \u001cEK<iC <iE<E JFC:?<E  ==<BK Q<i><E BFEEK<E 6\u0013\u0013\b \u0014\u000e\b \u0014\u00107\n    E$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0013            \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??>>  88  \u0007\u0007##''\u0019\u0019((**  \r\r  ##**55  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001d\u001d--\u001d\u001d**\u0015\u0015**  --##\"\"  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0018\u0018\u0019\u0019!!  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  \r\r\u0014\u0014**\u001d\u001d\u0019\u0019\"\"**\u0019\u0019\"\"44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \u000b\u000b\u0014\u0014**\u0019\u0019\u001b\u001b##''\u001d\u001d\u0019\u0019\"\"  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.         \nE$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0014            \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ????  88  \u0007\u0007##''\u0019\u0019((**  \r\r  ##**55  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001d\u001d--\u001d\u001d**\u0015\u0015**  --##\"\"  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0018\u0018\u0019\u0019!!  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  \r\r\u0014\u0014**\u001d\u001d\u0019\u0019\"\"**\u0019\u0019\"\"44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  11++((\u0015\u0015**11  \u001d\u001d\u0017\u0017\u001c\u001c\u0019\u0019\"\"  \n\n\"\"\u001c\u001c\u0014\u0014  **\u0019\u0019\"\"  \n\r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.  \nE$$ektivit\u00e4t der \u000bnterventionen  \n \u000f\u0015  \u001f\u001f..\u001f\u001f..22 \u0006\u0006\b\b\b\bEE\f\fTTII\u0019\u0019IITT\u0003\u0003TT\u0001\u0001\u000f\u000fAA\u0005\u0005HH\u0001\u0001\b\bEE\u0015\u0015\u0017\u0017\u000f\u000f\u0006\u0006HHEEIITT\u0015\u0015\u0015\u0015\u001c\u001c\u0015\u0015TTEE\u000e\u000e\u0001\u0001\u0017\u0017\u000f\u000f\u0006\u0006\u0001\u0001\u0013\u0013EETTTTII\u000f\u000fGG  $EJ><J8DK BFEEK<E .KL;i<E 8LJ Mi<I M<IJ:?i<;<E<E \"<JLE;?<iKJJPJK<D<E <iE><J:?CFJJ<E N<I;<E\n  iE< T9<I\tJi:?K X9<I  ==<BK>IWY<E\b ,L8CiKUK LE; +8Ki<EK<EQ8?C<E ;<I <iEQ<CE<E $EK<IM<EKiFE<E iE \u001c9?UE>i>B<iK ;<J A<\tN<iCi><E \"<JLE;?<iKJJPJK<DJ =iE;<K Ji:? iE \u001c99iC;LE> \r\u000e\n  .KL;i<E QL \u001dIi<=\t LE; +FJKB8IK<E<IiEE<ILE><E NLI;<E 8LJJ:?Ci<YCi:? iE <iE<D GIiM8K<E \"<JLE;?<iKJJPJK<D ;LI:?><=X?IK 6\u0013\u000f\b \u0013\u0015\b \u0014\r\b \u0014\u00107\n .(.\t IiEE<ILE><E Q<i>K<E iE QN<i HL8CiK8KiM ?F:?N<IKi><E +L9CiB8KiFE<E LEK<I <iE<I E8KiFE8C<E &I8EB<EM<IJi:?<ILE> <iE<E >IFY<E 6\u0014\u000e7\b iD E8KiFE8C<E \"<JLE;?<iKJ;i<EJK B<iE<E  ==<BK 6\u0013\u00137\n '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ N8I<E LEK<I E8KiFE8C<E LE; JFQi8C<E &I8EB<EM<IJi:?<ILE><E <==<BKiM 6\u0013\u0014\b \u0014\u00127\b NU?I<E; iD E8KiFE8C<E \"<JLE;?<iKJ;i<EJK B<iE  ==<BK <IQi<CK N<I;<E BFEEK< 6\u0014\u000f7\n \u001fi< -<\tMiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> BFEEK< iE QN<i .KL;i<E LEK<I E8KiFE8C<I &I8EB<EM<IJi:?<ILE> B<iE<E 6\u0013\u00127\b iD GIiM8K<E \"<JLE;?<iKJJPJK<D <iE<E >IFY<E  ==<BK <II<i:?<E 6\u0013\u00107\n \u001cL:?  IiEE<ILE>JJPJK<D< =XI RIQK< NLI;<E 8LJJ:?Ci<YCi:? iD GIiM8K<E \"<JLE;?<iKJJPJK<D LD><J<KQK 6\u0013\u0011\b \u0014\u00117\n $EJ><J8DK N8I<E .KL;i<E 8LJ ;<D E8KiFE8C<E \"<JLE;?<iKJ;i<EJK ;LI:? >LK< ,L8CiKUK LE; ?F?< +8Ki<EK<EQ8?\tC<E 8LJ><Q<i:?E<K\b <IQi<CK<E A<;F:? B<iE< Ji>Ei=iB8EK<E  ==<BK<\n +L9CiB8KiFE<E 8LJ E8KiFE8C<E F;<I JFQi8C<E &I8EB<EM<IJi:?<ILE><E =i<C<E F=K ;LI:? >IFY<  ==<BK<\b >LK< ,L8CiKUK LE; <?<I BC<iE< +8Ki<EK<EQ8?C<E 8L=\n E$$ektivit\u00e4t der \u000bnterventionen  \n \u0010\f   \n \n   \u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??@@  88  \u0005\u0005\u0014\u0014''((**\u0019\u0019    ++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  \u001d\u001d\"\"  \u000e\u000e\u0019\u0019  \u0014\u0014**\u001d\u001d##\"\"  11++!!  \u001e\u001e\u0019\u0019..\u0019\u0019\u001d\u001d  \u001d\u001d\u001b\u001b\u0019\u0019\"\"  \b\b\u0019\u0019((++\"\"\u0018\u0018\u001c\u001c\u0019\u0019\u001d\u001d**((77((00((**\u0019\u0019!!  \f\faattee\u001f\u001f''rrii,,iieerruunn\u001f\u001f  vv''nn  \u0006\u0006ffffeekktt\u001f\u001frr\u00f6\u00f6--ee na\u001bh RR in @GA ne\u001fativ9 RR Q G.FF, p Q F.FK8 @HA kein9 p T F.FK8 @IA m'derat9 G.FF Q RR S G.HK, p Q F.FK8 \u001fr'-9 G.HK Q RR S H.FF, p Q F.FK8 @JA ,ehr \u001fr'-9 RR R H.FF, p Q F.FK. \f\faattee\u001f\u001f''rrii,,iieerruunn\u001f\u001f  ddeerr  \u0011\u0011uuaalliitt\u0019\u0019tt  na\u001bh \u0011\u0007 in @KA niedri\u001f9 M Q \u0011\u0007 S GG8 @LA mittelm\u0019-i\u001f9 GG Q \u0011\u0007 S GK8 @MA h'\u001bh9 \u0011\u0007 R GK. \f\f''ddiieerruunn\u001f\u001f  ddeerr  SSttii\u001b\u001bhhpprr''bbeenn\u001f\u001frr\u00f6\u00f6--ee @SSA pr' Studie per \u0003la,en\u001fr\u00f6-e in @NA klein9 SS Q IFF8 @OA mittel9 IFF S SS Q KFFF8 @GFA \u001fr'-9 SS T KFFF.     \nE$$ektivit\u00e4t der \u000bnterventionen  \n \u0010\r             \n  \u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??AA  88  \u0005\u0005\u0014\u0014''((**\u0019\u0019    ++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001b\u001b''$$))\u0019\u0019  \u001d\u001d\"\"  \u0002\u0002\u0016\u0016\u001c\u001c\u0015\u0015\"\"\u001b\u001b\u001d\u001d\u001b\u001b\u001f\u001f\u0019\u0019\u001d\u001d**  \u0018\u0018\u0019\u0019''  \n\n!!%%\u001a\u001a&&++##**\u0019\u0019  \u0018\u0018\u0019\u0019''  \u000b\u000b##\"\"**''##    77\u001b\u001b''++%%%%\u0019\u0019   P \nnterventi'n einer Studie, \u001f\u001ff. Sub\u001fruppe.  P \u0014rendlinie    \nE$$ektivit\u00e4t der \u000bnterventionen  \n \u0010\u000e  \u001f\u001f..\u001f\u001f..\u001f\u001f \u0006\u0006\b\b\b\bEE\f\fTTII\u0019\u0019IITT\u0003\u0003TT\u0001\u0001\u000f\u000fAA\u0005\u0005HH\u0001\u0001\u000b\u000bOO\u000f\u000fTT\u0014\u0014OOLLLLGG\u0014\u0014\u0017\u0017\u0012\u0012\u0012\u0012EE\u000f\u000f\u001a\u001a\n\n\u000e\u000e\u0012\u0012\b\b\u0013\u0013\u0017\u0017OOTTEE  \u001cL=>ILE; ;<I )FKN<E;i>B<iK <iE<I J8iJFE8C<E \u001cL==IiJ:?LE> ;<I $E=CL<EQ8\t$DG=LE> LE; ;<I iEBFEJiJK<EK<E \u001cE>89<E iE ;<E .KL;i<E <IJ:?i<E ;i< \u001f8IJK<CCLE> ;<J  ==<BK<J ><><E ><D<JJ<E< $DG=HLFK<E 8LJ ;<I MFI?<\tIi><E $E=CL<EQ8\t.8iJFE Ei:?K JiEEMFCC\n \u001f<D<EKJGI<:?<E; iJK iE \u001c99iC;LE> \r\u000f ;i<  ==<BK>IWY< ;<I $EK<IM<E\tKiFE<E\b K<iCJ GIF .L9>ILGG<\b iE \u001c9?UE>i>B<iK ;<I $DG=HLFK< iE ;<I &FEKIFCC>ILGG< 8D  E;< ;<I $E=CL<EQ8\t.8iJFE 8L=><KI8><E\n \u001f<LKCi:? QL J<?<E iJK <iE< \u001c9E8?D< ;<I ><D<JJ<E<E  ==<BKJKUIB< DiK QLE<?D<E;<I $DG=HLFK< iE ;<I &FEKIFCC>ILGG<\b NFQL 8L:? <iE< I<:?E<IiJ:? 9<;iE>K< D8K?<D8KiJ:?< &8LJ8CiKUK <OiJKi<IK\n \u001c9 <iE<I $DG=HLFK< MFE \u0012\u0011\u0003 N8I <J 8CC<I;iE>J .KL;i<E ><E<I<CC Ei:?K D<?I DW>Ci:?\b Ji>Ei=iB8EK GFJiKiM<  I><9EiJJ< QL <IQi<C<E\b N8J =XI LEJ<I< +FGLC8KiFE #iEN<iJ< 8L= <iE< \u001cIK \u001f<:B<CLE>J<==<BK ><9<E BWEEK<\n \u001f\u001f..\u001f\u001f..   \u0006\u0006\b\b\b\bEE\f\fTTII\u0019\u0019IITT\u0003\u0003TT\u0001\u0001\u000f\u000fAA\u0005\u0005HH\u0001\u0001\u0015\u0015\u0012\u0012EE\u001d\u001dII\b\bII\u0015\u0015\u0005\u0005HHEE\u0014\u0014\u0001\u0001\b\b\u0014\u0014\u0017\u0017\u000f\u000f\u0006\u0006EE\u0014\u0014\f\f\u0014\u0014AA\u000f\u000f\f\f\u0017\u0017\u000f\u000fGG  $E \u001c99iC;LE> \r\u0010 =iE;<E Ji:? ;i<  I><9EiJJ< ;<I\b iE LEJ<I<E .KL;i<E ;LI:?><=X?IK<E\b .L9>ILGG<E8E8CPJ<E iE ><FI;E<K<I !FID\n  $EJ><J8DK Mi<I .KL;i<E Ci<=<IK<E .L9>ILGG<E8E8CPJ<E QL +8Ki<EK<E DiK :?IFEiJ:?<E #<IQ<IBI8EBLE><E 6\u0013\u0013\b \u0014\f\b \u0014\r\b \u0014\u000f7\n .i>Ei=iB8EK<  I><9EiJJ< BFEEK<E ?i<I ELI <iE<  IiEE<ILE>J\t.(. 6\u0013\u00137 LE; <iE G<IJFE8CiJi<IK<I \u001dIi<= 6\u0014\r7 <IQi<C<E\n \u001d<D<IB<EJN<IK iJK\b ;8JJ ;i< .(. iE ;<I \"<J8DKGFGLC8KiFE ;<I :?IFEiJ:? &I8EB<E B<iE< .i>Ei\t=iB8EQ <II<i:?<E BFEEK<\b iE ;<I ?i<I LEK<IJL:?K<E .L9GFGLC8KiFE A<;F:? ;LI:?8LJ\n \u001fI<i .KL;i<E 9<Ii:?K<K<E .L9>ILGG<E<I><9EiJJ< QL +8Ki<EK<E DiK \u001fi89<K<J D<CCiKLJ 6\u0013\u0013\b \u0014\f\b \u0014\u000f7\n  #i<I BFEEK< B<iE< <iEQi>< $EK<IM<EKiFE <iE Ji>Ei=iB8EK<J  I><9EiJ 9<NiIB<E\n 0EK<I +8Ki<EK<E DiK :?IFEiJ:?<E 'LE><E<IBI8EBLE><E <IQi<CK<E ;I<i MFE \u0015 $EK<IM<EKiFE<E 6\u0013\u0013\b \u0014\f\b \u0014\r\b \u0013\u0012\b \u0013\u0014\b \u0014\u0011\b \u0014\u00127 I<C<M8EK< -<JLCK8K<\u0016  iE< M<IJ<E;<K< <;LB8KiM< \u001dIFJ:?XI< 6\u0014\f7 LE; QN<i \u001e*+\u001f\t(8YE8?D<EG8B<K< DiK <;LB8KiM<E 2FIBJ?FGJ =XI D<;iQiEiJ:?<J +<IJFE8C 6\u0013\u0014\b \u0014\u00127 BFEEK<E Ji>Ei=iB8EK GFJiKiM<  ==<BK< ;<DFEJK\tIi<I<E\n +8Ki<EK<E DiK G8K?FCF>iJ:?<E &FE;iKiFE<E ;<J $DDLEJPJK<DJ NLI;<E iE ;I<i .KL;i<E LEK<IJL:?K 6\u0013\u0013\b \u0014\f\b \u0014\u000f7 LE; BFEEK<E iE <iE<I .KL;i< DiK  IiEE<ILE>J\t.(. 6\u0013\u00137 KIFKQ BC<iE<I !8CCQ8?C <iE Ji>Ei=iB8EK<J  I><9EiJ 8L=\tQ<i><E\b <IE<LK <EK><><E ;<I -<JLCK8K< =XI ;i< \"<J8DKGFGLC8KiFE\n  \u001cL:? ;i< 2iIBJ8DB<iK ;<I $EK<IM<EKiFE<E iE ;<E M<IJ:?i<;<E<E \u001cCK<IJ>ILGG<E NLI;< iE QN<i .KL;i<E LEK<I\tJL:?K 6\u0013\u0013\b \u0014\u00107\u0016  IiEE<ILE>J\t.(. <II<i:?K<E ELI iE +8Ki<EK<E MFE \r\u0014 9iJ \u000f\u0010 %8?I<E <iE Ji>Ei=iB8EK GFJiKiM<J  I><9EiJ\b +FJKB8IK<E ;<DFEJKIi<IK<E iE +8Ki<EK<E X9<I \u0010\f %8?I<E I<C<M8EK< -<JLCK8K< 6\u0014\u00107\n    E$$ektivit\u00e4t der \u000bnterventionen  \n \u0010\u000f  \r'difi5iert na\u001bh BGHH, GHIC mit \u0006rlaubni, der \"eweili\u001fen \u0016erla\u001fe.   \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??BB  88  \u0007\u0007##''\u0019\u0019((**  \r\r  ##**55  \u0012\u0012\u0016\u0016\u0019\u0019''((\u001d\u001d\u0017\u0017\u001c\u001c**  ,,\u0016\u0016\u0019\u0019''  \u0018\u0018++''\u0017\u0017\u001c\u001c\u001b\u001b\u0019\u0019\u001a\u001a,,\u001c\u001c''**\u0019\u0019  \u000f\u000f++\u0016\u0016\u001b\u001b''++%%%%\u0019\u0019\"\"\u0014\u0014\"\"\u0014\u0014  00((\u0019\u0019\"\"  \u001d\u001d\"\"  \u0018\u0018\u0019\u0019\"\"  \u0019\u0019\u001d\u001d\"\"\u001b\u001b\u0019\u0019((\u0017\u0017\u001c\u001c  ##((((\u0019\u0019\"\"\u0019\u0019\"\"  \u000f\u000f**++\u0018\u0018\u001d\u001d\u0019\u0019\"\"   Studien, wel\u001bhe nur ,ehr ,pe5ielle \u0010atientenp'pulati'nen unter,u\u001bhten, wurden bei Sinnhafti\u001fkeit in die \"eweili\u001fe \bruppe ein\u001fe,\u001bhl',,en.   \nEinordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0010  \u0019\u0019 \u0005\u0005\n\nSS\u000b\u000bUUSSSS\n\n\u000f\u000fNN  \u001c\u001c\u0015\u0015\u0019\u0019 EE\u000b\u000b\u0010\u0010\u0011\u0011\u0014\u0014DD\u0010\u0010UU\u0010\u0010\t\t  DDEE\u0014\u0014  EE\u0014\u0014\t\tEEBB\u0010\u0010\u000b\u000b\u0015\u0015\u0015\u0015EE  UU\u0010\u0010DD  \u000e\u000e\u0005\u0005\n\nLLUU\u0015\u0015\u0015\u0015FF\u0011\u0011LL\t\tEE\u0014\u0014UU\u0010\u0010\t\tEE\u0010\u0010    ..11..11 \u0002\u0002LLLLGGEE\u000e\u000eEEII\u000f\u000fEE\u0015\u0015  \u001fi< iE LEJ<I -<Mi<N <iE><J:?CFJJ<E<E .KL;i<E ;<:BK<E <iE< >IFY< \u001d8E;9I<iK< 8E 8CC><D<iED<;iQiEiJ:?<E 8D9LC8EK<E \u001d<KI<LLE>J=FID<E\b +8Ki<EK<E LE; $EK<IM<EKiFE<E 89\n 1i<C< M<IJ:?i<;<E< \u001cEJUKQ< BFEEK< i?I<  i>ELE> QLI .K<i><ILE> ;<I $E=CL<EQ8\t$DG=HLFK<E iE LEJ<I<I +FGLC8KiFE LEK<I \u001d<N<iJ JK<CC<E\n  \u001f<I 8D ?UL=i>JK<E 89><;<:BK< \u001cCK<IJ9<I<i:? N8I<E +8Ki<EK<E MFE \r\u0014 9iJ \u0012\u0010 %8?I<E\b iE ;<I (<?IQ8?C ;<I !UCC< NLI;<E LEK<I 8E;<I<D :?IFEiJ:?< GLCDFE8C<  IBI8EBLE><E LEK<IJL:?K\n #8LGK?<IBLE=KJC8E; N8I<E ;i< 0.\u001c DiK <iE<D GIiM8K<E \"<JLE;?<iKJJPJK<D\n   ..11..22 \n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f\u0001\u0001\u000e\u000eIITT\u0001\u0001\u0007\u0007OO\f\f\u0017\u0017\u0015\u0015\u0001\u0001AA\u0017\u0017\b\b\u0001\u0001\u000e\u000eEE\u0006\u0006II\u001d\u001dII\u000f\u000fII\u0015\u0015\u0005\u0005HHEE\u000e\u000e\u0001\u0001PPEE\u0014\u0014\u0015\u0015OO\u000f\u000fAALL  !FIK\t LE; 2<iK<I9iC;LE>JM<I8EJK8CKLE><E =XI D<;iQiEiJ:?<J +<IJFE8C iD -8?D<E MFE \"ILGG<EKI<==<E BFEE\tK<E iE <iE<D >IFY<E \u001eF:?I8E<\t-<Mi<N  ><E<I<CC 8CJ <==<BKiM =XI ;i< 1<I9<JJ<ILE> ;<I GIF=<JJiFE<CC<E +8Ki<E\tK<EM<IJFI>LE> LE; M<IJ:?i<;<E<I \"<JLE;?<iKJG8I8D<K<I ;<I +8Ki<EK<E ;8I><JK<CCK N<I;<E\b 8CC<I;iE>J 9Ci<9<E ;i<  ==<BK< DF;<I8K 6\u0014\u00137\n   $E LEJ<I<D -<Mi<N Q<i>K<E (8IBLE <K 8C\n \u0006\u000e\f\r\u0014\u0007 6\u0013\u00147 LE; 5N8I <K 8C\n \u0006\u000e\f\r\u0012\u0007 6\u0014\u00127 DiK #iC=< MFE \u001e*+\u001f\t=FBLJJi<IK<E 1<I8EJK8CKLE><E >LK< -<JLCK8K< \b NU?I<E; .iIiN8I;<E8 <K 8C\n \u0006\u000e\f\f\u000e\u0007 6\u0014\u000f7 ;LI:? <iE<E \u001cEJ8KQ DiK !FBLJ 8L= $DG=LE><E iE B<iE<I .L9>ILGG< .i>Ei=iB8EQ <II<i:?<E BFEEK<E\n  \"IXE;< =XI D8E><C?8=K< $DG=HLFK<E 9<i :?IFEiJ:? &I8EB<E 8L= .<iK<E ;<J D<;iQiEiJ:?<E +<IJFE8CJ BWEE<E 9<iJGi<CJN<iJ< ;i< MFIE<?DCi:?< *Ii<EKi<ILE> 8E G<IJWECi:?<E  iEJK<CCLE><E LE; 1FI9<?8CK<E JK8KK 8E <Mi\t;<EQ98Ji<IK<E  DG=<?CLE><E J<iE 6\r\u000f7\n (8YE8?D<E QLI RE;<ILE> ;i<J<J 1<I?8CK<EJ ><JK8CK<E Ji:? 8CC<I;iE>J J:?Ni<Ii>\b LE; ;i< DW>Ci:?<E  iE=CLJJ=8BKFI<E JiE; Mi<C=UCKi> LE; BFDGC<O\n \u001diJ?<Ii>< +L9CiB8KiFE<E J:?CLJJ\t=FC><IK<E\b ;8JJ ;8J +FK<EKi8C <iE<I 8CC<iEi><E '<?IM<I8EJK8CKLE> DiK 9I<iK<D K?<D8KiJ:?<D !FBLJ CiDiKi<IK LE; ;i<J< =XI ;i< (F;i=iB8KiFE MFE BFDGC<O<D 1<I?8CK<E ELI 9<;iE>K ><<i>E<K iJK 6\u0014\u0013\b \u0014\u00147\n \u001fi< &FD9iE8KiFE DiK 8E;<I<E (8YE8?D<E Ni< !<<;98:B\t F;<I  IiEE<ILE>JJPJK<D<E NLI;< iD \u001eF:?I8E<\t-<Mi<N <DG=F?C<E 6\u0014\u00137\b BFEEK< 8CC<I;iE>J iE LEJ<I<I \u001cI9<iK B<iE<E 1FIK<iC ;<DFEJKIi<I<E\n !XI ;i< +FGLC8KiFE ;<I :?IFEiJ:? &I8EB<E BWEEK< ;i< !FBLJJi<ILE> MFE '<?IM<I8EJK8CKLE> 8L= ;i< C<iKCiEi<E><I<:?K< 1<IJFI>LE> MFE >IFY<E &I8EB\t?<iKJ>ILGG<E 8D <==<BKiMJK<E J<iE\n \u001cLKFD8KiJi<IK<  IiEE<ILE>JJPJK<D< =XI RIQK< Q<i>K<E iE ;<I 9iJ?<Ii><E 'iK<I8KLI iE;i==<I<EK<  ==<BK<\u0016 $E <iE<I .KL;i< ;<DFEJKIi<IK<E Ji< <iE< Ji>Ei=iB8EK<  I?W?LE> ;<I $DG=HLFK<E 6\u0014\u00157\b iE <iE<I 8E;<I<E <iE< Ji>Ei=iB8EK< -<;LBKiFE ;<I +8Ki<EK<EDFI9i;iKUK NU?I<E; <iE<I $E=CL<EQ8\t.8iJFE 6\u0015\f7\n  iE< ;IiKK< .KL;i< BFEEK< 8CC<I;iE>J B<iE<E  ==<BK E8:?N<iJ<E 6\u0015\r7\n   Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0011  \u001cE8CF> ?i<IQL M<I?8CK<E Ji:? LEJ<I<  I><9EiJJ<\u0016 \u001e?8D9<IJ <K 8C\n \u0006\r\u0015\u0015\r\u0007 6\u0013\u00117 ><E<Ii<IK<E DiK  IiEE<ILE><E QLI $E=CL<EQ8\t$DG=LE> <iE<E >IFY<E Ji>Ei=iB8EK<E  ==<BK \b NU?I<E; /i<IE<P <K 8C\n \u0006\u000e\f\f\u0011\u0007 6\u0014\u00117 <iE<E E<>8KiM<E  ==<BK M<ILIJ8:?K<E\n $E <iE<I QLJUKQCi:?<E \"ILGG< ;<I <IJK<E .KL;i< <I?i<CK<E ;i< RIQK< ELI =XI ;i< #UC=K< ;<I ><<i>E<K<E +8Ki<EK<E  IiEE<ILE>JE8:?Ii:?K<E\b N8J =XI +8Ki<EK<E F?E< ;i<J< )8:?Ii:?K QL <iE<D Ji>Ei=iB8EK E<>8KiM<E  I><9EiJ M<I>Ci:?<E DiK ;<E &FEKIFCCG8Ki<EK<E =X?IK<\n /i<IE<P <K 8C\n \u0006\u000e\f\f\u0011\u0007 6\u0014\u00117 <II<i:?K<E DiK i?I<I $EK<IM<EKiFE <iE<E E<>8KiM<E  ==<BK\b NU?I<E; ;8J .PJK<D <9<EJF ELI =XI LE><=U?I \u0011\f\u0003 ;<I <iE><J:?CFJJ<E<E +8Ki<EK<E  IiEE<ILE><E ><E<Ii<IK<\n \u001fi< ><E8L<E \"IXE;< ?i<I=XI NLI;<E Ei:?K 8E><><9<E\n   \u001fi< 2iIBJ8DB<iK JFC:?<I $EK<IM<EKiFE<E BWEEK< 8CJF D8Y><9Ci:? MFE ;<I ,L8CiKUK ;<I 0DJ<KQLE> 89?UE><E\b Ni:?Ki> J<iE D8> iEJ9<JFE;<I< ;i< 5LM<ICUJJi>B<iK\b DiK N<C:?<I ;i<  IiEE<ILE>JE8:?Ii:?K<E ><E<Ii<IK N<I;<E\n $E <iE<I 0D=I8>< ELKQK<E N<Ei><I 8CJ \u000e\u0011\u0003 ;<I 9<=I8>K<E \u001cCC><D<iEUIQK< 8LKFD8KiJ:?< $DG=<IiEE<ILE>JJPJ\tK<D< 6\u0015\u000e7\b ;i< 0DJ<KQLE> JFC:?<I (8YE8?D<E ><J:?i<?K 8CJF 9iJ?<I iE \u001f<LKJ:?C8E; ELI JGFI8;iJ:?\n \u001fi< -<MiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> iD -8?D<E MFE FI>8EiJ8KFIiJ:?<E 1<IUE;<ILE><E NLI;< J:?FE \u000e\f\f\u000f iE <iE<D >IFY<E JPJK<D8KiJ:?<E -<Mi<N ;<J 0\n.\n \u001f<G8IK<D<EK F= #<8CK? 8E; #LD8E .<IMi:<J 8CJ <==<BKiM LE; <DG=<?C<EJN<IK QLI .K<i><ILE> MFE $DG=HLFK<E LE; ;<I  iE?8CKLE> MFE +IUM<EKiFEJC<iKCi\tEi<E <DG=F?C<E 6\u0015\u000f7\n \u001cBKL<CC<I< .KL;i<E BFEEK<E 8L:? iE LEJ<I<D -<Mi<N Ei:?K i;<EKi=iQi<IK N<I;<E\b N8J 9<iJGi<CJN<iJ< 8E ;<I MFI?8E;<E<E =CU:?<E;<:B<E;<E 0DJ<KQLE> JFC:?<I .PJK<D< iE ;<E 0.\u001c Ci<><E BWEEK<\b ;i< <iE< <IE<LK<  M8CL8KiFE JFC:?<I .PJK<D< ;LI:? .KL;i<E LE8KKI8BKiM LE; BFDGCiQi<IK ><JK8CK<E BWEEK<\n  \u001fi< .KL;i<E iE LEJ<I<D +IFA<BK ;<DFEJKIi<IK<E iE;i==<I<EK  ==<BK<\b 8L==8CC<E; N8I<E <iE< DiKKC<I< 9iJ Ei<;Ii>< .KL;i<EHL8CiKUK\b BC<iE< +8Ki<EK<EQ8?C<E LE; ;i< \u001d<J:?I<i9LE> MFE <iEi><E 0DJ<KQLE>JGIF9C<D<E\n \u001d<:B <K 8C\n \u0006\r\u0015\u0015\u0013\u0007 6\u0013\u00107 BFEEK< DiK ;<I 1<IJFI>LE> MFE :?IFEiJ:? &I8EB<E iD -8?D<E MFE \"ILGG<E9<JL:?<E iE ;<I +I8OiJ <iE GFJiKiM<J -<JLCK8K ><E<Ii<I<E\n )8:?JFI><9<JL:?< <iE<J \"<D<iE;<BI8EB<EG=C<><IJ E8:? &I8EB<E\t?8LJ<EKC8JJLE> <IQ<L>K<E 9<i #<IDiQ <K 8C\n \u0006\u000e\f\f\u000e\u0007 6\u0013\u00127 B<iE<E I<C<M8EK<E  iE=CLJJ 8L= ;i< $DG=HLFK<E\n \u001d<i;< $EK<IM<EKiFE<E iE ;i<J<D \u001d<I<i:? NLI;<E MFE LEJ 8CJ BFDGC<O< \u001cEJUKQ< <iE><JKL=K\n \"<D<iEJ8DB<iK 9<i;<I (8YE8?D<E N8I <iE ?F?<I \u001cL=N8E; QLI 0DJ<KQLE> ;<I (8YE8?D<E DiK 8LJ9C<i9<E;<E 9iJ DUYi><E  I=FC\t><E\b N8J QLDiE;<JK ;i<  ==iQi<EQ ;<I (8YE8?D<E iE !I8>< JK<CCK\n   ..11..\u001f\u001f \n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f\u0001\u0001\u000e\u000eIITT\u0001\u0001\u0007\u0007OO\f\f\u0017\u0017\u0015\u0015\u0001\u0001AA\u0017\u0017\b\b\u0001\u0001PPAATTIIEE\u000f\u000fTTEE\u000f\u000f  \"<E<I<CC NLI;<E +8Ki<EK<E<IiEE<ILE>JJPJK<D< QLI M<IJKUIBK<E $DGC<D<EKi<ILE> MFE $DDLEiJi<ILE>J\t LE; +IUM<EKiFEJD8YE8?D<E JFNF?C iE ;<I 9I<iK<E \u001d<MWCB<ILE> 8CJ 8L:? iE -iJiBFGFGLC8KiFE<E =XI <==<BKiM 9<\t=LE;<E 6\u0010\u0010\b \u0015\u000f7\b =iE8EQi<CC< \u001cEI<iQ< ;<DFEJKIi<IK<E F=K 9<JFE;<IJ >IFY<  ==<BK< 6\u0015\u000f\b \u0015\u00107\n $E LEJ<I<D +IFA<BK <IQi<CK<E  IiEE<ILE>J\t+FJKB8IK<E 6\u0013\u000f\b \u0014\u00107 LE; _9Ii<=< 6\u0013\u000f\b \u0013\u0015\b \u0014\r7 ><E<I<CC 9<JJ<I<  I><9\tEiJJ< 8CJ .(.\t.PJK<D< 6\u0013\u0013\b \u0014\u000e7\n \u001cCC<I;iE>J N8I<E ;i< .(.\t.KL;i<E ;<LKCi:? 8BKL<CC<I LE; <IJ:?i<E<E iE ;<E %8?I<E \u000e\f\r\u0011\t\u000e\f\r\u0013\b NU?I<E; LEJ<I< +L9CiB8KiFE<E QL \u001dIi<=<E LE; +FJKB8IK<E MFE \r\u0015\u0014\u0013 9iJ \r\u0015\u0015\u0014 ><;IL:BK NLI;<E\n \u001cL:? N<EE C<KQK<I< &8K<>FIi<E K<E;<EQi<CC 9<JJ<I< -<JLCK8K< ><E<Ii<IK<E\b BWEEK<E LEJ<I<  I><9EiJJ< iE ;i<J<D +LEBK Q<iKCi:? X9<I?FCK J<iE\n   .G<Qi<CC iD \u001d<I<i:? MFE ;i>iK8C<E \u001cEJUKQ<E 9<JK<?<E QNiJ:?<E \r\u0015\u0014\u0013 LE; \u000e\f\r\u0013 D8JJiM< 0EK<IJ:?i<;<\b N8J <iE< Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0012  RE;<ILE> iD \u001cEJGI<:?<E ;<I +8Ki<EK<E 8L= ;i< A<N<iCi><E \u001cLJCi<=<ILE>J=FID<E iD '8L=< ;<I 5<iK 9<;iE>K ?89<E BWEEK<\n $D \u001cCC><D<iE<E BFEEK<E .(.\t.PJK<D< =XI ;iM<IJ< +IUM<EKiFEJD8YE8?D<E iE 8E;<I<E +FGL\tC8KiFE<E >LK<  ==<BK< 9<i ?F?<I &FJK<E<==iQi<EQ ><E<Ii<I<E 6\u0015\u0011\b \u0015\u00127\n   iE< >IFY< T9<IJi:?KJ8I9<iK iDGCiQi<IK< J:?FE \u000e\f\f\u000f <iE<E 1FIK<iC MFE G<IJFE8CiJi<IK<E  IiEE<ILE><E ><><E\tX9<I ><E<IiJ:?<E \u001cEJUKQ<E 6\u0015\u000f7\n \u001cL:? iE LEJ<I<D -<Mi<N BFEEK< <iE 1FIK<iC =XI JFC:?< !FID<E ><Q<i>K N<I\t;<E\b G<IJFE8CiJi<IK< \u001cEJUKQ< DiK 1<IN<iJ 8L= <iE< JK8KK><=LE;<E< G<IJWECi:?< $E;iB8KiFEJJK<CCLE> ;LI:? ;<E #8LJ8IQK J:?EiKK<E 9<JJ<I 89\n  \u001fi< \"C8L9NXI;i>B<iK ;<I ,L<CC< 9<<iE=CLJJK ;i< JL9A<BKiM< \u001d<N<IKLE> MFE $E=FID8KiFE<E QL $DG=IiJiB<E LE; \tiE;iB8KiFE<E 6\u0015\u00137 LE; BWEEK< ;LI:? ;i< +<IJFE8CiJi<ILE> <I?W?K N<I;<E\n \u001cLY<I;<D JGi<CK ;i< G<IJWECi:?<  DG=<?CLE> ;<J #8LJ8IQK<J iE Mi<C<E !UCC<E <iE< D8Y><9Ci:?< -FCC<\b N8J =XI ;i< #+1\t$DG=LE> 6\u0015\u0014\b \u0015\u00157 LE; ;i< $E=CL<EQ8\t$DG=LE> iE #$1\t+8Ki<EK<E E8:?><Ni<J<E iJK 6\r\f\f7\n (W>Ci:?<IN<iJ< BUDG=<E JFNF?C $DG=\t9<DX?LE><E ><><E #+1 8CJ 8L:? ><><E $E=CL<EQ8 DiK X9<IGIFGFIKiFE8C<E 1FI9<?8CK<E iE ;<I \u001d<MWCB<ILE>\b N<J?8C9 9<i ;<I $E=CL<EQ8\t$DG=LE> ;i< *Ii<EKi<ILE> 8E '<iKCiEi<E QL \"LEJK<E ;<I ?8LJUIQKCi:?<E  DG=<?\tCLE> iE ;<E #iEK<I>ILE; IX:B<E BWEEK<\n \u001fi< +<IJFE8CiJi<ILE> MFE  IiEE<ILE>JE8:?Ii:?K<E BWEEK< ;i< \"C8L9\tNXI;i>B<iK ;<I ,L<CC< <I?W?<E LE; K<iCN<iJ< 8E8CF> QLI G<IJWECi:?<E  DG=<?CLE> ;<J #8LJ8IQK<J NiIB<E\b N8J ;<E 1FIK<iC ><><EX9<I Ei:?K G<IJFE8CiJi<IK<E .PJK<D<E <IBCUI<E NXI;<\n \u001fi< $EBCLJiFE <iE<J <;LB8KiM<E \u001cEK<iCJ iE  IiEE<ILE>JE8:?Ii:?K<E BFEEK< iE LEJ<I<D -<Mi<N B<iE<E 1FIK<iC ><><EX9<I (8YE8?D<E F?E< 5LJ8KQiE?8CK Q<i><E\n  iE< GFJK8CiJ:? M<IJ<E;<K< <;LB8KiM< \u001dIFJ:?XI< <II<i:?K< iE LEJ<I<D -<Mi<N 8CC<I;iE>J <iE<E J<?I >IFY<E  ==<BK 6\u0014\f7\n  \u001fi< >C<i:?< .KL;i< LEK<IJL:?K< QLJUKQCi:? <iE<E =iE8EQi<CC<E \u001cEI<iQ\b ><<i>E<K< +8Ki<EK<E BFEEK<E ?i<I E8:? <I=FC>K<I $DG=LE> 8E <iE<I 1<ICFJLE> MFE '<9<EJDiKK<C>LKJ:?<iE<E K<iCE<?D<E\n \u001fi<J< $EK<IM<EKiFE <II<i:?K< ;<E >IWYK<E  ==<BK iE LEJ<I<D -<Mi<N LE; N8I ;<I <;LB8KiM<E \u001dIFJ:?XI< X9<IC<><E\n  iE< &FD9iE8KiFE MFE \u001dIFJ:?XI< LE; \u001cEI<iQ <I>89 <9<E=8CCJ B<iE<E 1FIK<iC ><><EX9<I ;<I 8CC<iEi><E $DGC<D<EKi<ILE> ;<J =iE8EQi\t<CC<E \u001cEI<iQ<J\b N8J Ji:? DiK ;<E  IB<EEKEiJJ<E 9iJ?<Ii><I +L9CiB8KiFE<E ;<:BK 6\u0015\u000f7\n  \u001cCJ \"ILE; =XI D8E><C?8=K< $DG=HLFK<E 8L= .<iK<E ;<I +8Ki<EK<E iJK 9<iJGi<CJN<iJ< D8E><CE;<J 2iJJ<E X9<I ;i< iE;iMi;L<CC <DG=F?C<E<E $DG=LE><E ;<EB98I\b N8J ;i< $DG=HLFK<E E<>8KiM 9<<iE=CLJJ<E B8EE 6\r\u000e7\n  ;L\tB8KiM< (8YE8?D<E JiE; ><<i>E<K\b ;8J 2iJJ<E X9<I $DG=LE><E QL M<I9<JJ<IE 6\r\f\r7 LE; =X?I<E iE 9<JKiDDK<E +FGLC8KiFE<E ;LI:?8LJ QL Ji>Ei=iB8EK<E\b JK8IB GFJiKiM<E -<JLCK8K<E 6\r\f\u000e7\n (W>Ci:?<IN<iJ< iJK 89<I <iE 9<\tJKiDDK<I HL8EKiK8KiM<I 0D=8E> EWKi>\b LD <;LB8KiM< (8YE8?D<E NiIBJ8D LDJ<KQ<E QL BWEE<E\n  ==<BK LE;  ==<BKiMiKUK iE=FIDi<I<E;<I \u001cEJUKQ< 9C<i9<E NF?C F=K ?iEK<I =iE8EQi<CC<E \u001cEI<iQ<E LE;  IiEE<ILE>JJPJK<D<E QLIX:B 6\u0015\u000f7\b N8J ;i< \u001cKKI8BKiMiKUK ;i<J<J \u001cEJ8KQ<J iE !I8>< JK<CCK\n !iE8EQi<CC< \u001cEI<iQ< NLI;<E iE 8E;<I<E +F\tGLC8KiFE<E 8CJ ><E<I<CC <==<BKiMJK< (<K?F;< QLI .K<i><ILE> ;<I $DG=HLFK<E 9<J:?Ii<9<E 6\u0015\u000f7\n $?I<  ==iQi<EQ iJK 89<I 8L=>ILE; ;<I DW>Ci:?<E &FJK<EiEK<EJiKUK iE !I8>< QL JK<CC<E\n Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0013    ..11..   \u000b\u000bOO\u000e\u000e\u0012\u0012LLEE\u001b\u001bIITT\u0003\u0003TT\u0015\u0015GG\u0014\u0014AA\u0006\u0006\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000f  &FDGC<O< $EK<IM<EKiFE<E <I=I<L<E Ji:?\b iEJ9<JFE;<I< iD \u001d<I<i:? ;<I 1<IJFI>LE>J=FIJ:?LE>\b QLE<?D<E;<I \u001d<Ci<9K?<iK\n \"ILE;><;8EB< iJK ;i< &FD9iE8KiFE M<IJ:?i<;<E<I \u001cEK<iC< MFE\b QLMFI 8CJ <==<BKiM 9<Ni<J<E<E\b $EK<IM<EKiFE<E\b LD DW>Ci:?JK >IFY<  ==<BK< iE ?<K<IF><E<E +FGLC8KiFE<E LE; .<KKiE>J <II<i:?<E QL BWEE<E\n  \u001cCC<I;iE>J JiE; iD 1FI=<C; J:?FE 5N<i=<C 8E ;<I .iEE?8=Ki>B<iK JFC:?<I \u001cEJUKQ< 9<J:?Ii<9<E NFI;<E\n  iE JPJK<D8KiJ:?<I -<Mi<N =8E; ?<I8LJ\b ;8JJ BFDGC<O< \u001cEJUKQ< QLI 1<I9<JJ<ILE> ;<I '<iKCiEi<ELDJ<KQLE> iE ;<I \u001cCC><D<iED<;iQiE Ei:?K QNiE><E; MFIK<iC?8=K< -<JLCK8K< ><><EX9<I <iE=8:?<E $EK<IM<EKiFE<E <I9IiE><E 6\u0014\u00147\n  iE< T9<IJi:?K X9<I D<?I<I< JPJK<D8KiJ:?< -<Mi<NJ =8E; B<iE<E 1FIJGILE> DLCKi=8:<KKi<IK<I $EK<IM<EKiFE<E 9<i ;<I \u001d<<iE=CLJJLE> ;<J 1<I?8CK<EJ MFE D<;iQiEiJ:?<D !8:?G<IJFE8C 6\r\f\u000f7\n (F;<CC< QLI FI>8EiJi<IK<E 1<I\tJFI>LE> MFE :?IFEiJ:?<E &I8EB?<iK<E NLI;<E iE <iE=8:?<E \u001cEJUKQ<E U?ECi:? <==<BKiM 9<=LE;<E Ni< iE BFD\tGC<O<E \u001cEJUKQ<E 6\r\f\u00107\n  \u001cL:? iE LEJ<I<D -<Mi<N BFEEK<E BFDGC<O< $EK<IM<EKiFE<E B<iE<E 1FIK<iC ><><EX9<I <iE=8:?<E (8YE8?<D E8:?N<iJ<E\n .G<Qi<CC 8L= ;<D '<M<C ;<I 5<EKIi<ILE> 8L= D<;iQiEiJ:?<D +<IJFE8C N8I ;i< 0DJ<KQLE>JHL8CiKUK ;<I BFDGC<O<E $EK<IM<EKiFE<E ><E<I<CC DiKK<CDUYi> 9iJ ><IiE>\b F=K NLI;<E ?i<I +IF9C<D< iE ;<I $DGC<D<E\tKi<ILE> 9<J:?Ii<9<E\n \u001fi< 1FIK<iC<\b ;i< <iE BFDGC<O<I \u001cEJ8KQ ;LI:? J<iE 9I<iK<J \u001cEJGI<:?<E MFE ?<K<IF><E<E +FGLC8KiFE<E 9<JiKQ<E B8EE\b N<I;<E DW>Ci:?<IN<iJ< iE Mi<C<E !UCC<E ;LI:? ;i< D8E><C?8=K< 0DJ<KQLE> 89\tJFI9i<IK\n   ..11..!! \u0017\u0017II\u0014\u0014\f\f\u0015\u0015AA\u000e\u000e\f\fEEIITT\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f\u0001\u0001II\u000f\u000f\u0001\u0001\u0012\u0012EELLAATTIIOO\u000f\u000f\u0001\u0001\u001d\u001d\u0017\u0017\u000e\u000e\u0001\u0001\b\bEE\u0015\u0015\u0017\u0017\u000f\u000f\u0006\u0006HHEEIITT\u0015\u0015\u0015\u0015\u001c\u001c\u0015\u0015TTEE\u000e\u000e  \"<E<I<CC NLI;<E iE LEJ<I<D -<Mi<N 8LKFD8KiJi<IK<  IiEE<ILE>JJPJK<D< =XI RIQK< JFNi< \u001dIi<=\t LE; +FJKB8I\tK<E\t IiEE<ILE><E 8LJJ:?Ci<YCi:? iE <iE<D GIiM8K<E \"<JLE;?<iKJJPJK<D iDGC<D<EKi<IK\n .(.\t IiEE<ILE><E =8E;<E Ji:? iD .<KKiE> <iE<J JK88KCi:?<E \"<JLE;?<iKJ;i<EJK<J LE; <iE<I JK88KCi:?<E &I8EB<EM<IJi:?<ILE>\n  1FI8LJJ<KQLE> =XI ;i< <==iQi<EK< \u001cEN<E;LE> JFC:?<I $EK<IM<EKiFE<E JiE; <C<BKIFEiJ:?< +8Ki<EK<E;8K<E98E\tB<E\b 8LJ N<C:?<E Ji:? ><<i>E<K< +8Ki<EK<E DiK #iC=< MFE .L:?8C>FIiK?D<E 8LKFD8KiJ:? ?<I8LJ=iCK<IE C8JJ<E\n \u001fLI:? J<iE< MFCCJKUE;i>< S==ELE> =XI ;<E =I<i<E (8IBK =iE;<K iD GIiM8K<E \"<JLE;?<iKJJPJK<D ;<I 0.\u001c <iE ?F?<J (8Y 8E $EEFM8KiFE JK8KK\b LE; JFC:?< \u001eFDGLK<IJPJK<D< JiE; ;FIK J:?FE J<iK %8?I<E <iE<J ;<I .K8E;8I;\t8I9<iKJD8K<Ii8Ci<E Mi<C<I +I8O<E 6\r\f\u00117\n \u001cL:? iE JK88KCi:?<E .PJK<D<E =iE;<E Ji:? ?UL=i> J<?I LD=8E>I<i:?< \u001f8K<E98EB<E DiK +8Ki<EK<E;8K<E\b 9<;iE>K ;LI:? ;8J ?F?< (8Y 8E 5<EKI8CiJi<ILE> LE; .K8E;8I;iJi<ILE> 6\r\f\u00117\n $E .PJK<D<E DiK JFQi8C<I &I8EB<EM<IJi:?<ILE> =iE;<K ;i< 0DJ<KQLE> JFC:?<I .PJK<D< 9iJ?<I 8CC<I;iE>J Ei:?K =CU:?<E;<EB<E; JK8KK\b F=K JK<?<E ;<D \u001f8K<EJ:?LKQ9<;<EB<E iD 2<>\n .(.\t IiEE<ILE><E Q<i>K<E LEK<I ;<D  iE=CLJJ <iE<I JK88KCi:?<E &I8EB<EM<IJi:?<ILE> 9<JJ<I<  ==<BK<\b iD JK88KCi:?<E \"<JLE;?<iKJ;i<EJK N8I<E Ji< Ei:?K NiIBJ8D\n  iE<  IBCUILE> BWEEK< ;i< ><E<I<CC ?W?<I< \u001d8JiJiDG=\tHLFK< iE \"IFY9IiK8EEi<E J<iE\n  iE >IFY<I 0EK<IJ:?i<; QNiJ:?<E 9<i;<E .PJK<D<E iJK 8CC<I;iE>J 8L:? iE ;<I 1<IJFI>LE>J9<I<iKJK<CCLE> QL =iE;<E\u0016 2U?I<E; RIQK< iE \"IFY9IiK8EEi<E JK88KCi:?< \u001cE><JK<CCK< JiE;\b =iE;<K ;i< Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0014  1<IJFI>LE> iE \u001cLJKI8Ci<E ;LI:? GIiM8K< \u001cBK<LI< JK8KK 6\u0012\u00157\b N<C:?< DW>Ci:?<IN<iJ< <iE<I =C<Oi9C<I<E -<>LC8Ki\tFELEK<ICi<><E\n  9<EJF =iE;<E iD E8KiFE8C<E \"<JLE;?<iKJ;i<EJK ><E<I<CC Mi<C< +IUM<EKiFEJB8DG8>E<E JK8KK\b N8J <iE< 1<IJ:?C<i<ILE> ;<J iJFCi<IK<E  ==<BK<J ;<I .KL;i< 8LJ \"IFY9IiK8EEi<E ;LI:? 8E;<I<\b G8I8CC<C JK8KK=iE\t;<E;< $EK<IM<EKiFE<E 9<NiIBK ?89<E BWEEK<\n '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ Q<i>K<E ELI iD .<KKiE> <iE<I E8KiFE8C<E F;<I <iE<I JFQi8C<E &I8EB<EM<IJi:?<ILE> GFJiKiM<  ==<BK<\b 8L:? ?i<I BFEEK< iD E8KiFE8C<E \"<JLE;?<iKJ;i<EJK \"IFY9IiK8EEi<EJ B<iE< .i>Ei=iB8EQ <II<i:?K N<I;<E\n \u001cCC><D<iEUIQK< iE  E>C8E; 8I9<iK<E LEK<I ;<D  iE=CLJJ Mi<C<I 1FIJ:?Ii=K<E LE;  I=8?I<E ><E<I<CC LD=8E>I<i:?< 2<iK<I9iC;LE>JD8YE8?D<E 6\r\f\u00117\b N8J ;<E  iE=CLJJ <iE<I QLJUKQCi:?<E '<?IM<I8EJK8CKLE> CiDiKi<I<E BWEEK<\n \u001f<J 2<iK<I<E 9<JiKQ<E Ji< iE i?I<I \u001cI9<iKJN<iJ< 8CJ JK88KCi:?< \u001cE><JK<CCK< DW>Ci:?<IN<iJ< <iE ><IiE><I<J (8Y 8E !C<Oi9iCiKUK 8CJ RIQK<\b ;i< 8CJ .<C9JKJKUE;i>< 8I9<iK<E\n  \u001fi< -<MiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> BFEEK< ELI iE <iE<I .KL;i< iD GIiM8K<E \"<JLE;?<iKJJPJK<D <iE<E GFJiKiM<E  ==<BK ;<DFEJKIi<I<E\b <iE< 8E;<I< .KL;i< LEK<I ;<D  iE=CLJJ <iE<I E8KiFE8C<E &I8EB<EM<IJi\t:?<ILE> Q<i>K< <iE Ei:?K Ji>Ei=iB8EK<J E<>8KiM<J -<JLCK8K\n \u001fi< 0.\u001c JiE; 1FII<iK<I iE \u001d<QL> 8L= ;i< \u001f<C<>8KiFE UIQKCi:?<I \u001cL=>89<E 8E D<;iQiEiJ:?<J !8:?G<IJFE8C\n .8EiKUK<I ;XI=<E ?i<I 9<iJGi<CJN<iJ< <i><EJKUE;i> *Gi8K< M<I89I<i:?<E 6\r\f\u00127\b &I8EB<EG=C<><I J<C9JKJKUE;i> -<Q<GK< =XI 9<JKiDDK< (<;iB8D<EK< 8LJJK<CC<E\n 1i<C< 8E\t;<I< 'UE;<I =FC><E ;i<J<D \u001d<iJGi<C DiKKC<IN<iC<\b ;<EEF:? iJK 8EQLE<?D<E\b ;8JJ ;i< \u001cBQ<GK8EQ JFC:?<I \u001cE\tJUKQ< JFNF?C LEK<I +8Ki<EK<E 8CJ 8L:? RIQK<E iE ;<E 0.\u001c 9<JFE;<IJ ?F:? iJK\n \u001fi< .KL;i< 8LJ \u001cLJKI8Ci<E 9<Ii:?K<K< LEK<I 8E;<I<D MFE D8E><CE;<I \u001d<I<iKJ:?8=K ;<I #8LJUIQK< QLI &FFG<I8KiFE DiK \"<D<iE;<BI8E\tB<EG=C<><IE\n \u001f8 ;i< -<>LC8KiFE ;<I \"<JLE;?<iKJM<IJFI>LE> iD GIiM8K<E \"<JLE;?<iKJJPJK<D <9<EJF GIiM8K<E \u001cBK<LI<E F9Ci<>K \u0006Ji<?< /89<CC< \u0011\u0007 6\u0012\u00157\b JiE; ;i< \u001d8IIi<I<E QLI $DGC<D<EKi<ILE> JFC:?<I (8YE8?D<E NF?C DiEiD8C\b LE; ;i< <==<BKiM< 0DJ<KQLE> NiI; <IC<i:?K<IK\n    ..11..\"\" \u0017\u0017II\u0014\u0014\f\f\u0015\u0015AA\u000e\u000e\f\fEEIITT\u0001\u0001\u0006\u0006EE\u0014\u0014\u0001\u0001\n\n\u000f\u000fTTEE\u0014\u0014\u0019\u0019EE\u000f\u000fTTIIOO\u000f\u000fEE\u000f\u000f\u0001\u0001II\u000f\u000f\u0001\u0001\u0019\u0019EE\u0014\u0014\u0015\u0015\u0005\u0005HHIIEE\u0006\u0006EE\u000f\u000fEE\u000f\u000f\u0001\u0001\u0013\u0013\u0017\u0017\u0004\u0004GG\u0014\u0014\u0017\u0017\u0012\u0012\u0012\u0012EE\u000f\u000f   iE ?UL=i><I \"ILE; =XI =<?C<E;< .i>Ei=iB8EQ iE .L9>ILGG<E N8I<E ><E<I<CC ;i< BC<iE<E .Ki:?GIF9<E>IWY<E\n \u001f8J 1<IJ<E;<E <iE<I .(.\t IiEE<ILE>\b N<C:?< iE ;<I \"<J8DKGFGLC8KiFE B<iE< .i>Ei=iB8EQ <II<i:?K<\b Q<i>K< iE ;<I .L9>ILGG< ;<I +8Ki<EK<E DiK :?IFEiJ:?<E #<IQ<IBI8EBLE><E <iE<E BC<iE<E\b I<C<M8EK<E  ==<BK\n \u001cLY<I;<D N8I <iE G<IJFE8CiJi<IK<I \u001dIi<= QLI  II<i:?LE> ;<J 5i<C<J ><<i>E<K\n \u001fi< 58?C ;<I +8Ki<EK<E DiK iDDLEFCF>i\tJ:?<E +8K?FCF>i<E N8I ><E<I<CC X9<I 8CC< .KL;i<E M<I?UCKEiJDUYi> BC<iE\b ;<EEF:? BFEEK< <iE< .(.\t IiEE<\tILE> 8L:? ?i<I <iE<E BC<iE<E Ji>Ei=iB8EK<E  ==<BK <IQi<C<E\n +8Ki<EK<E DiK #<IQ\t LE; $DDLE<IBI8EBLE><E JGI8:?<E 8CJF 8L= .(.\t IiEE<ILE><E 9<JJ<I\b 8L= <iE< <;LB8KiM< \u001dIFJ:?XI< LE; <iE<E =iE8EQi<CC<E \u001cEI<iQ K<E;<EQi<CC J:?C<:?K<I 8E 8CJ ;i< \"<J8DKGFGLC8KiFE\n \u001fi< 28?IJ:?<iECi:?B<iK\b <iE< $E=CL<EQ8\t$DG=LE> QL <I?8CK<E JKi<> 9<i \u001fi89<KiB<IE iE <iE<I JG8EiJ:?<E .KL;i< DiK QLJUKQCi:?<I :?IFEiJ:?<I 'LE><E<IBI8EBLE> 8E LE; E8?D DiK JK<i><E;<D #9\u001c\r\u001e 89 6\r\f\u00137\n  iE< BFI<8\tEiJ:?< .KL;i< 8JJFQii<IK< LEK<I 8E;<I<D <iE ?F?<J !8DiCi<E<iEBFDD<E LE; IiJiBFCFJ<E \u001cCBF?FCBFEJLD DiK Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0010\u0015  <I=FC>K<I #<G8KiKiJ \u001d\t$DG=LE> LEK<I +8Ki<EK<E DiK \u001fi89<K<J 6\r\f\u00147\n $E LEJ<I<D -<Mi<N BFEEK<\b KIFKQ ?F?<I !8CCQ8?C<E\b B<iE< <iEQi>< .KL;i< I<C<M8EK<  ==<BK< <II<i:?<E\n $EJ><J8DK BWEEK<E ;i< $DG=HLFK<E 8CJF iE ;i<J<I +FGLC8KiFE DiK 89E<?D<E;<I \"<JLE;?<iK <9<EJF JiEB<E\n \"<E<I<CC BWEEK<E Ji< LEK<I;LI:?J:?EiKKCi:? 8L= $DG=9<DX?LE><E I<8>i<I<E\n +8Ki<EK<E DiK :?IFEiJ:?<E 'LE><E<IBI8EBLE><E N8I<E ;i< 8D ?UL=i>JK<E LEK<IJL:?K< .L9GFGLC8KiFE\b ;<D\t<EKJGI<:?<E; Ni:?<E ;i<  I><9EiJJ< 8D N<Ei>JK<E MFE ;<E<E ;<I \"<J8DKGFGLC8KiFE 89\n .i< GIF=iKi<IK<E iE LEJ<I<I \u001cI9<iK MFE <iE<I <;LB8KiM<E \u001dIFJ:?XI< LE; \u001e*+\u001f\t(8YE8?D<EG8B<K<E\n  IiEE<ILE>JJPJK<D< LE; \u001cGFK?<B<I\t98Ji<IK< $EK<IM<EKiFE<E NLI;<E iE 1FI8I9<iK<E 8CJ <==<BKiM 9<J:?Ii<9<E 6\r\f\u00157\n \"<E<I<CC >i9K <J Mi<C< .KL;i<E QL \u001cJK?D8\t LE; \u001e*+\u001f\t+8Ki<EK<E LE; ;i<J< J:?<iE<E iEJ><J8DK >LK 8L= $DG=iEK<IM<EKiFE<E 8EQLJGI<:?<E\n  iE<  IiEE<ILE>J\t+FJKB8IK< Q<i>K< iE +8Ki<EK<E DiK DiE;<JK<EJ \u0010\r %8?I<E I<C<M8EK<  ==<BK<\b <iE<  IiEE<\tILE>J\t.(. <II<i:?K< iE ALE><E  IN8:?J<E<E MFE \r\u0014 9iJ \u000f\u0010 %8?I<E Ji>Ei=iB8EK GFJiKiM< -<JLCK8K<\n  iE< T9<I\tJi:?KJ8I9<iK DiK %L><E;Ci:?<E LEK<I \r\u0015 %8?I<E 9<N<IK<K< .(.\t IiEE<ILE><E iE ;i<J<I \u001cCK<IJBC8JJ< 8CJ <==<BKiM 6\r\r\f7\n  iE< 8E;<I<I -<Mi<N 9<J:?Ii<9 GFJK8CiJ:?< $DG=\t IiEE<ILE><E =XI  CK<IE QLI $DG=LE> i?I<I &iE;<I 8CJ MFIK<iC?8=K ><><EX9<I ;i>iK8C<E \u001cEJUKQ<E 6\r\r\r7 \u001cE8CF> ?i<IQL M<I?i<CK<E Ji:? 8L:? LEJ<I<  I><9EiJJ<\n .(.\t IiEE<ILE><E JiE; DW>Ci:?<IN<iJ< =XI AXE><I< LE;  IiEE<ILE>J\t+FJKB8IK<E =XI UCK<I< +8Ki<EK<E 9<JJ<I ><<i>\tE<K\n   ..11..## \u0004\u0004EEIILLII\u000f\u000fGG\u0001\u0001\u0006\u0006\b\b\b\bEE\u0005\u0005TT  !XI Mi<C< (<;iB8D<EK< >iCK iE ;<I +?8ID8BFBiE<KiB ;i< \u001cEE8?D< <iE<J JF><E8EEK<E \u001e<iCiE>\t ==<BKJ\n !FC>Ci:? E<?D<E ;i< <INXEJ:?K<E 2iIBLE><E 89 <iE<I 9<JKiDDK<E 2iIBJKF==BFEQ<EKI8KiFE iD \u001dCLK 9<i  I?W?LE> ;<I \u001fFJiJ Ei:?K D<?I QL\b ;i< \u001fFJiJ\t2iIBLE>J\t&LIM< JK8>Ei<IK\b 9<MFI ;<I (8OiD8C<==<BK <iE<J (<;iB8D<EKJ <I\tQi<CK N<I;<E BFEEK< 6\r\r\u000e7\n \u001e<iCiE>\t ==<BK< JiE; 8LJ M<IJ:?i<;<E<E \u001d<I<i:?<E ;<I 2iJJ<EJ:?8=K 9<B8EEK 6\r\r\u000e\b \r\r\u000f7\n   $E \u001d<QL> 8L= LEJ<I /?<D8 9<J:?I<i9K <I <iE +?UEFD<E\b 9<i N<C:?<D ?F?< \u001d8JiJiDG=HLFK<E QL <iE<I -<;LB\tKiFE F;<I >8I &8J:?i<ILE> MFE  ==<BK<E =X?I<E\n \u001fi< \"IXE;< ?i<I=XI JiE; 9iJ?<I N<Ei> LEK<IJL:?K\b 8CC<I;iE>J iJK <iE DW>Ci:?<I  iE=CLJJ ;<J \u001e<iCiE>  ==<:KJ iE ;<I 'iK<I8KLI ?UL=i> 9<J:?Ii<9<E 6\u0013\u0011\b \r\r\u0010\b \r\r\u00117\n \u001cL:? iE LEJ<I<D -<Mi<N BFEEK< <iE< BFEJK8EK< \u001c9E8?D< ;<I  ==<BK>IWY< DiK 5LE8?D< ;<I \u001d8JiJiDG=HLFK< ><Q<i>K N<I;<E \u0006\u001c99iC;LE> \r\u000f\u0007\n   5LD <iE<E 9<JK<?K <iE JiDGC<I D8K?<D8KiJ:?<I 5LJ8DD<E?8E>\b ;<I 8LJ ;<I 28?C ;<J  ==<BKD8Y<J I<JLCKi<IK\n 2U?I<E; 9<i <iE<I $DG=HLFK< MFE \r\f\u0003 iE ;<I &FEKIFCC>ILGG< <iE <iE< D8OiD8C< -- MFE \r\f\n\f <II<i:?K N<I;<E B8EE\b JF iJK ;<I (8OiD8CN<IK =XI <iE< $DG=HLFK< MFE \u0011\f\u0003 iE ;<I &FEKIFCC>ILGG< ELI EF:? \u000e\n\f\n  $E \u001c99iC;LE> \r\u0011 iJK QLJUKQCi:? ;i< D8OiD8C QL <II<i:?<E;<  ==<BK>IWY< iE \u001c9?UE>i>B<iK ;<I &FEKIFCC>ILGG<E\t$DG=HLFK< ;8I><JK<CCK\n #i<I CUJJK Ji:? <IB<EE<E\b ;8JJ Ji:? ;i< <II<i:?K<E  ==<BK>IWY<E DiK JK<i><E;<I \u001d8JiJ\t$DG=HLFK< JF>8I JKUIB<I 8E ;8J (8OiDLD 8EEU?<IK<E\n  Einordnung der Ergebnisse und \u0015chluss$olgerungen  \n \u0011\f     \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??CC  88  \u0005\u0005\u0014\u0014''((**\u0019\u0019    ++\"\"\u001b\u001b  \u0018\u0018\u0019\u0019''  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001b\u001b''$$))\u0019\u0019  \u001d\u001d\"\"  \u0002\u0002\u0016\u0016\u001c\u001c\u0015\u0015\"\"\u001b\u001b\u001d\u001d\u001b\u001b\u001f\u001f\u0019\u0019\u001d\u001d**  \u0018\u0018\u0019\u0019''  \n\n!!%%\u001a\u001a&&++##**\u0019\u0019  \u0018\u0018\u0019\u0019''  \u000b\u000b##\"\"**''##    77\u001b\u001b''++%%%%\u0019\u0019  !!\u001d\u001d**  !!\u0014\u0014//\u001d\u001d!!\u0014\u0014    11++  \u0019\u0019''''\u0019\u0019\u001d\u001d\u0017\u0017\u001c\u001c\u0019\u0019\"\"\u0018\u0018\u0019\u0019''  \u0006\u0006\u001a\u001a\u001a\u001a\u0019\u0019\u001f\u001f**\u001b\u001b''$$))\u0019\u0019   P \nnterventi'n einer Studie, \u001f\u001ff. Sub\u001fruppe.  P \u0014rendlinie8  P ma3imal errei\u001bhbare \u0006ffekt\u001fr\u00f6-e in Ab>h\u0019n\u001fi\u001fkeit der \nmpf*u'te in der \f'ntr'll\u001fruppe \nLimitationen  \n \u0011\r  \"<E<I<CC J:?<iEK 8CJF <iE \"IFYK<iC ;<J J:?<iE98I<E \u001e<iCiE>  ==<:KJ 8L= ;<I 28?C ;<J  ==<BKD8Y<J LE; ;<JJ<E \u001d<I<:?ELE> QL 9<IL?<E\n \u001f<EEF:? Ci<Y<E Ji:? 9<i &FEKIFCC>ILGG<E\t$DG=HLFK<E MFE DiE;<JK<EJ \u0012\u0011\u0003 B<iE< Ji>Ei=iB8EK GFJiKiM<E  I><9EiJJ< D<?I 9<F98:?K<E\b N8J 8L= <iE<E .UKKi>LE>JN<IK =XI $EK<IM<EKiFE<E iE ;<I \u001cCC><D<iED<;iQiE 9<QX>Ci:? ;<I $E=CL<EQ8\t$DG=LE> iE 9<JKiDDK<E \u001d<MWCB<ILE>J>ILGG<E ?iE;<LK<E BWEEK<\n   iE >IFY<I 8D<IiB8EiJ:?<I \"<JLE;?<iKJ;i<EJKC<iJK<I iDGC<D<EKi<IK< =XI ;i< .8iJFE \u000e\f\r\r\u000b\u000e\f\r\u000e <iE<E 8BKL<CC<E $E=CL<EQ8\t$DG=J:?LKQ 8CJ +=Ci:?KD8YE8?D< =XI 8CC< J<iE< \u001cE><JK<CCK<E\n #i<I;LI:? BFEEK<E ;i< $DDLEiJi<\tILE>JI8K<E ;<J D<;iQiEiJ:?<E +<IJFE8CJ MFE \u0013\r\u0003 iD %8?I \u000e\f\r\f 8L= \u0015\u0013\b\u0013\u0003 iD %8?I \u000e\f\r\r ><JK<i><IK N<I;<E\n \u001fi< NiIKJ:?8=KCi:?<E LE; FI>8EiJ8KFIiJ:?<E !FC><E N8I<E ><IiE> LE; 8LJ>C<i:?98I\n 6\r\r\u00127 $E \u001e?iE8 >i9K <J =XI Mi<C< $DG=LE><E E8KiFE8C< $DG=B8DG8>E<E\b N<C:?< Ji:? ;<LKCi:? MFE ;<E &8DG8>E<E iE * \u001e\u001f\t'UE;<IE LEK<IJ:?<i;<E\u0016  iE 8BKL<CC<I $DDLEiJi<ILE>JJK8KLJ iJK F9Ci>8KFIiJ:? =XI ;i< \u001d<J:?U=Ki>LE> iE Mi<C<E \u001d<IL=<E LE; =XI ;<E \u001d<JL:? MFE &iE;<I9<KI<LLE>J<iEIi:?KLE><E\b 9<i $DG=B8DG8>E<E N<I;<E J:?Ci:?K 8CC< ><<i>E<K<E +8Ki<EK<E\b LE89?UE>i> ;<J iE;iMi;L<CC<E $DDLEiJi<ILE>JJK8KLJ\b iD 5N<i=<C I<;LE;8EK ><iDG=K\n #i<IDiK <I\tI<i:?K ;8J '8E; 9<iJGi<CJN<iJ< =XI ;i< (8J<IE =CU:?<E;<:B<E;< $DG=HLFK<E MFE D<?I 8CJ \u0014\f\u0003 iE ;<E 5i<C\tGFGLC8KiFE<E\n 6\r\r\u00137    iE< \u001c9B<?I MFD &FEQ<GK ;<I $DDLEiJi<ILE> 8L= =I<iNiCCi><I \u001d8JiJ =XI 9<JKiDDK< +FGLC8KiFE<E BWEEK< 8CJF <iE< (W>Ci:?B<iK QLI  I=XCCLE> MFE $DDLEiJi<ILE>JQi<C<E ;8IJK<CC<E\n $E <iE<I I<GIUJ<EK8KiM<E 0D=I8>< ;<I .:?N<EEiE><I &I8EB<EB8JJ< iE \u001f<LKJ:?C8E; >89<E \u0013\u0013\u0003 ;<I \u001d<=I8>K<E 8E\b <iE< $DG=G=Ci:?K =XI 9<JKiDDK< +<IJFE<E>ILGG<E ><E<I<CC QL LEK<IJKXKQ<E 6\r\r\u00147\n \u001fi< \u001cBQ<GK8EQ JFC:?<I (8YE8?D<E iE ;<I \u001d<MWCB<ILE> ;<I * \u001e\u001f\t'UE;<I iJK iEJ><J8DK J:?N<I MFI?<IJ<?98I\b iE A<;F:? \u001e?iE8 ;XI=K< Ji<\b 8L=>ILE; ;<I GFCiKiJ:?<E -8?\tD<E9<;iE>LE><E\b iD 1<I>C<i:? Ji:?<ICi:? ?W?<I J<iE\n \u001c\u001c\u0015\u0015\u001a\u001a \t\t\u000b\u000bMM\u000b\u000b\u0016\u0016\u0002\u0002\u0016\u0016\u000b\u000b\u0011\u0011\u0010\u0010EE\u0010\u0010    ..22..11 \b\bEE\u000f\u000fEE\u0014\u0014EELLLLEE\u0001\u0001\f\fII\u000e\u000eIITTAATTIIOO\u000f\u000fEE\u000f\u000f  /IFKQ ;<I -<:?<I:?< iE Mi<I >IFY<E \u001f8K<E98EB<E 9<JK<?K ;<EEF:? ;i< (W>Ci:?B<iK\b ;8JJ I<C<M8EK< .KL;i<E X9<IJ<?<E NLI;<E\n \u001fi< ,L8CiKUK ;<I .KL;i<E N8I LEK<IJ:?i<;Ci:? LE; iEJ><J8DK DiKK<CDUYi>\b 8LY<I;<D N8I<E ;i< .Ki:?GIF9<E>IWY<E iE <iEi><E !UCC<E F==<EJi:?KCi:? Ei:?K 8LJI<i:?<E; 9<D<JJ<E\b LD QL <IN8IK<E;< 0E\tK<IJ:?i<;< QNiJ:?<E \"ILGG<E ;<K<BKi<I<E QL BWEE<E\n 0EJ<I ,L8CiKUKJ=8BKFI\b ;i< ><J8DK< -iJB\tF=\t\u001di8J\t\u001d<\tN<IKLE> LE; ;i<  iEK<iCLE> MFE  ==<BK<E iE &8K<>FIi<E <EK?8CK<E iE A<;<D !8CC JL9A<BKiM< &FDGFE<EK<E ;<I \u001cLKFI<E LE; BWEEK<E JFDiK ;LI:? G<IJWECi:?<  iEJK<CCLE><E 9<<iE=CLJJK NFI;<E J<iE\n   ..22..22 PP\u0017\u0017\u0004\u0004LLII\f\fAATTIIOO\u000f\u000f\u001a\u001a\u0003\u0003IIAA\u0015\u0015  5LI \u001c9J:?UKQLE> ;<J +L9CiB8KiFEJ9i8J <I=FC>K< ;i< \u001f8IJK<CCLE> MFE  I><9EiJJ<E LE; +8Ki<EK<EQ8?C<E iE !LE\tE<C +CFKJ \u0006\u001c99iC;LE><E \r\u0012\b \r\u0013\u0007\n  iE< \"ILGGi<ILE> ;<I  I><9EiJJ< LD ;<E N8?I<E  ==<BK 8L= <iE< JPDD<KIi\tJ:?< \u001cIK LE; 2<iJ< D8:?K <iE<E E<EE<EJN<IK<E  iE=CLJJ ;<J +L9CiB8KiFEJ9i8J<J LEN8?IJ:?<iECi:?<I\b J:?Ci<YK i?E 8CC<I;iE>J ;<EEF:? Ei:?K 8LJ 6\r\r\u00157\n   Limitationen  \n \u0011\u000e  \u001cL=>ILE; ;<I ?F?<E #<K<IF><EiKUK LEJ<I<I .KL;i<E N8I <iE +FFCiE> ;<I .KL;i<E;8K<E 8CJ \u001cEEU?<ILE> 8E ;<E N8?I<E  ==<BK Ei:?K JiEEMFCC\b NF;LI:? ;i< \u001cLJJ8><BI8=K ;<J !LEE<C +CFKJ <iE><J:?IUEBK LE; ;<JJ<E $EK<I\tGI<K8KiFE 9<<iE=CLJJK NiI;\n $EJ><J8DK =i<C ;<I \"IFYK<iC ;<I  I><9EiJJ< LEJ<I<I $EK<IM<EKiFE<E GFJiKiM 8LJ\b ELI <iE< (iE;<I?<iK Q<i>K< E<>8KiM<  I><9EiJJ<\n &<iE< <iEQi>< .KL;i< 9<Ii:?K<K< <iE Ji>Ei=iB8EK E<>8KiM<J  I><9EiJ\n  iE< JPDD<KIiJ:?< 1<IK<iCLE> N8I Ei:?K <IB<EE98I\b iEJ><J8DK C8JJ<E ;i< \"I8G?<E <iE< \u001cJPDD<KIi< QL \"LEJ\tK<E >IFY<I  ==<BK< 8LJ BC<iE<E .KL;i<E M<IDLK<E\n \u001cL:? N<EE ;8J #<IMFIIL=<E MFE E<>8KiM<E  I><9EiJJ<E ;LI:? $EK<IM<EKiFE<E iE LEJ<I<D !FIJ:?LE>J9<I<i:? Ei:?K 9<JFE;<IJ N8?IJ:?<iECi:? iJK\b BWEEK< ;i< iEJ><\tJ8DK 1<IK<iCLE> ;<I  I><9EiJJ< 8L= <iE<E E<EE<EJN<IK<E  iE=CLJJ ;<J +L9CiB8KiFEJ9i8J ?iE;<LK<E\n   ..22..\u001f\u001f \u0012\u0012AA\u000f\u000f\u0006\u0006OO\u000e\u000eII\u0015\u0015IIEE\u0014\u0014\u0017\u0017\u000f\u000fGG\u0015\u0015\u001a\u001a\r\rEE\u0005\u0005HHAA\u000f\u000fII\u0015\u0015\u000e\u000eEE\u000f\u000f  2U?I<E; ;i<  I=8JJLE> ;<J *LK:FD<J iDD<I 8L= ;<I +8Ki<EK<E<9<E< JK8KK=8E;\b NLI;< iE LEJ<I<E .KL;i<E ?UL=i> 8L= \u001cIQK\t F;<I +I8O<E<9<E< I8E;FDiJi<IK\n \u001fi<J< \u001fiJBI<G8EQ B8EE QL <iE<I JK8KiJKiJ:?<E 1<IQ<IILE> =X?I<E\b ;i< <iE< 8IKi=iQi<CC ?W?<I< .i>Ei=iB8EQ ;<I  I><9EiJJ< JiDLCi<IK\n '<i;<I N8I <J LEJ Ei:?K DW>Ci:?\b =XI 8CC< .KL;i<E 8E ;<E -8E;FDiJi<ILE>JD<:?8EiJDLJ 8E><G8JJK<  I><9EiJJ< QL M<IN<E;<E\b N8J QL <iE<D 0EiK\tF=\t8E8CPJiJ\t<IIFI ><=X?IK ?89<E BWEEK<\n   ..22..   \t\tEETTEE\u0014\u0014OOGGEE\u000f\u000fIITT\u0003\u0003TT  5NiJ:?<E LEJ<I<E .KL;i<E 9<JK8E;<E Q8?CI<i:?< 0EK<IJ:?i<;<\b N<C:?< iEJ><J8DK <iE< ?F?< #<K<IF><EiKUK 9<;iE><E\n \u001cCC><D<iED<;iQiE =iE;<K N<CKN<iK iE Mi<C<E M<IJ:?i<;<E<E !FID<E JK8KK\b LE; ;<D<EKJGI<:?<E; JK8IB LEK<IJ:?i<;<E Ji:? LEJ<I< .<KKiE>J\b JFNF?C 9<QX>Ci:? ;<I *I>8EiJ8KiFEJ=FID ;<I \u001cCC><D<iED<;iQiE 8CJ 8L:? ;<J 9<<iE=CLJJ<E;<E \"<JLE;?<iKJJPJK<DJ\n $E LEJ<I<E .KL;i<E NLI;<E +8Ki<EK<E M<IJ:?i<;<EJK<E \u001cCK<IJ LE; DiK LEK<IJ:?i<;Ci:?<E  IBI8EBLE><E LEK<IJL:?K\b K<iCN<iJ< NLI;<E 8L:? ELI <iEQ<CE<  IBI8EBLE><E 8LJ LEJ<I<E  iEJ:?CLJJBIiK<Ii<E iE .KL;i<E 9<KI8:?K<K\n \u001fi< $EK<IM<EKiFE<E N8I<E K<iCJ BFDGC<O LE; ;i< &8K<>FIi\tJi<ILE> ;LI:? \u001d<JKiDDLE> ;<J iD 1FI;<I>ILE; JK<?<E;<E \u001cEK<iCJ 9<I<iK<K< K<iCN<iJ< +IF9C<D<\n $EJ><J8DK 9<J:?IUEBK ;i<J<J \u001cLJD8Y 8E #<K<IF><EiKUK ;i< \u001cLJJ8><BI8=K LE; T9<IKI8>98IB<iK LEJ<I<I  I><9EiJJ<\n      Limitationen  \n \u0011\u000f     \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??DD  88  \u0007\u0007++\"\"\"\"\u0019\u0019    \r\r  ##**55  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  \r\r\u0014\u0014**\u001d\u001d\u0019\u0019\"\"**\u0019\u0019\"\"  ? P \nnterventi'n einer Studie, \u001f\u001ff. Sub\u001fruppe \n\u0002\u0002\u0016\u0016\u0016\u0016\u001d\u001d  \u0018\u0018++\"\"\u001b\u001b  ??EE  88  \u0007\u0007++\"\"\"\"\u0019\u0019    \r\r  ##**55  \n\n\"\"**\u0019\u0019''--\u0019\u0019\"\"**\u001d\u001d##\"\"\u0019\u0019\"\"  !!\u001d\u001d**  \u0007\u0007##\u001f\u001f++((  \u0014\u0014++\u001a\u001a  !!\u0019\u0019\u0018\u0018\u001d\u001d11\u001d\u001d\"\"\u001d\u001d((\u0017\u0017\u001c\u001c\u0019\u0019!!  \r\r\u0019\u0019''((##\"\"\u0014\u0014    ? P \nnterventi'n einer Studie, \u001f\u001ff. Sub\u001fruppe Fazit  \n \u0011\u0010  \u001c\u001c\u0015\u0015\u001b\u001b FF\u0002\u0002\u001d\u001d\u000b\u000b\u0016\u0016  1i<C< M<IJ:?i<;<E< $EK<IM<EKiFE<E BWEE<E QLI .K<i><ILE> ;<I $E=CL<EQ8\t$DG=HLFK<E ><<i>E<K J<iE\b i?I< 2iIB\tJ8DB<iK ?UE>K E<9<E ;<D $EK<IM<EKiFEJKPG MFE ><E8L<I +FGLC8KiFE\b \"<JLE;?<iKJJPJK<D LE; <M<EKL<CC MFE ;<I $DG=HLFK< ;<I 1<I>C<i:?J>ILGG< 89\n /IFKQ ;<I 0DJ<KQLE> MFE JKI<E> C<iKCiEi<EFIi<EKi<IK<I (<K?F;iB J:?IUEB<E ;i< K<iCJ J<?I ><IiE>< \u001cEQ8?C 8E .KL;i<E\b ;8J \u001cCK<I ;<I +L9CiB8KiFE<E JFNi< ;i< (W>Ci:?B<iK<E <iE<J 0EiK\tF=\t8E8CPJiJ\t<IIFI LE; +L9Ci:8KiFE 9i8J ;i< \u001cLJJ8><BI8=K LEJ<I<I  I><9EiJJ< <iE\b ;<I ><E<I<CC<  Mi;<EQ>I8; LEJ<I<I .:?CLJJ=FC><ILE><E iJK 8CJ DiKK<CDUYi> <iEQLJ:?UKQ<E\n  '<?IM<I8EJK8CKLE><E =XI D<;iQiEiJ:?< /<8DJ JiE; iEJ9<JFE;<I< ;8EE ?iC=I<i:?\b N<EE Ji< Ji:? 8L= ;i< 1<IJFI\t>LE> <iE<I 9<JKiDDK<E  IBI8EBLE> =FBLJJi<I<E\n \u001fi< -<MiJiFE ;<I 9<IL=Ci:?<E -FCC<EM<IK<iCLE> B8EE iEJ><\tJ8DK 8CJ Mi<CM<IJGI<:?<E; <iE><FI;E<K N<I;<E\b BFEEK< i?I 2iIBJ8DB<iK 8CC<I;iE>J ELI iD GIiM8K<E \"<JLE;\t?<iKJJPJK<D LEK<I \u001d<N<iJ JK<CC<E\n 2<iK<I< !FIJ:?LE> iE M8Iii<I<E;<E  iE=CLJJ9<I<i:?<E NUI< ?i<I NXEJ:?<EJ\tN<IK\n  9<EJF NiIBJ8D JiE; 8LKFD8KiJ:?<  IiEE<ILE>JJPJK<D< =XI RIQK< iE GIiM8K<E \"<JLE;?<iKJJPJK<D<E\b N<EE Ji< ><<i>E<K< +8Ki<EK<E DiK ?F?<I 5LM<ICUJJi>B<iK <IB<EE<E\n  0EK<I  iE9<Qi<?LE> N<iK<I=X?I<E;<I 'iK<I8KLI JiE;  IiEE<ILE><E G<I .(. M<IDLKCi:? NiIBJ8D =XI :?IFEiJ:? &I8EB<\b 9<JFE;<IJ ><<i>E<K J<iE BWEEK<E Ji< =XI AXE><I< JFNi< ?<IQ\t LE; iDDLEBI8EB< +8Ki<EK<E iD 0D=<C; <iE<I E8KiFE8C<E &I8EB<EM<IJi:?<ILE>\n \u001dIi<=< LE; +FJKB8IK<E Q<i>K<E iE Mi<C<E .KL;i<E <iE< ><E<I<CC >LK< 2iIBJ8DB<iK iE ;<I .G?UI< <iE<J GIiM8K<E \"<JLE;?<iKJJPJK<DJ\b 8BKL<CC< \u001f8K<E 8LJ 8E;<I<E  iE=CLJJ9<I<i:?<E Ci<><E 89<I Ei:?K MFI\n  iE< Ji>Ei=iB8EK< .K<i><ILE> ;<I $DG=HLFK<E iE +8Ki<EK<E DiK \u001fi89<K<J D<CCiKLJ BFEEK< DiK ;<E LEK<IJL:?K<E (<K?F;<E Ei:?K <II<i:?K N<I;<E LEJ iJK ;<J?8C9 DW>Ci:?<IN<iJ< DiK 9<JFE;<I<E .:?Ni<Ii>B<iK<E 9<?8=K<K\n  5LI BFJK<E<==iQi<EK<E 0DJ<KQLE> MFE 8LKFD8KiJi<IK<E  IiEE<ILE>JJPJK<D<E JFNF?C =XI RIQK< 8CJ 8L:? =XI +8Ki<EK<E N<I;<E LD=8E>I<i:?< \u001f8K<E98EB<E DiK D<;iQiEiJ:?<E $E=FID8KiFE<E 9<EWKi>K\b N<C:?< A< E8:? I<>LC8KFIiJ:?<D 0D=<C; Ei:?K iE A<;<D !8CC MFI?8E;<E F;<I C<>8C iDGC<D<EKi<I98I JiE;\n   \u001d<Qi<?K D8E ;<E 0DJ<KQLE>J8L=N8E; DiK <iE\b ;XI=K<E .(.\t IiEE<ILE><E 9<i MFI?8E;<E<I D<;iQiEiJ:?<I \u001f8K<E98EB ;i< <==iQi<EK<JK< $EK<IM<EKiFE ;8IJK<CC<E\n .KL;i<E QL N<iK<I<E ;i>iK8C<E \u001cEJUKQ<E Ni<  \t(8iC\t IiE\tE<ILE><E F;<I #8E;P\t\u001cGGJ BFEEK<E Ei:?K i;<EKi=iQi<IK N<I;<E\b iE ;i<J<D \u001d<I<i:? NUI< N<iK<I< !FIJ:?LE> NXEJ:?<EJN<IK\n   2<I;<E F?E< QLJUKQCi:?<E  iE>Ii== J:?FE $DG=HLFK<E MFE X9<I \u0012\u0011\u0003 <II<i:?K\b JF iJK ;8J .K<i><ILE>JGFK<EKi8C ;LI:? ;i< MFE LEJ LEK<IJL:?K<E $EK<IM<EKiFE<E N8?IJ:?<iECi:? 8CJ 9<>I<EQK <iEQLJ:?UKQ<E\n &<iE< LEJ<I<I $EK<IM<EKiFE<E BFEEK< $DG=HLFK<E 9<i <iE<I &FEKIFCC>ILGG<EHLFK< MFE DiE;<JK<EJ \u0012\u0011\u0003 Ji>Ei=iB8EK M<I9<J\tJ<IE\n \u001fi<J iJK GIF9C<D8KiJ:?\b ;8 JFDiK N<iK<I?iE LEBC8I 9C<i9K\b Ni< ><E8L ;i< 8E><JKI<9K<E ,LFK<E MFE \u0014\f 9iJ \u0015\f\u0003 K8KJU:?Ci:? <II<i:?K N<I;<E BWEE<E\n  iE< <==<BKiM< (W>Ci:?B<iK BWEEK< iE ;<I  iE=X?ILE> <iE<I $DG=\tFazit  \n \u0011\u0011  G=Ci:?K =XI 9<JKiDDK< +FGLC8KiFE<E 9<JK<?<E\b ;i< \u001cBQ<GK8EQ JFC:?<I (8YE8?D<E iE ;<I \u001d<MWCB<ILE> iJK 8C\tC<I;iE>J J:?N<I 89QLJ:?UKQ<E\n\u0016abellenverzeichnis \n 3$  \u0005\u0005 EE\n\n\u0005\u0005EESSSS\u0012\u0012AA\u0012\u0012\u0012\u0012\f\f\n\n\u0004\u0004\t\tEE  \u0014\u0014EE\u0010\u0010SS\n\n\u0004\u0004\t\tEE\u0010\u0010UUNNGG   Felix Brombacher \u0015cheuchzerstrasse K3 \u0005\n-N00L \u001d\u00fcrich    \u000bch erkl\u00e4re hiermit an Eides statt< dass ich die vorliegende Dissertation mit dem \u0016hema  @\u000bnterventionen zur \u0015teigerung der saisonalen \u000bn$luenza-\u000bm-$.uote bei chronisch Kranken in der \u0002llgemeinmedizin= Ein s8stematischer \u0014eview?  selbstst\u00e4ndig ver$asst< mich au1er der angegebenen keiner weiteren \nil$smittel bedient und alle Erkenntnisse< die aus dem \u0015chri$ttum ganz oder ann\u00e4hernd \u00fcbernommen sind< als solche kenntlich gemacht und nach ihrer \nerkun$t unter Bezeichnung der Fundstelle einzeln nachge-wiesen habe>   \u000bch erkl\u00e4re des \u001aeiteren< dass die hier vorgelegte Dissertation nicht in gleicher oder \u00e4hnlicher Form bei einer anderen \u0015telle zur Erlangung des akademischen \trades eingereicht wurde>   BBBBBBBBBBBBBBBBBBBBBB BBBBBBBBBBBBBBBBBBBBBBBBBBBB \u0011rt< Datum Unterschri$t    Z\u00fcrich, 08.08.2023Felix BrombacherDurchge$\u00fchrte \u0015uchen \n 3$$  EE AANN\t\tAANNGG  II \u0004\u0004UU\u0014\u0014\u0005\u0005\n\n\t\tEEFF\u0018\u0018\n\n\u0014\u0014\u0016\u0016EE  \u000e\u000eUU\u0005\u0005\n\nEE\u0010\u0010    ..\u001f\u001f..11 \u000b\u000bEE\u001c\u001c\u001a\u001aOO\u0014\u0014\u0006\u0006\u001a\u001a\u0013\u0013\u0017\u0017\u0005\u0005HHEE\u000f\u000f  :.3.1.1 \u000f\u0016ID @ @\u001bhr'ni\u001bD 'r l'n\u001fterm 'r \u001b'nditi'nD 'r multiple 'r per,i,tD 'r 'n\u001f'in\u001f 'r de\u001feneratD 'r hi\u001fh ri,k 'r di,abD 'r illnD 'r di,ea,D 'r \u001b'n\u001fenital 'r in\u001burabD 'r defe\u001btD 'r di,'rderD 'r ,i\u001bkD 'r ,4ndr'mD 'r di,p',iti'nD 'r di,abilD 'r fail>ure 'r a,thma 'r \u001b'pd 'r \u001birrh',D 'r hepatitD 'r renal in,uffD 'r diabetD 'r immun'defi\u001bD 'r immun',upprD 'r ,\u001bler',D 'r \t\n\u0016 'r human immun'defi\u001bien\u001b4 viru, 'r A\nDS 'r A\u001b*uired immun'defi\u001bien\u001b4 ,4ndr'me 'r \u001ban\u001berD 'r mali\u001fnD 'r tum'rDA  and  @influen5aD 'r fluA  and  @,4,temD 'r ,trate\u001fD 'r pr'\u001framD 'r \u001bampai\u001fnD 'r edu\u001batD 'r parti\u001bipatD 'r remindD ,4,temD 'r re\u001ballD 'r p',t>\u001bardD 'r letterD 'r Dph'ne \u001bampai\u001fnD= 'r Dph'ne \u001ballD= 'r finan\u001bial in\u001bentivD 'r en\u001b'ura\u001fement 'r m'tivati'n 'r bui,ne,, h'urD 'r 'penin\u001f h'urD 'r h'me vi,itD 'r h'u,e \u001ballD 'r bureau\u001bra\u001b4 'r tran,ferD 'r re,p'n,ibD 'r \u001b'mpe>tenD 'r liabilD 'r inf'rmD 'r remindD 'r \u001b'mmendatDA  and  @immunD 'r va\u001b\u001binD 'r unva\u001b\u001binD 'r unimmunD 'r in'\u001bulatDA  and  @rate 'r uptake 'r \u001b'vera\u001fe 'r tar\u001fet 'r per\u001benta\u001feA  and  @rand'mi5ed \u001b'ntr'lled trial 'r \u001b'ntr'lled \u001blini\u001bal trial 'r rand'mi5ed 'r pla\u001beb' 'r dru\u001f therap4 'r rand'ml4 'r trial 'r \u001fr'up, 'r d'uble blind 'r r\u001bt 'r \u001b'ntr'lledA A.tw :.3.1.2 \u0004O\u0004\t\u0011ANE\u0001\fI\u0003A\u0011A\u0011\u0017 EG @\u001bhr'ni\u001bD 'r l'n\u001fterm 'r \u001b'nditi'nD 'r multiple 'r per,i,tD 'r 'n\u001f'in\u001f 'r de\u001feneratD 'r hi\u001fh ri,k 'r di,abD 'r illnD 'r di,ea,D 'r \u001b'n\u001fenitalD 'r in\u001burabD 'r defe\u001btD 'r di,'rderD 'r ,i\u001bkD 'r ,4ndr'mD 'r di,p',iti'nD 'r di,a>bilD 'r failure 'r a,thma 'r \u001b'pd 'r \u001birrh',D 'r hepatitD 'r renal in,uffD 'r diabetD 'r immun'defi\u001bD 'r immun'>,upprD 'r ,\u001bler',D 'r \t\n\u0016 'r human immun'defi\u001bien\u001b4 viru, 'r aid, 'r a\u001b*uired immun'defi\u001bien\u001b4 viru, 'r \u001ban\u001berD 'r mali\u001fnD 'r tum'rDA9ti,ab,kw EH  @influen5aD 'r fluA9ti,ab,kw  EI  @,4,temD 'r ,trate\u001fD 'r pr'\u001framD 'r \u001bampai\u001fnD 'r edu\u001batD 'r parti\u001bipatD 'r remindD ,4,temD 'r re\u001ballD 'r p',t\u001bardD 'r letterD 'r Dph'ne \u001bampai\u001fnD 'r Dph'ne \u001ballD 'r finan\u001bial in\u001bentivD 'r en\u001b'ura\u001fement 'r m'tiva>ti'n 'r bui,ne,, h'urD 'r 'penin\u001f h'urD 'r h'me vi,itD 'r h'u,e \u001ballD 'r bureau\u001bra\u001b4 'r tran,ferD 'r re,p'n,ibD 'r \u001b'mpetenD 'r liabilD 'r inf'rmD 'r remindD 'r \u001b'mmendatDA9ti,ab,kw EJ  @immunD 'r va\u001b\u001binD 'r unva\u001b\u001binD 'r unimmunD 'r in'\u001bulatDA9ti,ab,kw EK  @rate 'r uptake 'r \u001b'vera\u001fe 'r tar\u001fet 'r per\u001benta\u001feA9ti,ab,kw EL  @rand'mi5ed \u001b'ntr'lled trial 'r \u001b'ntr'lled \u001blini\u001bal trial 'r rand'mi5ed 'r pla\u001beb' 'r dru\u001f therap4 'r ran>d'ml4 'r trial 'r \u001fr'up, 'r d'uble blind 'r r\u001bt 'r \u001b'ntr'lledA9ti,ab,kw EM  EG and EH and EI and EJ and EK and EL Durchge$\u00fchrte \u0015uchen \n 3$$$  :.3.1.3 \u0006\u0011I\u0004 @influen\u001be 'r fluA  and  @va\u001b\u001bine 'r immuneA  and  @rate 'r \u001b'vera\u001fe 'r uptakeA   ..\u001f\u001f..22 \u0014\u0014HHEE\u0015\u0015AA\u0017\u0017\u0014\u0014\u0017\u0017\u0015\u0015\u001a\u001a\u0013\u0013\u0017\u0017\u0005\u0005HHEE  :.3.2.1 \u000f\u0016ID G  e3p \u001bhr'ni\u001b di,ea,e= H  e3p \u001b'n\u001fenital di,'rder= I  e3p a,thma= J e3p \u001bhr'ni\u001b 'b,tru\u001btive lun\u001f di,ea,e= K e3p \u001bardi'm4'path4= L e3p immun',uppre,,ive treatment= M e3p diabete, mellitu,= N e3p mali\u001fnant ne'pla,m= O e3p \tuman immun'defi\u001bien\u001b4 viru,= GF e3p a\u001b*uired immune defi\u001bien\u001b4 ,4ndr'me= GG  e3p influen5a= GH  e3p preventive health ,ervi\u001be= GI e3p h'me \u001bare= GJ  e3p medi\u001bal ,taff= GK e3p health behavi'r= GL e3p attitude t' health= GM e3p immuni5ati'n= GN e3p va\u001b\u001binati'n= GO e3p \u001b'ntr'lled \u001blini\u001bal trial= HF @@EG 'r EH 'r EI 'r EJ 'r EK 'r EL 'r EM 'r EN 'r EO 'r EGFA and EGG and @EGH 'r EGI 'r EGJ 'r EGK 'r EGLA and @EGM 'r EGNA and EGOA.mp. BmpPtitle, ab,tra\u001bt, headin\u001f w'rd, dru\u001f trade name, 'ri\u001final title, devi\u001be manufa\u001b>turer, dru\u001f manufa\u001bturer, devi\u001be trade name, ke4w'rd, fl'atin\u001f ,ubheadin\u001f w'rd, \u001bandidate term w'rdC HG G 'r H 'r I 'r J 'r K 'r L 'r M 'r N 'r O 'r GF HH GH 'r GI 'r GJ 'r GK 'r GL HI GM 'r GN HJ GG and GO and HG and HH and HI  Durchge$\u00fchrte \u0015uchen \n 3$1  :.3.2.2 \u0004O\u0004\t\u0011ANE\u0001\fI\u0003\u0011A\u0011\u0017 EG \reS\t de,\u001bript'r9 B\u0004hr'ni\u001b Di,ea,eC e3pl'de all tree, EH \reS\t de,\u001bript'r9 B\u0004'n\u001fenital, \tereditar4, and Ne'natal Di,ea,e, and Abn'rmalitie,C e3pl'de all tree, EI \reS\t de,\u001bript'r9 BA,thmaC e3pl'de all tree, EJ \reS\t de,\u001bript'r9 B\u0010ulm'nar4 Di,ea,e, \u0004hr'ni\u001b Ob,tru\u001btiveC e3pl'de all tree, EK \reS\t de,\u001bript'r9 B\u0004ardi'm4'pathie,C e3pl'de all tree, EL \reS\t de,\u001bript'r9 B\nmmun',uppre,,i'nC e3pl'de all tree, EM \reS\t de,\u001bript'r9 BDiabete, \rellitu,C e3pl'de all tree, EN \reS\t de,\u001bript'r9 BNe'pla,m,C e3pl'de all tree, EO \reS\t de,\u001bript'r9 B\t\n\u0016C e3pl'de all tree, EGF \reS\t de,\u001bript'r9 BA\u001b*uired \nmmun'defi\u001bien\u001b4 S4ndr'meC e3pl'de all tree, EGG \reS\t de,\u001bript'r9 B\nnfluen5a, \tumanC e3pl'de all tree, EGH \reS\t de,\u001bript'r9 B\u0010reventive \tealth Servi\u001be,C e3pl'de all tree, EGI \reS\t de,\u001bript'r9 B\t'u,e \u0004all,C e3pl'de all tree, EGJ \reS\t de,\u001bript'r9 B\redi\u001bal StaffC e3pl'de all tree, EGK \reS\t de,\u001bript'r9 BAttitude t' \tealthC e3pl'de all tree, EGL \reS\t de,\u001bript'r9 B\nmmunit4C e3pl'de all tree, EGM \reS\t de,\u001bript'r9 B\u0016a\u001b\u001bine,C e3pl'de all tree, EGN \reS\t de,\u001bript'r9 BRand'mi5ed \u0004'ntr'lled \u0014rialC e3pl'de all tree, EGO @EG 'r EH 'r EI 'r EJ 'r EK 'r EL 'r EM 'r EN 'r EO 'r EGFA and EGG and @EGH 'r EGI 'r EGJ 'r EGKA and @EGL 'r EGMA EHF EGO and EGN :.3.2.3 \u0010\u0014\u0003\rED EL Sear\u001bh @EG and EH and EI and EJ and EKA  EK Sear\u001bh \u001blini\u001bal trial,, rand'mi5edB\reS\t \u0014erm,CA EJ Sear\u001bh @immuni5ati'nB\reS\t \u0014erm,CA OR va\u001b\u001binati'nB\reS\t \u0014erm,CA EI Sear\u001bh @@@@preventive health ,ervi\u001beB\reS\t \u0014erm,CA OR h'me \u001bareB\reS\t \u0014erm,CA OR medi\u001bal ,taffB\reS\t \u0014erm,CA OR health behavi'rB\reS\t \u0014erm,CA OR health, attitude t'B\reS\t \u0014erm,CA EH Sear\u001bh influen5aB\reS\t \u0014erm,CA EG Sear\u001bh @@@@@@@@@\u001bhr'ni\u001b di,ea,eB\reS\t \u0014erm,CA OR \u001b'n\u001fenital di,'rderB\reS\t \u0014erm,CA OR a,thmaB\reS\t \u0014erm,CA OR \u001bhr'ni\u001b 'b,tru\u001btive lun\u001f di,ea,eB\reS\t \u0014erm,CA OR \u001bardi'm4'pathie,B\reS\t \u0014erm,CA OR immun',up>pre,,i'nB\reS\t \u0014erm,CA OR diabete, mellitu,B\reS\t \u0014erm,CA OR \u001ban\u001berB\reS\t \ra\"'r \u0014'pi\u001bCA OR human immun'de>fi\u001bien\u001b4 viru,B\reS\t \u0014erm,CA OR a\u001b*uired immune defi\u001bien\u001b4 ,4ndr'meB\reS\t \u0014erm,CA  Extrahierte \u000btems \n 31  IIII EE\u001b\u001b\u0016\u0016\u0014\u0014\u0002\u0002\n\n\u000b\u000bEE\u0014\u0014\u0016\u0016EE  II\u0016\u0016EEMM\u0015\u0015  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  FF  88  \u0006\u0006//**''\u0014\u0014\u001c\u001c\u001d\u001d\u0019\u0019''**\u0019\u0019  \n\n**\u0019\u0019!!((  ..\u0015\u0015\u001c\u001c''\u0019\u0019\"\"\u0018\u0018  \u0018\u0018\u0019\u0019''  \u0005\u0005\u0014\u0014**\u0019\u0019\"\"\u0019\u0019//**''\u0014\u0014\u001f\u001f**\u001d\u001d##\"\"44  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \r\r\u001d\u001d****  \u0019\u0019''  \u0019\u0019**  \u0014\u0014  66  99??@@>>::  \n  \u000b\u000b\u0002\u0002\u0013\u0013\u0006\u0006\b\b\u000f\u000f\u0011\u0011II\u0006\u0006  \u0012\u0012\u0014\u0014\u0003\u0003\u000b\u000b\u0002\u0002\u0013\u0013\u0006\u0006\b\b\u000f\u000f\u0011\u0011II\u0006\u0006  \u0003\u0003\u0006\u0006\u0012\u0012\u0004\u0004\t\t\u0011\u0011\u0006\u0006II\u0003\u0003\u0014\u0014\u000e\u000e\b\b  \n\fethoden Studiendesign . Bescheibung des Studiendesigns, einschlie\u00dflich  . /uteilungsverh\u00e4ltnis der Patienten zu den Gruppen . Wichtige Lnderungen der Methoden nach Studienbeginn Probanden\bPatienten . Eignungskriterien der Probanden\bPatienten . *mgebung und $rt der Studiendurchf\u00fchrung Intervention\bBehand-lung . \u0019urchgef\u00fchrte Interventionen in ;eder Gruppe mit pr\u00e4zisen \u0019etails Endpunkte . Vollst\u00e4ndig definierte, prim\u00e4re und sekund\u00e4re Endpunkte . Wie und wann sie erhoben wurden Fallzahlbestimmung . Wie wurde die Fallzahl berechnet\u0015 . Falls zutreffend, Erkl\u00e4rung aller /wischenanalysen  . und Abbruchkriteren \nRandomisier\u001eng Erzeugung der Behand-lungsfolge . Methode zur Generierung der /ufallszuteilung . Art der Randomisierung . \u0019etails ;edweder Restriktion Mechanismen der Ge-heimhaltung der Behand-lungsfolge . Mechanismen zur *msetzung der /uteilungsseBuenz . Beschreibung aller Schritte zur Geheimhaltung der SeBuenz bis zur In-terventionszuordnung \u0019urchf\u00fchrung . Wer f\u00fchrte die /ufallszuteilung durch\u0015  . Wer nahm die Teilnehmer in die Studie auf\u0015 . Wer teilte die Teilnehmer den Interventionen zu\u0015 Verblindung . Falls durchgef\u00fchrt, wer war bei der Interventionszuordnung verblindet\u0015  . Falls relevant, Beschreibung der Lhnlichkeit der Interventionen Statistische Methoden . Statistische Methoden, die zum Vergleich der Gruppen hinsichtlich pri-m\u00e4rer und sekund\u00e4rer Entpunkte eingesetzt wurden . Methoden, die f\u00fcr zus\u00e4tzliche Analysen eingesetzt wurden, wie Sub-gruppenanalysen und ad;ustierte Analysen \brgebnisse Ein- und Ausschl\u00fcsse F\u00fcr ;ede Gruppe . Anzahl der Studienteilnehmer, die randomisiert wurden,  . die die geplante Intervention erhielten  . die hinsichtlich des prim\u00e4ren Endpunktes analysiert wurden . /ahl der Studienausscheider und Ausschl\u00fcsse nach Randomisierung mit Angabe von Gr\u00fcnden Aufnahme\bRekrutierung . /eitraum der Rekrutierung und #achbeobachtung . Warum die Studie beendet oder gestoppt wurde Patientencharakteristika zu Studienbeginn . \u0019emographische und klinische \u0018harakteristika f\u00fcr ;ede Gruppe (Ge-schlechterverteilung und Bildungsstand) Extrahierte \u000btems \n 31$    \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  FF  77  \u0007\u0007##''**((\u0019\u0019**11++\"\"\u001b\u001b  \n     \brgebnisse \u0002\torts\u0005\u0003 Anzahl der ausgewerte-ten Probanden\bPatienten F\u00fcr ;ede Gruppe . Anzahl der Teilnehmer, die in die Analyse eingeschlossen wurde  . Angabe, ob diese der Anzahl der urspr\u00fcnglich zugeteilten Gruppen ent-sprach Ergebnisse und Sch\u00e4tz-methoden F\u00fcr ;eden prim\u00e4ren und sekund\u00e4ren Endpunkt  . Ergebnisse f\u00fcr ;ede Gruppe und die gesch\u00e4tzte Effektgr\u00f6\u00dfe sowie ihre Pr\u00e4zision . F\u00fcr bin\u00e4re Endpunkte wird empfohlen, sowohl die absoluten als auch die relativen Effektgr\u00f6\u00dfen anzugeben /us\u00e4tzliche Analysen . Resultate von weiteren Analysen, einschlie\u00dflich Subgruppenanalysen und ad;ustierte Analysen . Angabe, ob diese pr\u00e4spezifiziert oder eIploratorisch durchgef\u00fchrt wur-den \u0007isk\u001ession !imitierungen . Studienlimitierungen mit Angabe zu potentieller Verzerrung, fehlender Pr\u00e4zision . falls relevant, Multiplizit\u00e4t von Analysen Generalisierbarkeit . Generalisierbarkeit der Studienergebnisse Interpretation . Interpretation konsistent mit den Ergebnissen .  Abw\u00e4gung des #utzens und Schadens . Ber\u00fccksichtigung anderer relevanter Evidenz \u0006ndere In\u0013ormatio-nen Registrierung . Registierungsnummer und #ame des Studienregisters Protokoll . Wo das vollst\u00e4ndige Protokoll eingesehen werden kann, falls verf\u00fcgbar Finanzierung . &uellen der Finanzierung und anderer *nterst\u00fctzung . Rolle des Geldgebers \u0012\u0014\u000b\u0015M\u0002-\u0005heckliste \n 31$$  IIIIII \u000b\u000b\r\rII\u000e\u000eMM\u0002\u0002\u0016\u0016\u0003\u0003\n\nEE\u0005\u0005KKLL\u000b\u000b\u0015\u0015\u0016\u0016EE  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  GG  88  \r\r\u000e\u000e\n\n\u000f\u000f\f\f\u0002\u000277\u0004\u0004\u001c\u001c\u0019\u0019\u0017\u0017\u001f\u001f  \u001d\u001d((**\u0019\u0019  \"\"\u0014\u0014\u0017\u0017\u001c\u001c  \u000f\u000f\u001c\u001c\u0014\u0014!!((\u0019\u0019\u0019\u0019''  99??@@??::  \n \u0010\u0010\u0014\u0014\u0003\u0003\f\fII\u000b\u000b\u0002\u0002\u0013\u0013II\u000f\u000f\u000e\u000e\u0012\u0012\u0002\u0002\u0003\u000322\u0012\u0012\u0004\u0004\t\t\u000e\u000eII\u0013\u0013\u0013\u0013  55  \u0017\u0017\u0014\u0014\u0012\u0012\u0002\u0002\r\r\r\r\u0006\u0006\u000e\u000e\u0007\u0007\u0002\u0002\u0012\u0012\u0012\u0012\u0014\u0014\u000e\u000e\b\b  \u000f\u000f\u0011\u0011\u0013\u0013  \u0013\u0013!!**\u001d\u001d##  Titel \n Identifikation als Bericht einer systematischen Pbersicht, Meta-Analyse oder beidem\u0007 Titel \u0017\u0017++))\u0018\u0018$$$$\u001d\u001d%%\u001e\u001e\u0018\u0018))))++%%\u001f\u001f  Strukturierte /usammenfas-sung 2 Strukturierte /usammenfassung mit den Stichworten (sofern geeignet)\u0013 Hintergrund\u0014 /iele\u0014 \u0019atenBuellen\u0014 Auswahlkriterien der Studien, Teilnehmer und Interventionen\u0014 Bewertung der Studie und Methoden der Synthese\u0014 Ergebnisse\u0014 Einschr\u00e4nkungen\u0014 Schlussfolgerungen und Implikation der wichtigsten Ergebnisse\u0014 Registrierungsnummer der systematischen Pbersicht\u0007 S\u0007 I-II \u0006\u0006!!%%##\u001d\u001d!!**++%%\u001f\u001f  Hintergrund und Rationale \f Wissenschaftlicher Hintergrund und Begr\u00fcndung der Studie\u0007 S\u0007 2-\n\t /iele 4 Pr\u00e4zise Angabe der Fragestellungen mit Bezug auf Teilnehmer, Interventionen, Vergleiche, /ielkriterien und Studiendesign (engl\u0007\u0013 participants, interventions, comparisons, outcomes, and study design\u0014 PI\u0018$S)\u0007 S\u0007 \n\t \r\r\u001d\u001d**  &&\u001c\u001c\u001d\u001d%%  Protokoll und Registrierung 5 EIistiert ein Studienprotokoll f\u00fcr die Pbersichtsarbeit\u0015 Wenn ;a, wo kann es gefunden bzw\u0007 wie kann es bezogen werden (z\u0007B\u0007 Webseite)\u0014 wenn verf\u00fcgbar\u0013 Informationen zur Registrierung einschlie\u00dflich Angabe der Registrierungsnummer\u0007 S\u0007 \n\n Auswahlkriterien 6 Merkmale der Studien (z\u0007B\u0007, PI\u0018$S, \u0019auer der #achbeobachtung) und der Berichte (z\u0007B\u0007, /eitraum der Studien, Sprache, Publikationsstatus), die als Auswahlkriterien verwendet wurden, mit Begr\u00fcndung\u0007 S\u0007 \n\n-\n4 InformationsBuellen \u0010 Beschreibung aller InformationsBuellen (z\u0007B\u0007, \u0019atenbanken mit /eitpunkten der Berichterstattung, Kontakt mit Autoren von Studien, um zus\u00e4tzliche Studien zu identifizieren), die bei der Suche verwendet wurden einschlie\u00dflich des letzten Suchdatums\u0007 S\u0007 \n4-\n6 Suche 8 Beschreibung der vollst\u00e4ndigen elektronischen Suchstrategie f\u00fcr mindestens eine \u0019atenbank, einschlie\u00dflich gew\u00e4hlter !imitierungen, so dass die Suche repliziert werden k\u00f6nnte\u0007 S\u0007 \n4-\n6 S\u0007 -III--V \u0012\u0014\u000b\u0015M\u0002-\u0005heckliste \n 31$$$  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  GG  77  \u0007\u0007##''**((\u0019\u0019**11++\"\"\u001b\u001b  \n \r\r\u001d\u001d**  &&\u001c\u001c\u001d\u001d%%  33\u0007\u0007&&((**))..44  Auswahl der Studien \u0012 Beschreibung des Auswahlprozesses von Studien (das hei\u00dft Vorauswahl, Eignung, Einschluss in die systematische Pbersicht und, falls zutreffend, in die Meta-Analyse)\u0007 S\u0007 \n6-\n\u0010 Prozess der \u0019atengewinnung \n\t Beschreibung der Methode der \u0019ateneItraktion aus Berichten (z\u0007B\u0007 Erhebungsbogen, unabh\u00e4ngig, doppelt) und alle Prozesse, um \u0019aten von *ntersuchern zu erhalten und zu best\u00e4tigen\u0007 S\u0007 \n8-\n\u0012 \u0019atendetails \n\n Aufz\u00e4hlung und \u0019efinition aller Variablen, nach denen ge-sucht wurde (z\u0007B\u0007, PI\u0018$S, FinanzierungsBuellen) sowie An-nahmen und durchgef\u00fchrte Vereinfachungen\u0007\u0007 S\u0007 \n8-\n\u0012 S\u0007 -VI--VII Risiko der Verzerrung in den einzelnen Studien \n2 Methoden zur Beurteilung des Risikos von Verzerrungen der einzelnen Studien (einschlie\u00dflich der Angabe, ob dieses auf der Studienebene oder f\u00fcr das /ielkriterium durchgef\u00fchrt wurde) und wie diese Information bei der \u0019atensynthese ber\u00fccksichtigt wurde\u0007 S\u0007 \n\u0010-\n8 Effektsch\u00e4tzer \n\f Wichtigste Effektsch\u00e4tzer (z\u0007B\u0007 relatives Risiko, Mittelwertsdifferenz)\u0007 S\u0007 2\t Synthese der Ergebnisse \n4 Beschreibung der Methoden zum *mgang mit den \u0019aten und der Kombination der Ergebnisse der Studien\u0014 falls diese berechnet wurden, einschlie\u00dflich Ma\u00dfzahlen zur Homogenit\u00e4t der Ergebnisse (z\u0007B\u0007 I2) f\u00fcr ;ede Meta-Analyse\u0007 S\u0007 \n\u0012-2\f Risiko der Verzerrung \u00fcber Studien hinweg \n5 Beschreibung der Beurteilung des Risikos von Verzerrungen, die die kumulative Evidenz beeinflussen k\u00f6nnten (z\u0007B\u0007 Publikationsverzerrung, selektives Berichten innerhalb von Studien)\u0007 S\u0007 \n8 /us\u00e4tzliche Analysen \n6 Methoden f\u00fcr zus\u00e4tzliche Analysen (z\u0007B\u0007 Sensitivit\u00e4tsanalysen, Subgruppenanalysen, Meta- Regression) mit Beschreibung, welche vorab spezifiziert waren\u0007 - \u0006\u0006((\u001f\u001f\u001d\u001d\u001a\u001a%%!!))))\u001d\u001d  Auswahl der Studien \n\u0010 Anzahl der Studien, die in die Vorauswahl aufgenommen, auf Eignung gepr\u00fcft und in die Pbersicht eingeschlossen wurden, mit Begr\u00fcndung f\u00fcr Aus-schluss in ;eder Stufe, idealerweise unter Verwendung eines Flussdiagramms\u0007 S\u0007 24-25 Studienmerkmale \n8 F\u00fcr ;ede Studie \u0019arstellung der Merkmale, nach denen \u0019aten eItrahiert wurden (z\u0007B\u0007 Fallzahl, PI\u0018$S, #achbeobachtungs-zeitraum), !iteraturstelle der Studie\u0007 S\u0007 24-\f2 Risiko der Verzerrung inner-halb der Studien \n\u0012 \u0019aten zum Risiko von Verzerrungen innerhalb ;eder Studie und, falls verf\u00fcgbar, eine Beurteilung der G\u00fcte der /ielkriterien (siehe Item \n2)\u0007 S\u0007 \f\n-\f2 \u0012\u0014\u000b\u0015M\u0002-\u0005heckliste \n 3$3  \u0010\u0010\u0014\u0014\u0016\u0016\u0019\u0019    \u0019\u0019  GG  77  \u0007\u0007##''**((\u0019\u0019**11++\"\"\u001b\u001b  \u0006\u0006((\u001f\u001f\u001d\u001d\u001a\u001a%%!!))))\u001d\u001d  33\u0007\u0007&&((**))..44  Ergebnisse der einzelnen Studien 2\t F\u00fcr ;ede Studie \u0019arstellung aller Endpunkte (Wirksamkeit und #ebenwirkungen)\u0013 (a) einfache zusammenfassende \u0019aten f\u00fcr ;ede Interventionsgruppe, (b) Effektsch\u00e4tzer und Konfidenzintervalle, idealerweise mit Forest Plot\u0007 S\u0007 \f\f-42 Ergebnissynthese 2\n \u0019arstellung der Meta-Analyse, einschlie\u00dflich Konfidenzintervalle und Heterogenit\u00e4tsma\u00dfe\u0007 S\u0007 \f\f-42 Risiko von Verzerrungen \u00fcber Studien hinweg 22 \u0019arstellung der Ergebnisse zur Beurteilung des Risikos von Verzerrungen \u00fcber alle Studien hinweg (siehe Item \n5)\u0007 S\u0007 5\t-52 /us\u00e4tzliche Analysen 2\f Pr\u00e4sentation der Ergebnisse der zus\u00e4tzlichen Analysen, falls durchgef\u00fchrt (z\u0007B\u0007 Sensitivit\u00e4ts- oder Subgruppenanalysen, Meta-Regression 0siehe Item \n61)\u0007 S\u0007 \f\f-42 \u0005\u0005!!))\"\"++))))!!&&%%  /usammenfassung der Evi-denz 24 /usammenfassung der Hauptergebnisse einschlie\u00dflich der St\u00e4rke der Evidenz f\u00fcr ;edes Hauptzielkriterium\u0014 Relevanz f\u00fcr /ielgruppen (z\u0007B\u0007 Gesundheitsdienstleister, Anwender, politi-sche Entscheidungstr\u00e4ger)\u0007 S\u0007 4\f-5\t Einschr\u00e4nkungen 25 \u0019iskutiere Einschr\u00e4nkungen der Studie auf Studienebene und auf Ebene der /ielkriterien (z\u0007B\u0007 Risiko von Verzerrungen) sowie auf Ebene der Pbersicht (z\u0007B\u0007 unvollst\u00e4ndiges Auffinden der identifizierten Forschung, Verzerrung des Berichts)\u0007 S\u0007 5\t-5\n Schlussfolgerungen 26 Interpretation der Ergebnisse unter Ber\u00fccksichtigung des Stands der Forschung und Schlussfolgerungen f\u00fcr weitere Forschung\u0007 S\u0007 5\f-54 Literatur \n 33$  FF \f\f\n\n\u0012\u0012EE\u0010\u0010AA\u0012\u0012UU\u0010\u0010  \r\n (OH!ER -\n \u0006\u000e\f\r\u0014\u0007\n Einf\u00fchrung in die EbM. $E\u0016 Systematische Lbersichtsarbeiten - EinfNhrung in die evidenz-basierte Gesundheitsversorgung. \u001eF:?I8E< \u001f<LKJ:?C8E;\n !I<i9LI>\b 8D \f\u0010\n *BKF9<I \u000e\f\r\u0014\n \u0004-ortrag\u0005 \u000e\n 2$R!\u0019 #EA!TH *RGA#I/ATI$#\n Ten threats to global health in 2019\n -erfNgbar unter\u0015 https\u0015\n\nwww.who.int\nemergencies\nten-threats-to-global-health-in-\r\u000b\f\u0014\n 5LC<KQK ><GIX=K 8D \f\r\n !<9IL8I \u000e\f\r\u0015\n \u000f\n (A\u0018\u001f$#A!\u0019 )\n  \n \u0006\u000e\f\r\u0011\u0007\n Vaccine hesitancy: Definition, scope and determinants. -accine \u000f\u000f\u0016\u0010\r\u0012\r_\u0010\r\u0012\u0010\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vaccine.\r\u000b\f\u0010.\u000b\u000f.\u000b\u000e\u0011 \u0010\n  *R$PEA# \u001eE#TRE F$R \u001fISEASE +REVE#TI$# A#\u0019 \u001e$#TR$! \u0006\u000e\f\r\u0015\u0007\n Monthly Measles and Ru-bella monitoring report, March 2019. .KF:B?FCD\n -erfNgbar unter\u0015 https\u0015\n\necdc.europa.eu\nsites\nportal\nfi-les\ndocuments\nmeasles-monthly-report-march-\r\u000b\f\u0014.pdf \u0011\n Epidemiologisches Bulletin des Robert Koch-Instituts Ausgabe 33/2018. $E\u0016 Epidemiologisches Bul-letin\n -erfNgbar unter\u0015 https\u0015\n\nwww.rki.de\nDE\nContent\nInfekt\nEpidBull\nArchiv\n\r\u000b\f\u0013\nAusga-ben\n\u000e\u000e1\f\u0013.pdf\u001711blob\u0016publicationFile \u0012\n RR/TE5EIT*#G\n SPD und Spahn: Masern-Impfpflicht im Gespr\u00e4ch\n -erfNgbar unter\u0015 https\u0015\n\nwww.aerztezeitung.de\nmedizin\nkrankheiten\ninfektionskrankheiten\nmasern\narticle\n\u0014\u0013\u000e\u0011\u0012\u0012\nspd-spahn-ma-sern-impfpflicht-gespraech.html\u0017sh\u0016\u0010\u0003h\u0016\r\f\u000e\u0012\u000b\u0011\u000b\u0010\u0013\u000f\n 5LC<KQK ><GIX=K 8D \u000e\u0014\n (UIQ \u000e\f\r\u0015\n \u0013\n 2$#G \u001e\n\t(\n\b \u001eHA# &\n\t+\n\b #E\u0019!E. \u001c\n %\n\b +EIRIS %\n .\n (\n \u0006\u000e\f\f\u0010\u0007\n Influenza-Associated Mortality in Hong Kong. Clin Infect Dis \u000f\u0015\u0016\r\u0012\r\r_\r\u0012\r\u0013\n \u0014\n \u001dETS\u0018H \u001e\n\b \u001dOHM -\n\b \u001eHAPMA# \"\n \u001d\n \u0006\u000e\f\r\u0011\u0007\n Using Behavioral Insights to Increase Vaccination Policy Effectiveness. Policy Insights Behav Brain Sci \u000e\u0016\u0012\r_\u0013\u000f\n \u001f*$ \f\u000b.\f\f\u0012\u0012\n\r\u000e\u0012\r\u0012\u000e\r\r\f\u0010\u0011\u000b\u000b\u0012\f\u0011 \u0015\n .\u0018HMI\u0019 +\n\b \u001dETS\u0018H \u001e\n \u0006\u000e\f\r\u0013\u0007\n Impfm\u00fcdigkeit \u2013 Psychologische Erkl\u00e4rungs- und Interventions-ans\u00e4tze. $E\u0016 Fortbildungsveranstaltung fNr Betriebs- und Werks\u00e4rzte.  I=LIK?\b 8D \f\u0014\n )FM<D9<I \u000e\f\r\u0013\n \u0004-ortrag\u0005 \r\f\n .T$RR \u001e\n\b .A#FTE#BERG '\n\b .\u0018HE!!I#G %\n\b #EI#I#GER 0\n\b .\u0018H#EI\u0019ER \u001c\n \u0006\u000e\f\r\u0014\u0007\n Measles Status-Barriers to Vaccination and Strategies for Overcoming Them. Dtsch Arztebl Int \r\r\u0011\u0016\u0013\u000e\u000f_\u0013\u000f\f\n \u001f*$ \f\u000b.\u000e\r\u000e\u0013\narztebl.\r\u000b\f\u0013.\u000b\u0012\r\u000e \r\r\n 'E\u0019IG /\n\b  GI\u0019I \"\n\b .\u0018H#EI\u0019ER\t-ATHERT 2\n\b 0EBE! /\n \u0006\u000e\f\f\u0015\u0007\n Impfen um jeden Preis? Impfm\u00fcdigkeit in Deutschland? Ein Positionspapier der Deutschen Gesellschaft f\u00fcr Allgemein-medizin und Familienmedizin (DEGAM). 0eitschrift fNr Allgemeinmedizin \u0014\u0011\u0016\u0015\u0010_\u0015\u0012\n \u001f*$ \f\u000b.\u000e\r\u000e\u0013\nzfa.\r\u000b\u000b\u0014.\u000b\u000b\u0014\u000f Literatur  \n 33$$  \r\u000e\n \u001cKMAT$V (\n &\n\b -PBSAME# )\n\b \u001fE.#EK$ $\n 1\n\b &AR\u0018H \u001c\n\b (IK$!AJ\u0018/.K -\n /\n \u0006\u000e\f\r\u0014\u0007\n Poor knoIledge of vaccination recommendations and negative attitudes toIards vaccinations are independently associated Iith poor vaccination uptake among adults\n Findings of a population-based panel study in #oIer SaJony, Germany. -accine \u000f\u0012\u0016\u000e\u0010\r\u0013_\u000e\u0010\u000e\u0012\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vac-cine.\r\u000b\f\u0013.\u000b\u000e.\u000b\u0010\u000b \r\u000f\n \u001dETS\u0018H \u001e\n\b 2I\u0018KER .\n \u0006\u000e\f\r\u0010\u0007\n Personal attitudes and misconceptions, not official recommenda-tions guide occupational physicians\u0004 vaccination decisions. -accine \u000f\u000e\u0016\u0010\u0010\u0013\u0014_\u0010\u0010\u0014\u0010\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vaccine.\r\u000b\f\u000f.\u000b\u0011.\u000b\u000f\u0011 \r\u0010\n #AAS 2\n\b \u001dER#ER -\n \u0006\u000e\f\f\u0015\u0007\n Influenza\n Pr\u00e4vention, Diagnostik, Therapie und Offentliche Ge-sundheit. Elsevier Urban \u0003 Fischer. (XE:?<E\n \r\u0011\n \"RPBER \u001c\n \u0006\u000e\f\r\u000e\u0007\n Standardimpfungen f\u00fcr Kinder, !ugendliche und ErIachsene\n Influenza\n $E\u0016 \u001fITTMA## .\n \u0006#IJ>\u0007 Handbuch der ImpfpraJis\b \r\n \u001cL=C8><\n DGK Beratung \u0006 -ertrieb\b (8I9LI>\b . \r\u0011\u0013_\r\u0013\u0015 \r\u0012\n #ARPER .\n \u001c\n\b \u001dRA\u0019!E. %\n .\n\b  #G!*#\u0019 %\n \u001c\n <K 8C\n \u0006\u000e\f\f\u0015\u0007\n Seasonal Influenza in Adults and \u001ahil-dren - Diagnosis, Treatment, \u001ahemoprophylaJis, and Institutional Outbreak Management\n \u001alinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis \u0010\u0014\u0016\r\f\f\u000f_\r\f\u000f\u000e\n \u001f*$ \f\u000b.\f\u000b\u0013\u0011\n\u0010\u0014\u0013\u0010\f\u000e \r\u0013\n -$BERT\t&$\u0018H\t$#STIT*T \u0006-&$\u0007 \u0006\u000e\f\r\u0014\u0007\n Bericht zur Epidemiologie der Influenza in Deutschland, Saison 201\u0012/18. \u001d<ICiE\n -erfNgbar unter\u0015 https\u0015\n\ninfluenza.rki.de\nSaisonberichte\n\r\u000b\f\u0012.pdf \r\u0014\n !!EMI#G \u001f\n (\n\b /A.!$R -\n\b #AG*I#ET !\n <K 8C\n \u0006\u000e\f\r\u0012\u0007\n Influenza-attributable burden in United Kingdom primary care. Epidemiol Infect \r\u0010\u0010\u0016\u0011\u000f\u0013_\u0011\u0010\u0013\n \u001f*$ \f\u000b.\f\u000b\f\u0012\nS\u000b\u0014\u0010\u000b\r\u0011\u0013\u0013\f\u0010\u000b\u000b\f\f\f\u0014 \r\u0015\n (ATIAS \"\n\b /A.!$R -\n\b #AG*I#ET !\n\b .\u0018H*\u0018K\t+AIM \u001e\n\b '*STIG -\n\b .HI#\u0019E 1\n \u0006\u000e\f\r\u0013\u0007\n Estimates of hospitalization attributable to influenza and RSV in the US during 199\u0012\u20132009, by age and risk status. BMC Publ Health \r\u0013\u0016\u000e\u0013\r\n \u001f*$ \f\u000b.\f\f\u0013\u0011\ns\f\r\u0013\u0013\u0014-\u000b\f\u0012-\u000f\f\u0012\u0012-z \u000e\f\n /A#RI$VER (\n \u001f\n\b \u001dAG\u0018I \u001d$SI /\n\b */ISIK '\n <K 8C\n \u0006\u000e\f\r\u0013\u0007\n Poor outcomes among elderly patients hospitalized for influenza-like illness. Curr Med Res Opin. DOI \f\u000b.\f\u000b\u0013\u000b\n\u000b\u000e\u000b\u000b\u0012\u0014\u0014\u0010.\r\u000b\f\u0012.\f\u000e\u0013\f\u000b\u0012\u0013 \u000e\r\n (E.ER \u001e\n\b \u001f$GA#\u0018. \u001c\n\b 5EPP !\n \u0006\u000e\f\r\u000e\u0007\n Einleitung\n Immunologische Grundlagen der Impfung\n $E\u0016 \u001fITTMA## .\n \u0006#IJ>\u0007 Handbuch der ImpfpraJis\b \r\n \u001cL=C8><\n DGK Beratung \u0006 -ertrieb\b (8I9LI>\b . \u0011\r_\u0012\u000f \u000e\u000e\n \u001eE#TERS F$R \u001fISEASE \u001e$#TR$! \u0006\u000e\f\r\u0014\u0007\n Recombinant Influenza (Flu) Vaccine\n (uestions and ansIers\n -erfNgbar unter\u0015 https\u0015\n\nwww.cdc.gov\nflu\nprotect\nvaccine\nBa1flublok-vaccine.htm\n 5LC<KQK ><GIX=K 8D Literatur \n 33$$$  \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u000e\u000f\n \u001eE#TERS F$R \u001fISEASE \u001e$#TR$! \u0006\u000e\f\r\u0015\u0007\n #ive Attenuated Influenza Vaccine 1#AIV2\n -erfNgbar un-ter\u0015 https\u0015\n\nwww.cdc.gov\nflu\nabout\nBa\nnasalspray.htm\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u000e\u0010\n \u0006\u000e\f\r\u0013\u0007\n Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am RKI 201\u0012/2018. $E\u0016 Epidemi-ologisches Bulletin, \u000f\u0010\u000b\r\u0013 \u000e\u0011\n \"R$HSK$PF '\n \u001c\n\b .$K$!$W '\n 5\n\b \u001dR$\u0019ER &\n -\n\b 2A!TER  \n \u001d\n\b !R. \u001c\n (\n\b %ER#IGA# \u001f\n \u001d\n \u0006\u000e\f\r\u0014\u0007\n Prevention and \u001aontrol of Seasonal Influenza Iith Vaccines\n Recommendations of the Advisory \u001aommittee on Immunization PracticesTUnited States, 2018\u201319 Influenza Season. MMWR Recomm Rep \u0012\u0013\u0016\r_\u000e\f\n \u001f*$ \f\u000b.\f\u0010\u0010\u0013\u0010\nmmwr.rr\u0011\u0012\u000b\u000ea\f \u000e\u0012\n #ARPER .\n \u001c\n\b !*K*\u0019A &\n\b 0.EKI /\n (\n\b \u001e$- )\n %\n\b \u001dRI\u0019GES \u001e\n \u001d\n \u0006\u000e\f\f\u0010\u0007\n Prevention and \u001aontrol of Influenza\n Recommendations of the Advisory \u001aommittee on Immunization Practices (A\u001aIP). MMWR Recomm Rep \u0011\u000f\u0016\r_\u0010\f\n \u000e\u0013\n 2$R!\u0019 #EA!TH *RGA#I/ATI$# \u0006\u000e\f\r\u000e\u0007\n Vaccines against influenza\n .HO position paper. Wkly Epidemiol Rec \u0010\u0013\u0016\u0010\u0012\r_\u0010\u0013\u0012\n \u000e\u0014\n \u001eE#TERS F$R \u001fISEASE \u001e$#TR$! \u0006\u000e\f\r\u0013\u0007\n Guillain-BarrN syndrome and Flu Vaccine\n (uestions \u0003 AnsIers\n -erfNgbar unter\u0015 https\u0015\n\nwww.cdc.gov\nflu\nprotect\nvaccine\nguillainbarre.htm\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u000e\u0015\n \u001eE#TERS F$R \u001fISEASE \u001e$#TR$! \u0006\u000e\f\r\u0015\u0007\n %arcolepsy FolloIing PandemriJ Influenza Vaccination in Europe\n -erfNgbar unter\u0015 https\u0015\n\nwww.cdc.gov\nvaccinesafety\nconcerns\nhistory\nnarcolepsy-flu.html\n 5LC<KQK ><\tGIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u000f\f\n -ESTIV$ 1\n\b \u001e$STA#TI#$ \u001e\n\b \u001d$#$ .\n <K 8C\n \u0006\u000e\f\r\u0014\u0007\n Influenza vaccine effectiveness among high-risk groups: A systematic literature revieI and meta-analysis of case-control and cohort studies. Hum -accin Immunother \r\u0010\u0016\u0013\u000e\u0010_\u0013\u000f\u0011\n \u001f*$ \f\u000b.\f\u000b\u0013\u000b\n\r\f\u0011\u000f\u0010\u0010\f\u0010.\r\u000b\f\u0012.\f\u000e\r\f\u0012\r\r \u000f\r\n %AIW$#G \u001e\n\b )GAMPHAIB$$# %\n \u0006\u000e\f\r\u0011\u0007\n Effects of inactivated influenza vaccine on respiratory illnesses and asthma-related events in children Iith mild persistent asthma in Asia. Asian Pac J Allergy Immunol \u000f\u000f\u0016\u000f_\u0013\n \u001f*$ \f\u000b.\f\r\u0014\u000e\r\nAP\u000b\u0010\f\f.\u000e\u000e.\r.\r\u000b\f\u0010 \u000f\u000e\n \u001dEKKAT\t\u001dERKA#I -\n\b 2I!KI#S$# /\n\b \u001d*\u0018H. +\n <K 8C\n \u0006\u000e\f\r\u0013\u0007\n Seasonal influenza vaccination in pa-tients Iith \u001aOPD: a systematic literature revieI. BMC Pulm Med \r\u0013\u0016\u0013\u0015\n \u001f*$ \f\u000b.\f\f\u0013\u0011\ns\f\r\u0013\u0014\u000b-\u000b\f\u0012-\u000b\u000f\r\u000b-\u0013 \u000f\u000f\n -EMS\u0018HMI\u0019T \u001e\n\b 2I\u0018HMA## *\n\b #AR\u0019ER /\n \u0006\u000e\f\r\u0010\u0007\n Influenza vaccination in patients Iith end-stage renal disease: systematic revieI and assessment of Cuality of evidence related to vaccine Literatur  \n 33$1  efficacy, effectiveness, and safety. BMC Med \r\u000e\u0016\u000e\u0010\u0010\n \u001f*$ \f\u000b.\f\f\u0013\u0011\ns\f\r\u0014\f\u0011-\u000b\f\u000f-\u000b\r\u000f\u000f-\u0014 \u000f\u0010\n &A\u0019$G!$* )\n +\n  \n\b \u001dRA\u0018KE !\n\b .IMMERS /\n\b /SI$\u0019RAS .\n\b +ARISSIS %\n \u0006\u000e\f\r\u0013\u0007\n Influenza infection and heart failure - vaccination may change heart failure prognosis? Heart Fail Rev \u000e\u000e\u0016\u000f\u000e\u0015_\u000f\u000f\u0012\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\ns\f\u000b\u0012\u000f\f-\u000b\f\u0012-\u0014\u0011\f\u000f-\u0012 \u000f\u0011\n +!A#S\t-*BIZ +\n \u0006\u000e\f\r\u000e\u0007\n The vaccination coverage reCuired to establish herd immunity against influenza viruses. Prev Med \u0011\u0011\u0016\u0013\u000e_\u0013\u0013\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.ypmed.\r\u000b\f\r.\u000b\r.\u000b\f\u0010 \u000f\u0012\n \u001dO\u0019EKER \u001d\n\b -EMS\u0018HMI\u0019T \u001e\n\b (PTERS .\n\b 2I\u0018HMA## *\n \u0006\u000e\f\r\u0011\u0007\n ImpfCuoten unter ErIachsenen in Deutschland f\u00fcr die Impfungen gegen saisonale Influenza, Tetanus und Pertussis ($E=CL<EQ8\b K<K8ELJ\b 8E; G<IKLJJiJ M8::iE8KiFE :FM<I8>< 8DFE> 8;LCKJ iE \"<ID8EP\u0007\n Bundesgesundheitsbl \u0011\u0014\u0016\r\u0013\u0010_\r\u0014\r\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\ns\u000b\u000b\f\u000b\u000e-\u000b\f\u000f-\r\u000b\u0014\u0012-y \u000f\u0013\n \u001d.E$# &\n #\n\b &IM %\n\b \u001eH$I \u001d\n\b \u001eH$I \u001d\n 4\n \u0006\u000e\f\r\u0014\u0007\n The coverage rates for influenza vaccination and related factors in Korean adults aged \u00100 and older Iith chronic disease: based on 201\u0011 \u001aommu-nity Health Survey data. Epidemiol Health \u0010\f\u0016<\u000e\f\r\u0014\f\u000f\u0010\n \u001f*$ \f\u000b.\u000f\f\u0012\u0013\nepih.e\r\u000b\f\u0013\u000b\u000e\u000f \u000f\u0014\n )ITS\u0018H\t*S*\u0018H \u001c\n\b \"$\\^BIAK $\n\b 2.S/K$WSKA \u001f\n <K 8C\n \u0006\u000e\f\r\u0013\u0007\n Influenza Vaccination \u001aoverage Among Polish Patients Iith \u001ahronic Diseases. Adv Exp Med Biol \u0015\u0012\u0014\u0016\r\u0015_\u000f\u0010\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\n\u0010\u0010\u0013\u000f1\r\u000b\f\u00111\f\u0014\u000e \u000f\u0015\n #$FSTETTER \u001c\n (\n\b \u001eAMARG$ .\n\b )ATARAJA# &\n\b -$SE#THA! .\n '\n\b .T$\u0018KWE!! (\n .\n \u0006\u000e\f\r\u0013\u0007\n Vac-cination \u001aoverage of Adolescents .ith \u001ahronic Medical \u001aonditions. Am J Prev Med \u0011\u000f\u0016\u0012\u0014\f_\u0012\u0014\u0014\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.amepre.\r\u000b\f\u0012.\u000b\u0012.\u000b\f\u0012 \u0010\f\n &AT/ \u001c\n\b (ARTE#S +\n\b \u001eHATEA* \u001f\n\b \u001d$G\u0019A#$VI\u0018 \u001d\n\b &$SEVA $\n \u0006\u000e\f\r\u0010\u0007\n Do primary care physi-cians coordinate ambulatory care for chronic disease patients in \u001aanada? BMC Fam Pract \r\u0011\u0016\r\u0010\u0014\n \u001f*$ \f\u000b.\f\f\u0013\u0011\n\f\u000f\u0012\f-\r\r\u0014\u0011-\f\u0010-\f\u000f\u0013 \u0010\r\n (*!R$W \u001e\n \u001f\n \u0006\r\u0015\u0015\u0010\u0007\n Rationale for systematic revieIs. BMJ \u000f\f\u0015\u0016\u0011\u0015\u0013_\u0011\u0015\u0015\n \u0010\u000e\n \u001e$\u0018HRA#E \u001e$!!AB$RATI$# \u0006\u000e\f\r\u0015\u0007\n \u001aochrane Strategy to 2020\n -erfNgbar unter\u0015 https\u0015\n\nwww.cochrane.org\nabout-us\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0010\u000f\n \"REE# .\n\b #IGGI#S %\n +\n /\n\b \u001c!\u0019ERS$# +\n\b \u001e!ARKE (\n\b (*!R$W \u001e\n \u001f\n\b *-MA# \u001c\n \u001f\n \u0006\u000e\f\r\r\u0007\n \u001ahaper 1: Introduction\n 1.2 Systematic revieIs\n $E\u0016 #IGGI#S %\n +\n /\n\b \"REE# .\n \u0006#IJ>\u0007 \u001aochrane Handbook for Systematic RevieIs of Interventions\b 1<IJiFE \u0011\n\r\n\f 6LG;8K<; (8I:? \u000e\f\r\r7 \u0010\u0010\n /H$MAS -\n  \n\b '$RE#/ETTI \u001f\n '\n \u0006\u000e\f\r\u0010\u0007\n Interventions to increase influenza vaccination rates of those \u00110 years and older in the community. Cochrane Database Syst Rev \u0013\n \u001f*$ Literatur \n 331  \f\u000b.\f\u000b\u000b\r\n\f\u000f\u0011\u0010\f\u0013\u0010\u0013.CD\u000b\u000b\u0010\f\u0013\u0013.pub\u000e \u0010\u0011\n .\u0018HMI\u0019 +\n\b -A*BER \u001f\n\b \u001dETS\u0018H \u001e\n\b 'I\u0019$!T \"\n\b \u001fE#KER (\n\t'\n \u0006\u000e\f\r\u0013\u0007\n Barriers of Influenza Vac-cination Intention and Behavior - A Systematic RevieI of Influenza Vaccine Hesitancy, 200\u0010 - 201\u0011. PLoS ONE \r\u000e\u0016<\f\r\u0013\f\u0011\u0011\f\n \u001f*$ \f\u000b.\f\u000e\u0012\f\n;ournal.pone.\u000b\f\u0012\u000b\u0010\u0010\u000b \u0010\u0012\n !X#H*S (\n .\n\b \u001fA!SBX /\n &\n\b %$HA#SE# (\n\b !RETHEIM \u001c\n\b .KIRBEKK #\n\b !!$TT$RP .\n \u001c\n \u0006\u000e\f\r\u0014\u0007\n Patient-mediated interventions to improve professional practice (RevieI). Cochrane Database Syst Rev \u0015\n \u001f*$ \f\u000b.\f\u000b\u000b\r\n\f\u000f\u0011\u0010\f\u0013\u0010\u0013.CD\u000b\f\r\u000f\u0012\r.pub\r \u0010\u0013\n %A\u0018$BS$# 1A## %\n \u001e\n\b %A\u0018$BS$# -\n (\n\b \u001e$.#E\t\u001dEAS!E. /\n\b \u001cSAF*\t\u001c\u0019JEI %\n &\n\b ./I!AG.I +\n \"\n \u0006\u000e\f\r\u0014\u0007\n Patient reminder and recall interventions to improve immunization rates (RevieI). Cochrane Database Syst Rev \r\u0016\u001e\u001f\f\f\u000f\u0015\u0010\r\n \u001f*$ \f\u000b.\f\u000b\u000b\r\n\f\u000f\u0011\u0010\f\u0013\u0010\u0013.CD\u000b\u000b\u000e\u0014\u000f\f.pub\u000e \u0010\u0014\n .A#FTE#BERG '\n\b \u001dR$MBA\u0018HER !\n\b \"E#SI\u0018HE# %\n \u0006\u000e\f\r\u0014\u0007\n A systematic revieI on strategies for increasing vaccination rates against influenza in patients Iith chronic diseases in primary care. +-*.+ -* \u000e\f\r\u0014 \u001e-\u001f\u0010\u000e\f\r\u0014\r\r\u0010\r\u0012\u000f\n -erfNgbar unter\u0015 http\u0015\n\nwww.crd.york.ac.uk\nPROSPERO\ndisplay1re-cord.php\u0017ID\u0016CRD\u000f\r\u000b\f\u0013\f\f\u000f\f\u0011\u000e \u0010\u0015\n 0#ITE\u0019 )ATI$#S .TATISTI\u0018S \u001fIVISI$# \u0006\u000e\f\r\u0015\u0007\n Methodology: Standard country or area codes for statistical use (M\u000f9)\n Developed regions\n -erfNgbar unter\u0015 https\u0015\n\nunstats.un.org\nunsd\nmethodology\nm\u000f\u0014\n\n 5LC<KQK ><GIX=K 8D \u000f\r\n %8EL8I \u000e\f\r\u0015\n \u0011\f\n \u001cMERI\u0018A# \u001cSS$\u0018IATI$# $F !AMI!. +H.SI\u0018IA#S \u0006\u001c\u001c!+\u0007 \u0006\u000e\f\r\u0014\u0007\n Primary \u001aare Policies\n Definition \u00021 - Primary \u001aare\n -erfNgbar unter\u0015 https\u0015\n\nwww.aafp.org\nabout\npolicies\nall\nprimary-care.html\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0011\r\n 2$!TERS &!*WER \u0006\u000e\f\r\u0015\u0007\n Ovid\n -erfNgbar unter\u0015 http\u0015\n\nwww.ovid.com\nsite\nindex.;sp\n 5LC<KQK ><GIX=K 8D \f\u0012\n (UIQ \u000e\f\r\u0015\n \u0011\u000e\n )ATI$#A! \u001eE#TER F$R \u001dI$TE\u0018H#$!$G. $#F$RMATI$# \u0006\u000e\f\r\u0015\u0007\n PubMed\n -erfNgbar unter\u0015 https\u0015\n\nwww.ncbi.nlm.nih.gov\npubmed\n\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0011\u000f\n \u001e$\u0018HRA#E \u001e$!!AB$RATI$# \u0006\u000e\f\r\u0015\u0007\n \u001aochrane #ibrary\n -erfNgbar unter\u0015 https\u0015\n\nwww.cochraneli-brary.com\n\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0011\u0010\n $#STIT*TE $F  \u0019*\u0018ATI$# .\u0018IE#\u0018ES \u0006\u000e\f\r\u0015\u0007\n ERI\u001a - Education Resources Information \u001aenter\n -erfNgbar unter\u0015 https\u0015\n\neric.ed.gov\n\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0011\u0011\n 0. )ATI$#A! 'IBRAR. $F (E\u0019I\u0018I#E \u0006\u000e\f\r\u0015\u0007\n \u001alinicalTrials.gov\n -erfNgbar unter\u0015 https\u0015\n\nclinicaltri-als.gov\n\n 5LC<KQK ><GIX=K 8D \r\r\n !<9IL8I \u000e\f\r\u0015\n Literatur  \n 331$  \u0011\u0012\n  *R$PEA# (E\u0019I\u0018I#ES \u001cGE#\u0018. \u0006\u000e\f\r\u0015\u0007\n EU \u001alinical Trials Register\n -erfNgbar unter\u0015 https\u0015\n\nwww.cli-nicaltrialsregister.eu\n\n 5LC<KQK ><GIX=K 8D \f\u000e\n \u001cGIiC \u000e\f\r\u0015\n \u0011\u0013\n \u001dRAMER 2\n (\n\b -ETH!EFSE# (\n '\n\b &!EIJ#E# %\n\b !RA#\u0018$ *\n #\n \u0006\u000e\f\r\u0013\u0007\n Optimal database combi-nations for literature searches in systematic revieIs: a prospective eJploratory study. Syst Rev \u0012\u0016\r_\r\u000e\n \u001f*$ \f\u000b.\f\f\u0013\u0011\ns\f\u000e\u0011\u000f\u000e-\u000b\f\u0012-\u000b\u0011\u000f\u000f-y \u0011\u0014\n \u001e$\u0018HRA#E \u001fE*TS\u0018H!A#\u0019\b \u001cRBEITSGEMEI#S\u0018HAFT \u0019ER 2ISSE#S\u0018HAFT!I\u0018HE# (E\u0019I/I#IS\u0018HE# !A\u0018HGESE!!S\u0018HAFTE# \t $#STIT*T FPR (E\u0019I/I#IS\u0018HES 2ISSE#SMA#AGEME#T\n \u0006\u000e\f\r\u0012\u0007\n BeIertung des Biasrisikos (Risiko systematischer Fehler) in klinischen Studien: ein Manual f\u00fcr die #eitli-nienerstellung, 1<IJiFE \r\n\f MFD \f\u0010\n\f\u0011\n\u000e\f\r\u0012\n -erfNgbar unter\u0015 http\u0015\n\nwww.cochrane.de\nde\nrob-manual \u0011\u0015\n ($HER \u001f\n\b 'IBERATI \u001c\n\b /ET/!AFF %\n\b \u001c!TMA# \u001f\n \"\n\b /HE +-$.(\u001c \"R$*P \u0006\u000e\f\f\u0015\u0007\n Preferred Re-porting Items for Systematic RevieIs and Meta-Analyses: The PRISMA Statement. PLoS Med \u0012\u0016<\r\f\f\f\f\u0015\u0013\n \u001f*$ \f\u000b.\f\u000e\u0012\f\n;ournal.pmed.\f\u000b\u000b\u000b\u000b\u0014\u0012 \u0012\f\n \u001f$##ER \u001c\n\b +IAGGI$ \"\n\b 1I!!AR %\n \u0006\u000e\f\f\r\u0007\n Statistical methods for the meta-analysis of cluster randomization trials. Stat Methods Med Res \r\f\u0016\u000f\u000e\u0011_\u000f\u000f\u0014\n \u001f*$ \f\u000b.\f\f\u0012\u0012\n\u000b\u0014\u0011\r\r\u0013\u000b\r\u000b\f\u000b\f\u000b\u000b\u000b\u0010\u000b\r \u0012\r\n \u001f$##ER \u001c\n\b +IAGGI$ \"\n\b 1I!!AR %\n \u0006\u000e\f\f\u000f\u0007\n Meta-analyses of cluster randomization trials. PoIer considerations. Eval Health Prof \u000e\u0012\u0016\u000f\u0010\f_\u000f\u0011\r\n \u001f*$ \f\u000b.\f\f\u0012\u0012\n\u000b\f\u0011\u000e\r\u0012\u0013\u0012\u000b\u000e\r\u0010\u0010\r\u000e\u000f \u0012\u000e\n \u001fIVI#E \"\n 2\n\b \u001dR$W# /\n %\n\b !RA/IER '\n (\n \u0006\r\u0015\u0015\u000e\u0007\n The Unit of Analysis Error in Studies about Physicians\u0004 Patient \u001aare Behavior. J Gen Int Med \u0013\u0016\u0012\u000e\u000f_\u0012\u000e\u0015\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\nBF\u000b\r\u0010\u0014\u0014\r\u000b\f \u0012\u000f\n 2EARS -\n '\n \u0006\u000e\f\f\u000e\u0007\n Advanced Statistics: Statistical Methods for Analyzing \u001aluster and \u001aluster-randomized Data. Acad Emerg Med \u0015\u0016\u000f\u000f\f_\u000f\u0010\r\n \u001f*$ \f\u000b.\f\f\u0014\u0012\naem;.\u0014.\u000f.\u000e\u000e\u000b \u0012\u0010\n .\u0018H*!/ &\n !\n\b \u001c!TMA# \u001f\n \"\n\b ($HER \u001f\n\b F$R THE \u001e*).*-/ \"R$*P \u0006\u000e\f\r\f\u0007\n \u001aO%SORT 2010 Statement\n updated guidelines for reporting parallel group randomised trials. BMJ \u000f\u0010\f\u0016:\u000f\u000f\u000e\n \u001f*$ \f\u000b.\f\f\u000e\u0011\nbm;.c\u000e\u000e\r \u0012\u0011\n -A#\u0019$!PH -\n \u001aO%SORT 2010 \u001ahecklist\n -erfNgbar unter\u0015 https\u0015\n\nwww.elsevier.com\n11data\npro-mis1misc\nCONSORT-\r\u000b\f\u000b-Checklist.pdf \u0012\u0012\n (A#T \u001f\n \u0006\u000e\f\f\u0014\u0007\n The problem Iith usual care. Br J Gen Pract \u0011\u0014\u0016\u0013\u0011\u0011_\u0013\u0011\u0012\n \u001f*$ \f\u000b.\u000e\u000e\u0014\u0014\nb;gp\u000b\u0013/\u000e\u000f\r\u0011\u000e\u000e \u0012\u0013\n .ME!T \u001c\n !\n #\n\b VA# \u0019ER 2EE!E \"\n (\n\b \u001d!$M %\n 2\n\b \"*SSEK!$$ %\n\b \u001cSSE#\u0019E!FT 2\n %\n %\n \u0006\u000e\f\r\f\u0007\n HoI usual is usual care in pragmatic intervention studies in primary care? An overvieI of recent trials. Br J Gen Pract \u0012\f\u0016<\u000f\f\u0011\t\r\u0014\n \u001f*$ \f\u000b.\u000e\u000e\u0014\u0014\nb;gp\f\u000b/\u0010\f\u000f\u0013\f\u0014 Literatur \n 331$$  \u0012\u0014\n \u001e$\u0018HRA#E  FFE\u0018TIVE +RA\u0018TI\u0018E A#\u0019 *RGA#ISATI$# $F \u001eARE -EVIEW \"R$*P \u0006 +*\u001e\u0007 \u0006\u000e\f\r\u0011\u0007\n EPO\u001a TaJonomy\n -erfNgbar unter\u0015 https\u0015\n\nepoc.cochrane.org\nepoc-taxonomy \u0012\u0015\n \u001dOHM &\n\b .\u0018HMI\u0019 \u001c\n\b \"OT/E -\n\b 'A#\u0019WEHR \u001e\n\b -$THGA#G #\n \u0006\u000e\f\r\u000f\u0007\n Five types of OE\u001aD healthcare systems\n Empirical results of a deductive classification. Health Policy \r\r\u000f\u0016\u000e\u0011\u0014_\u000e\u0012\u0015\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.healthpol.\r\u000b\f\u000e.\u000b\u0014.\u000b\u000b\u000e \u0013\f\n (A.HEW \u001c\n\b (\u0018\u001c*!E. '\n\b -AMSA. \u001e\n \u001aochrane Effective Practice and Organisation of \u001aare Re-vieI Group (EPO\u001a)\n Data \u001aollection \u001ahecklist\n -erfNgbar unter\u0015 https\u0015\n\nepoc.cochrane.org\nresources\nepoc-resources-review-authors \u0013\r\n \u001fEEKS %\n %\n\b #IGGI#S %\n +\n /\n\b \u001c!TMA# \u001f\n \"\n\b $# BEHA!F $F THE \u001e$\u0018HRA#E .TATISTI\u0018A! (ETH$\u0019S \"R$*P \u0006\u000e\f\r\r\u0007\n \u001ahapter 9: Analysing data and undertaking meta-analyses. $E\u0016 #IGGI#S %\n +\n /\n\b \"REE# .\n \u0006#IJ>\u0007 \u001aochrane Handbook for Systematic RevieIs of Interventions\b 1<IJiFE \u0011\n\r\n\f 6LG\t;8K<; (8I:? \u000e\f\r\r7 \u0013\u000e\n \u001cHME\u0019 !\n\b !RIE\u0019MA# \u001e\n\b !RA#KS \u001c\n <K 8C\n \u0006\u000e\f\f\u0010\u0007\n Effect of the FreCuency of Delivery of Remind-ers and an Influenza Tool Kit on Increasing Influenza Vaccination Rates Among Adults .ith High-risk \u001aonditions. Am J Manag Care \r\f\u0016\u0012\u0015\u0014_\u0013\f\u000e\n \u0013\u000f\n \u001dAKER \u001c\n (\n\b (\u0018\u001eARTH. \u001d\n\b \"*R!E. 1\n !\n\b 4$$\u0019 (\n 0\n \u0006\r\u0015\u0015\u0014\u0007\n Influenza Immunization in a Managed \u001aare Organization. J Gen Int Med \r\u000f\u0016\u0010\u0012\u0015_\u0010\u0013\u0011\n \u001f*$ \f\u000b.\f\u000b\u000f\u0011\n;.\f\u0010\r\u0010-\f\u000f\u0014\u0012.\f\u0014\u0014\u0013.\u000b\u000b\f\u000e\u0011.x \u0013\u0010\n \u001dE\u0018K \u001c\n\b .\u0018$TT %\n\b 2I!!IAMS +\n <K 8C\n \u0006\r\u0015\u0015\u0013\u0007\n A Randomized Trial of Group Outpatient Visits for \u001ahronically Ill Older HMO Members\n The \u001aooperative Health \u001aare \u001alinic. J Am Geriatr Soc \u0010\u0011\u0016\u0011\u0010\u000f_\u0011\u0010\u0015\n \u0013\u0011\n \u001eHAMBERS \u001e\n 1\n\b \u001dA!ABA# \u001f\n %\n\b \u001eAR!S$# \u001d\n '\n\b \"RASBERGER \u001f\n (\n \u0006\r\u0015\u0015\r\u0007\n The Effect Of Micro-computer-Generated Reminders On Influenza Vaccination Rates In A University-Based Family Practice \u001aenter. J Am Board Fam Med \u0010\u0016\r\u0015_\u000e\u0012\n \u0013\u0012\n #ERMI/ *\n\b \u001e$MI#$  \n\b (ARKS \"\n\b \u001fAFF*R# &\n\b 2I!S$# .\n\b #ARRIS (\n \u0006\u000e\f\f\u000e\u0007\n Randomised con-trolled trial of home based care of patients Iith chronic obstructive pulmonary disease. BMJ Online \u000f\u000e\u0011\u0016\u0015\u000f\u0014\n \u0013\u0013\n #ERRETT  \n\b 2I!!IAMS$#  \n\b VA# .TAA /\n <K 8C\n \u0006\u000e\f\r\u0012\u0007\n TeJt messaging reminders for influenza vaccine in primary care: a cluster randomised controlled trial (T/T\u000fF#U!AB). BMJ Open \u0012\u0016<\f\r\f\f\u0012\u0015\n \u001f*$ \f\u000b.\f\f\u000e\u0011\nbm;open-\r\u000b\f\u0010-\u000b\f\u000b\u000b\u0011\u0014 \u0013\u0014\n (ARK*# .\n\b -$SEMA## /\n\b \u001fA!!A\t'A#A &\n\b .TE*RER\t.TE. \u001e\n \u0006\u000e\f\r\u0014\u0007\n \u001aare in \u001ahronic Obstructive #ung Disease (\u001aARO#): a randomised trial in general practice. Eur Respir J \u0011\r\u0016\r\u0013\f\r\u0014\u0013\u000f\n \u001f*$ Literatur  \n 331$$$  \f\u000b.\f\f\u0013\u000e\n\f\u000e\u0014\u0014\u000e\u000b\u000b\u000e.\u000b\f\u0013\u0012\u000e-\r\u000b\f\u0012 \u0013\u0015\n ($RA# 2\n +\n\b )E!S$# &\n\b 2$FF$R\u0019 %\n '\n\b 1E!E/ -\n \u0006\r\u0015\u0015\u000e\u0007\n \u001aomputer-generated Mailed Remind-ers for Influenza Immunization\n A \u001alinical Trial. J Gen Int Med \u0013\u0016\u0011\u000f\u0011_\u0011\u000f\u0013\n \u0014\f\n ($RA# 2\n +\n\b )E!S$# &\n\b 2$FF$R\u0019 %\n '\n\b 1E!E/ -\n\b \u001eASE '\n \u001f\n \u0006\r\u0015\u0015\u0012\u0007\n Increasing Influenza Im-munization among High-Risk Patients\n Education or Financial Incentive? Am J Med \r\f\r\u0016\u0012\r\u000e_\u0012\u000e\f\n \u001f*$ \f\u000b.\f\u000b\f\u0011\ns\u000b\u000b\u000b\r-\u0014\u000e\u000f\u000e\u0004\u0014\u0011\u0005\u000b\u000b\u000e\r\u0012-\u000b \u0014\r\n (*!!$$!. %\n +\n \u0006\r\u0015\u0014\u0013\u0007\n Increasing Influenza Vaccination among High-Risk Elderly: A Random-ized \u001aontrolled Trial of a Mail \u001aue in an HMO Setting. Am J Public Health \u0013\u0013\u0016\u0012\u000e\u0012_\u0012\u000e\u0013\n \u0014\u000e\n -EGA# \u001c\n &\n\b \u001d!$$MFIE!\u0019 '\n\b +ETERS $\n\b  FF!ER +\n 1\n \u0006\u000e\f\r\u0013\u0007\n Randomized \u001aontrolled Trial of TeJt Message Reminders for Increasing Influenza Vaccination. Ann Fam Med \r\u0011\u0016\u0011\f\u0013_\u0011\r\u0010\n \u001f*$ \f\u000b.\f\u000e\u0012\u000b\nafm.\r\f\r\u000b \u0014\u000f\n .IRIWAR\u0019E#A )\n \u001c\n\b -ASHI\u0019 \u001c\n\b %$H#S$# (\n -\n \u001f\n\b \u001fEWE. (\n  \n \u0006\u000e\f\f\u000e\u0007\n \u001aluster randomised con-trolled trial of an educational outreach visit to improve influenza and pneumococcal immunisa-tion rates in primary care. Br J Gen Pract \u0011\u000e\u0016\u0013\u000f\u0011_\u0013\u0010\f\n \u0014\u0010\n .PA*!\u0019I#G .\n \u001c\n\b &*G!ER %\n +\n \u0006\r\u0015\u0015\r\u0007\n Influenza Immunization\n The Impact of %otifying Patients of High-Risk Status. J Fam Pract \u000f\u000f\u0016\u0010\u0015\u0011_\u0010\u0015\u0014\n \u0014\u0011\n /IER#E. 2\n (\n\b *VERHAGE %\n (\n\b (*RRA. (\n \u001f\n <K 8C\n \u0006\u000e\f\f\u0011\u0007\n \u001aan \u001aomputer-Generated Evidence-Based \u001aare Suggestions Enhance Evidence-Based Management of Asthma and \u001ahronic Ob-structive Pulmonary Disease? A Randomized, \u001aontrolled Trial. Health Serv Res \u0010\f\u0016\u0010\u0013\u0013_\u0010\u0015\u0013\n \u001f*$ \f\u000b.\f\f\f\f\n;.\f\u000f\u0012\u0010-\u0011\u0012\u0012\u000e.\r\u000b\u000b\u0010.\u000b\u000b\u000e\u0011\u0013.x \u0014\u0012\n 5WAR )\n \u001c\n\b \u001d*#KER %\n (\n\b -E\u0019\u0019E! #\n &\n <K 8C\n \u0006\u000e\f\r\u0012\u0007\n Early intervention for chronic obstructive pulmonary disease by practice nurse and GP teams\n a cluster randomized trial. Fam Pract \u000f\u000f\u0016\u0012\u0012\u000f_\u0012\u0013\f\n \u001f*$ \f\u000b.\f\u000b\u0014\u000e\nfampra\ncmw\u000b\u0012\u0012 \u0014\u0013\n !$RSET!*#\u0019 '\n\b \u001dJXR#\u0019A! \u001c\n\b -ASHI\u0019IA# \u001c\n <K 8C\n \u0006\u000e\f\f\u0015\u0007\n \u001aontinuing education meetings and Iorkshops\n effects on professional practice and health care outcomes. Cochrane Database Syst Rev \u000e\n \u001f*$ \f\u000b.\f\u000b\u000b\r\n\f\u000f\u0011\u0010\f\u0013\u0010\u0013.CD\u000b\u000b\u000e\u000b\u000e\u000b.pub\r \u0014\u0014\n &$VA\u0018S  \n\b .TR$B! -\n\b +HI!!IPS \u001c\n <K 8C\n \u0006\u000e\f\r\u0014\u0007\n Systematic RevieI and Meta-analysis of the Ef-fectiveness of Implementation Strategies for %on-communicable Disease Guidelines in Primary Health \u001aare. J Gen Int Med \u000f\u000f\u0016\r\r\u0010\u000e_\r\r\u0011\u0010\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\ns\f\f\u0011\u000b\u0011-\u000b\f\u0013-\u000f\u000f\u000e\u0010-\u0010 Literatur \n 33$3  \u0014\u0015\n (\u0018\u001f$#A!\u0019 \u001e\n %\n\b #*I .\n '\n\b .MITH \u001f\n (\n <K 8C\n \u0006\r\u0015\u0014\u0010\u0007\n Reminders to Physicians from an Introspec-tive \u001aomputer Medical Record\n A TIo-0ear Randomized Trial. Ann Intern Med \r\f\f\u0016\r\u000f\f_\r\u000f\u0014\n \u001f*$ \f\u000b.\u0012\u000e\r\u0011\n\u000b\u000b\u000b\u000e-\u000f\u0013\f\u0014-\f\u000b\u000b-\f-\f\u000e\u000b \u0015\f\n (\u0018\u001f$#A!\u0019 \u001e\n %\n\b #*I .\n '\n\b /IER#E. 2\n (\n \u0006\r\u0015\u0015\u000e\u0007\n Effects of computer reminders for influenza vaccination on morbidity during influenza epidemics. MD Comput \u0015\u0016\u000f\f\u0010_\u000f\r\u000e\n \u0015\r\n \u001dART$# (\n \u001d\n\b .\u0018H$E#BA*M .\n \u001e\n \u0006\r\u0015\u0015\f\u0007\n Improving Influenza Vaccination Performance in an HMO Setting: The Use of \u001aomputer-Generated Reminders and Peer \u001aomparison Feedback. Am J Public Health \u0014\f\u0016\u0011\u000f\u0010_\u0011\u000f\u0012\n \u001f*$ \f\u000b.\r\f\u000b\u0010\nAJPH.\u0013\u000b.\u0010.\u0010\u000e\u000f \u0015\u000e\n .\u0018HE!!I#G %\n\b /H$RVA!\u0019SS$# $\n\b .A#FTE#BERG '\n \u0006\u000e\f\r\u0015\u0007\n Elektronische Impfmanagementsys-teme in der PraJis zur Verbesserung der ImpfCuoten. Bundesgesundheitsbl \r\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\ns\u000b\u000b\f\u000b\u000e-\u000b\f\u0014-\u000b\r\u0014\f\r-\r \u0015\u000f\n .HEKE!!E +\n \"\n\b .T$#E  \n \"\n\b (AG!I$#E (\n \u001c\n <K 8C\n \u0006\u000e\f\f\u000f\u0007\n Interventions that Increase the Utili-zation of Medicare-Funded Preventive Services for Persons Age \u0011\u0010 and Older. RAND \u0015\u0010\n .T$#E  \n \"\n\b ($RT$# .\n \u001e\n\b #*!S\u0018HER (\n  \n <K 8C\n \u0006\u000e\f\f\u000e\u0007\n Interventions That Increase Use of Adult Immunization and \u001aancer Screening Services: A Meta-Analysis. Ann Intern Med \r\u000f\u0012\u0016\u0012\u0010\r_\u0012\u0011\r\n \u0015\u0011\n #AMI#E .\n\b \"ERTH\t\"*.ETTE  \n\b !A*!- \u001f\n\b \"REE# \u001d\n \u001d\n\b \"I#SB*RG \u001c\n .\n \u0006\u000e\f\r\u0011\u0007\n Impact of mHealth \u001ahronic Disease Management on Treatment Adherence and Patient Outcomes\n A Sys-tematic RevieI. J Med Internet Res \r\u0013\u0016<\u0011\u000e\n \u001f*$ \f\u000b.\r\f\u0014\u0011\n;mir.\u000e\u0014\u0010\f \u0015\u0012\n .T$\u0018KWE!! (\n .\n\b &HARBA#\u0019A  \n *\n\b (ARTI#E/ -\n \u001c\n \u0006\u000e\f\r\u000e\u0007\n Effect of a TeJt Messaging Inter-vention on Influenza Vaccination in an Urban, #oI-Income Pediatric and Adolescent Popula-tion. JAMA \u000f\f\u0013\u0016\r\u0013\f\u000e_\r\u0013\f\u0014\n \u001f*$ \f\u000b.\f\u000b\u000b\f\n;ama.\r\u000b\f\r.\u0010\u000b\r \u0015\u0013\n #AASE )\n\b \u001dETS\u0018H \u001e\n\b -E#KEWIT/ !\n \u0006\u000e\f\r\u0011\u0007\n Source \u001aredibility and the Biasing Effect of %arra-tive Information on the Perception of Vaccination Risks. J Health Commun \u000e\f\u0016\u0015\u000e\f_\u0015\u000e\u0015\n \u001f*$ \f\u000b.\f\u000b\u0013\u000b\n\f\u000b\u0013\f\u000b\u0012\u000e\u000b.\r\u000b\f\u0010.\f\u000b\f\u0013\u0011\u000b\u0010 \u0015\u0014\n \u001dA!AKRISH#A# 1\n .\n \u0006\u000e\f\r\u0011\u0007\n PhysiciansU recommendation affects HPV vaccination uptake. Lancet Oncol \r\u0012\u0016<\u0011\u0015\u000e\n \u001f*$ \f\u000b.\f\f\u0010\u0013\n\f\u000b\u0010\u0010-\u0014\u0014\u0011\u0010.EPI-\f\u0010-\u000b\u000e\r\u0011 \u0015\u0015\n #SWE# 4\n\b \"I!KE. (\n \u001d\n\b -IMER \u001d\n &\n\b \u001dREWER )\n /\n \u0006\u000e\f\r\u0013\u0007\n Improving physician recommenda-tions for HPV vaccination: The role of professional organizations. Sex Transm Dis \u0010\u0010\u0016\u0010\u000e_\u0010\u0013\n \u001f*$ \f\u000b.\f\u000b\u0014\u0012\nOLQ.\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u000b\u0010\u000f\u000e Literatur  \n 333  \r\f\f\n #ARRIS$# )\n\b +$EPP! 2\n\b #ERK#ER #\n <K 8C\n \u0006\u000e\f\r\u0013\u0007\n Predictors for and coverage of influenza vac-cination among HIV-positive patients\n a cross-sectional survey. HI- Med \r\u0014\u0016\u0011\f\f_\u0011\f\u0012\n \u001f*$ \f\u000b.\f\f\f\f\nhiv.\f\r\u000f\u0013\u000e \r\f\r\n #$ #\n %\n\b \u001eHA# 4\n 4\n\b $BRAHIM (\n \u001c\n \u001d\n\b 2AG!E \u001c\n \u001c\n\b 2$#G \u001e\n (\n\b \u001eH$W \u001c\n \u0006\u000e\f\r\u0013\u0007\n A formative research-guided educational intervention to improve the knoIledge and attitudes of seniors to-Iards influenza and pneumococcal vaccinations. -accine \u000f\u0011\u0016\u0012\u000f\u0012\u0013_\u0012\u000f\u0013\u0010\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vac-cine.\r\u000b\f\u0012.\f\u000b.\u000b\u000b\u0010 \r\f\u000e\n \u001c!TA. (\n\b \u001cTE] d\n\b \u001c!TA. !\n \u001c\n\b &AP!A# (\n\b \u001cKMA S\n\b S/KARA \u001c\n \u0006\u000e\f\r\u0012\u0007\n Does education effect the rates of prophylactic vaccination in elderly diabetics? Diabetes Res Clin Pract \r\u000e\f\u0016\r\r\u0013_\r\u000e\u000f\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.diabres.\r\u000b\f\u0011.\u000b\u0013.\u000b\u000b\r \r\f\u000f\n .&*IRES %\n  \n\b .*!!IVA# &\n\b  \u0018\u0018!ES (\n +\n\b 2$RSWI\u0018K %\n\b \"RIMSHAW %\n (\n \u0006\u000e\f\r\u0010\u0007\n Are multifaceted interventions more effective than single-component interventions in changing health-care pro-fessionalsU behaviours? An overvieI of systematic revieIs. Imp Sci \u0015\u0016\r\u0011\u000e\n \r\f\u0010\n \u001d$\u0019E#HEIMER /\n\b 2AG#ER  \n #\n\b \"R*MBA\u0018H &\n \u0006\u000e\f\f\u000e\u0007\n Improving Primary \u001aare for Patients .ith \u001ahronic Illness\n The \u001ahronic \u001aare Model, Part 2. JAMA \u000e\u0014\u0014\u0016\r\u0015\f\u0015_\r\u0015\r\u0010\n \u001f*$ \f\u000b.\f\u000b\u000b\f\n;ama.\r\u0013\u0013.\f\u000f.\f\u0012\u0012\u0010 \r\f\u0011\n /A##ER (\n \u0006\u000e\f\f\u0014\u0007\n The Grass Is %ot AlIays Greener\n A #ook at %ational Health \u001aare Systems Around the .orld. Cato Policy Analysis Paper \u0012\r\u000f\u0016\r_\u0010\u0014\n \r\f\u0012\n 2IKIPE\u0019IA \u0006\u000e\f\r\u0015\u0007\n Paramedics in the United States\n -erfNgbar unter\u0015 https\u0015\n\nen.wikipedia.org\nw\nin-dex.php\u0017oldid\u0016\u0013\u0011\u000f\u0010\f\u0013\u0012\r\u0014\n 5LC<KQK ><GIX=K 8D \f\u0013\n (UIQ \u000e\f\r\u0015\n \r\f\u0013\n %IMN#E/\t\"AR\u0018IA -\n\b '$PE/\t\u0019E\t\u001c#\u0019RES \u001c\n\b #ER#A#\u0019E/\t\u001dARRERA 1\n <K 8C\n \u0006\u000e\f\r\u0013\u0007\n Influenza vac-cination in people Iith type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a \u0012years folloI up study. -accine \u000f\u0011\u0016\r\f\r_\r\f\u0014\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vac-cine.\r\u000b\f\u0011.\f\f.\u000b\u000e\u0014 \r\f\u0014\n .HI# #\n\t4\n\b \u001eH*#G %\n #\n\b #WA#G #\n\t%\n\b &IM /\n #\n \u0006\u000e\f\r\u0014\u0007\n Factors influencing on influenza vac-cination and its trends of coverage in patients Iith diabetes in Korea: A population-based cross-sectional study. -accine \u000f\u0012\u0016\u0015\r_\u0015\u0013\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vaccine.\r\u000b\f\u0012.\f\f.\u000b\u000e\u0010 \r\f\u0015\n &!ASSI#G #\n (\n\b -*ISI#GER %\n !\n\b +R$HASKA  \n .\n\b (E!T$# \u001d\n '\n \u0006\u000e\f\r\u0014\u0007\n Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients Iith Asthma or \u001aOPD. J Community Health \u0010\u000f\u0016\u000e\u0015\u0013_\u000f\f\u000f\n \u001f*$ \f\u000b.\f\u000b\u000b\u0012\ns\f\u000b\u0014\u000b\u000b-\u000b\f\u0012-\u000b\u000f\r\f-\u0014 Literatur \n 333$  \r\r\f\n \u001eR$\u0018KER\t\u001d*&*E /\n\b  \u0019E!STEI# (\n\b ($*#IER\t%A\u0018K .\n \u0006\u000e\f\r\u0013\u0007\n Interventions to reduce ineCuali-ties in vaccine uptake in children and adolescents aged \u001619 years: a systematic revieI. J Epidemiol Community Health \u0013\r\u0016\u0014\u0013_\u0015\u0013\n \u001f*$ \f\u000b.\f\f\u000e\u0011\n;ech-\r\u000b\f\u0011-\r\u000b\u0012\u0010\u0012\r \r\r\r\n #ARVE. #\n\b -EISS!A#\u0019 )\n\b (AS$# %\n \u0006\u000e\f\r\u0011\u0007\n Parental reminder, recall and educational interven-tions to improve early childhood immunisation uptake: A systematic revieI and meta-analysis. -accine \u000f\u000f\u0016\u000e\u0014\u0012\u000e_\u000e\u0014\u0014\f\n \u001f*$ \f\u000b.\f\u000b\f\u0011\n;.vaccine.\r\u000b\f\u0010.\u000b\u000f.\u000b\u0013\u0010 \r\r\u000e\n 2IKIPE\u0019IA \u0006\u000e\f\r\u0015\u0007\n \u001aeiling-Effekt (Pharmakologie)\n -erfNgbar unter\u0015 https\u0015\n\nde.wikipedia.org\nw\nin-dex.php\u0017oldid\u0016\f\u0012\u0014\u000b\u000e\f\u000f\u000b\u0012\n 5LC<KQK ><GIX=K 8D \u000e\u0012\n !<9IL8I \u000e\f\r\u0015\n \r\r\u000f\n 2IKIPE\u0019IA \u0006\u000e\f\r\u0015\u0007\n Deckeneffekt\n -erfNgbar unter\u0015 https\u0015\n\nde.wikipedia.org\nw\nindex.php\u0017oldid\u0016\f\u0012\u0014\u000b\u000e\u000b\u000f\u000b\u0013\n 5LC<KQK ><GIX=K 8D \f\r\n (UIQ \u000e\f\r\u0015\n \r\r\u0010\n &RIEGER %\n 2\n\b \u001eAST$RI#A %\n .\n\b 2A!!S (\n '\n\b 2EAVER (\n -\n\b \u001eISKE .\n \u0006\u000e\f\f\f\u0007\n Increasing Influenza and Pneumococcal Immunization Rates: A Randomized \u001aontrolled Study of a Senior \u001aenter\u2013Based Intervention. Am J Prev Med \r\u0014\u0016\r\u000e\u000f_\r\u000f\r\n \r\r\u0011\n (ARSHA!! \"\n .\n\b #APPE '\n  \n\b '*#A\u0018SEK *\n  \n <K 8C\n \u0006\u000e\f\f\u0013\u0007\n Use of \u001aombination Vaccines Is As-sociated .ith Improved \u001aoverage Rates. Pediatr Infect Dis J \u000e\u0012\u0016\u0010\u0015\u0012_\u0011\f\f\n \u001f*$ \f\u000b.\f\u000b\u0014\u0012\nINF.\u000bb\u000b\f\u000ee\u000e\f\u0013\u000b\u0010d\u0012f\f\u0012 \r\r\u0012\n .MITH \u001f\n -\n\b VA# \u001e!EAVE \u001d\n \u0006\u000e\f\r\u000e\u0007\n Influenza Vaccination as a \u001aondition of Employment for a #arge Regional Health \u001aare System. WMJ \r\r\r\u0016\u0012\u0014_\u0013\r\n \r\r\u0013\n (A \u001e\n\b 'I !\n\b 5HE#G 3\n <K 8C\n \u0006\u000e\f\r\u0011\u0007\n Measles vaccine coverage estimates in an outbreak three years after the nation-Iide campaign in \u001ahina: implications for measles elimination, 2013. BMC Infect Dis \r\u0011\u0016\u000e\u000f\n \u001f*$ \f\u000b.\f\f\u0013\u0011\ns\f\r\u0013\u0012\u0014-\u000b\f\u0010-\u000b\u0012\u0010\r-z \r\r\u0014\n \u001fIE .\u0018HWE##I#GER &RA#KE#KASSE \u0006\u000e\f\r\u0015\u0007\n Gesundheit 2019 - BevOlkerungsrepr\u00e4sentative Um-frage zum Thema Impfen\n -erfNgbar unter\u0015 http\u0015\n\npresse.die-schwenninger.de\nfileadmin\npresse\nuser1up-load\nStudien\nSKK1\f\u0014\u000b\r\f\u000f1Umfrage1Impfen1PDF1Web.pdf \r\r\u0015\n .TER#E %\n \u001c\n \u001e\n\b  GGER (\n\b ($HER \u001f\n\b $# BEHA!F $F THE \u001e$\u0018HRA#E \u001dIAS (ETH$\u0019S \"R$*P \u0006\u000e\f\r\r\u0007\n \u001ahapter 10: Addressing reporting biases\n 10.\u000f Detecting reporting biases\n $E\u0016 #IGGI#S %\n +\n /\n\b \"REE# .\n \u0006#IJ>\u0007 \u001aochrane Handbook for Systematic RevieIs of Interventions\b 1<IJiFE \u0011\n\r\n\f 6LG;8K<; (8I:? \u000e\f\r\r7 \r\u000e\f\n +ITT!ER (\n #\n\b \u001d!PM!E \u001c\n\b (EERP$H! %\n %\n\b \u001c#TES \"\n \u0006\u000e\f\r\r\u0007\n \u001aO%SORT 2010: Aktualisierte #eit-linie f\u00fcr Berichte randomisierter Studien im Parallelgruppen-Design. Dtsch med Wochenschr \r\u000f\u0012\u0016<\u000e\f\t<\u000e\u000f\n \u001f*$ \f\u000b.\f\u000b\u0010\u0010\ns-\u000b\u000b\u000e\f-\f\r\u0012\r\u0014\u0013\u000b Literatur  \n 333$$  \r\u000e\r\n .HAMSEER ' \u0006\u000e\f\r\u0015\u0007\n PRISMA German checklist\n -erfNgbar unter\u0015 http\u0015\n\nwww.prisma-state-ment.org\ndocuments\nPRISMA\u0002\r\u000bGerman\u0002\r\u000bchecklist.pdf\n 5LC<KQK ><GIX=K 8D \r\r\n !<9IL8I \u000e\f\r\u0015\n \r\u000e\u000e\n .A#FTE#BERG '\n\b \u001dR$MBA\u0018HER !\n\b .\u0018HE!!I#G %\n ET A!\n \u0006\u000e\f\r\u0015\u0007\n Increasing influenza vaccination rates in people Iith chronic illness - a systematic revieI of measures in primary care. Dtsch Arz-tebl Int \r\r\u0012\u0016\u0012\u0010\u0011_\u0011\u000e\n \u001f*$\u0016 \f\u000b.\u000e\r\u000e\u0013\narztebl.\r\u000b\f\u0014.\u000b\u0011\u000f\u0010 \r\u000e\u000f\n \u001dR$MBA\u0018HER !\n\b .A#FTE#BERG '\n\b &!*G .\n%\n ET A!\n \u0006\u000e\f\u000e\r\u0007\n Impfen gegen Influenza \u2013 Internatio-nale Bestandsaufnahme und Perspektiven f\u00fcr Deutschland. 0EFQ \r\u0012\r\u0016 \u0010\u000e\t\u0010\u0015\n \u001f*$\u0016 \f\u000b.\f\u000b\f\u0011\n;.zefB.\r\u000b\r\f.\u000b\f.\u000b\u000b\u0012   ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}